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Abstract 
 
The work detailed herein describes the developments made using electrons to 
initiate bond dissociation via electronic excitation.  Electron Capture Dissociation 
(ECD) uses low energy electrons to analyse multiply charged cations, providing a 
complementary series of product ions to vibrational excitation techniques Collision-
Induced Dissociation (CID) and Infrared Multiphoton Dissociation (IRMPD).  ECD 
has been adapted to analyse small singly charged ions by increasing the electron 
energy, known as Electron-Induced Dissociation (EID).  The effect of electron 
energy has been studied, indicating optimal results occurring at 18 - 20 eV.  EID has 
been carried out on a range of small organic molecules, resulting in a high degree of 
fragmentation.  EID results suggest that bond dissociation can occur via multiple 
dissociation mechanisms, forming a combination of odd-electron and even-electron 
species, resulting in a unique set of product ions.  Developments have been made 
to combine Liquid Chromatography (LC) with EID in order to analyse complex 
mixtures of small organic molecules with a wide dynamic concentration range.  In-
depth analysis has been carried out by LC-EID and LC-CID on the pharmaceutical 
reaction mixture of cediranib, allowing structural inferences to be made for the ten 
unknown low abundance components observed in the sample, proving each 
compound to be analogous to cediranib. 
 
Investigations of protein modifications have focussed on two proteins; the Multiple 
transferrable resistance Regulator (MtrR) protein and the Matrix (M) protein.  ECD 
and CID successfully identified and located an insertion on the flexible N-terminus of 
the M protein that could not be resolved by X-ray crystallography.  Mass 
spectrometry analysis has been used to identify the chemical alterations of both 
proteins resulting from reactions with small molecules, and ECD has been used to 
confirm the location of the reaction site for one modified peptide. 
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Abbreviations 
 
AC Alternating Current 
AGC Automatic Gain Control 
AI ECD Activated Ion Electron Capture Dissociation 
APCI Atmospheric Pressure Chemical Ionisation 
ASAP Atmospheric pressure Solids Analysis Probe 
CAD Collision-Activated Dissociation 
CID Collision-Induced Dissociation 
DBE Double Bond Equivalents (otherwise known as RDB) 
DC Direct Current 
DI Direct Infusion 
DTT Dithiothreitol 
ECD Electron Capture Dissociation 
EDD Electron Detachment Dissociation 
EI Electron Ionisation 
EID Electron-Induced Dissociation 
EIEIO Electron-Impact Excitation of Ions from Inorganics 
EE Electronic Excitation 
EED Electronic Excitation Dissociation 
ETD Electron Transfer Dissociation 
ESI Electrospray Ionisation 
FT Fourier-Transform 
FT-ICR Fourier Transform-Ion Cyclotron Resonance 
FWHM Full-Width-at-Half-Maximum 
GC Gas Chromatography 
hECD Hot Electron-Capture Dissociation 
HPLC High Performance Liquid Chromatography 
hRSV Human Respiratory Syncytial Virus 
IRMPD Infrared Multiphoton Dissociation 
IR Infrared 
IT Ion Trap 
LC Liquid Chromatography 
LOD Limit of Detection 
M Matrix [protein] 
MALDI Matrix-Assisted Laser Desorption/Ionisation 
MS Mass Spectrometry 
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MS/MS Tandem Mass Spectrometry 
MtrR Multiple transferrable resistance Regulator [protein] 
NBD-Cl 4-Chloro-7-nitrobenzofurazan 
niECD Negative Ion Electron Capture Dissociation 
PDS Photodissociation Spectroscopy 
PTM Post-Translational Modification 
QET Quasi-Equilibrium Theory 
QToF Quadrupole Time-of-Flight 
RDB Ring-plus-Double Bonds (otherwise known as DBE) 
R.I. Relative Intensity 
S/N Signal-to-Noise 
TFA Trifluoroacetic acid 
Tris Tris(hydroxymethyl)aminomethane 
ToF Time-of-Flight 
UV Ultra-Violet 
VE Vibrational Excitation 
 
 
Amino Acid Abbreviations 
 
Name 3-letter abv 1-letter abv Molecular Formula 
Alanine Ala A C3H5NO 
Arginine Arg R C6H12N4O 
Asparagine Asn N C4H6N2O2 
Aspartic Acid Asp D C4H5NO3 
Cysteine Cys C C3H5NOS 
Glutamic Acid Glu E C5H7NO3 
Glutamine Gln Q C5H8N2O2 
Glycine Gly G C2H3NO 
Histidine His H C6H7N3O 
Isoleucine Ile I C6H11NO 
Leucine Leu L C6H11NO 
Lysine Lys K C6H12N2O 
Methionine Met M C5H9NOS 
Phenylalanine Phe F C9H9NO 
Proline Pro P C5H7NO 
Serine Ser S C3H5NO2 
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Threonine Thr T C4H7NO2 
Tryptophan Trp W C11H10N2O 
Tyrosine Tyr Y C9H9NO2 
Valine Val V C5H9NO 
 
Units 
°C Degrees Celsius 
A Ampere 
Å  Ångström 
Da Dalton 
eV Electron Volt 
hr Hour 
keV Kilo Electron Volt 
kV Kilovolt 
L Litres 
M Molarity in Moles per Litre 
min Minute 
mg Milligram 
mL Millilitre 
mM Millimole 
mm Millimetre 
mmu Milli Mass Units 
ms Millisecond 
m/z Mass-to-Charge  
nm Nanometre 
pg Picogram 
pM Picomole 
ppm Parts-Per-Million 
psi Pounds-per-Square-Inch 
s Second 
T Tesla 
µg Microgram 
µL Microlitre 
µM Micromole 
µm Micrometre 
V Volt 
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1. Introduction 
 
1.1. Mass Spectrometry 
Over the last century the use of mass spectrometry has grown in popularity, 
performance and functionality, resulting in it becoming an indispensible and 
informative analytical technique.  Mass spectrometry separates and detects sample 
ions according to their mass-to-charge (m/z) ratios, allowing the molecular weight of 
the observed ions to be calculated and thereby confirming or refuting the identity of 
expected samples, or helping to identify unknown samples.  The first mass spectra 
were recorded by J. J. Thomson in 1912, detecting atomic and diatomic ions hitting 
a photographic plate to generate a spectrum of charge-to-mass.1  Since then, mass 
spectrometric analysis has advanced exponentially, generating MS data for > 100 
kDa biological molecules and generating data that is accurate enough to suggest or 
confirm elemental composition.  Major developments over the last forty years have 
included the advent of Electrospray Ionisation (ESI) and Matrix-Assisted Laser 
Desorption/Ionisation (MALDI), two methods of sample ionisation that have 
revolutionised the MS analysis of macromolecules.  Both discoveries resulted in the 
presentation of the 2002 Nobel Prize for Chemistry to the pioneers John Fenn2-6 and 
Koichi Tanaka7-8 for ground-breaking developments in ESI and MALDI respectively.  
Other notable accomplishments include the development of high mass accuracy and 
resolving power MS instruments, such as Fourier Transform-Ion Cyclotron 
Resonance (FT-ICR)9 and the Orbitrap mass spectrometer10, both of which measure 
the frequency of ion precession within an ion-trapping cell, as opposed to directly 
measuring the mass-to-charge ratio, allowing ions to be detected with much higher 
mass accuracy. 11  The high mass accuracy and resolving power capabilities 
become particularly useful when analysing unknown compounds, complex mixtures 
or performing tandem mass spectrometry.12 
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The resolving power of an instrument, defined in Equation 1.1, is a key 
performance factor used to describe the ability to separate two ions with a very 
small mass difference at a defined peak height; where R is the resolution or 
resolving power, m is the mass of the peaks and Δm is the difference between the 
maxima of two resolved peaks, shown in Figure  1.1(a) to be separated at 10% peak 
height.  Using this definition, an instrument with a resolving power of 100,000 
FWHM would be able to fully resolve two peaks with a mass difference of 0.004 Da 
at m/z 400.   
 
 
Δm
m
R    Equation ‎1.1 
 
The mass resolution of an isolated peak can also be described by Equation 1.1, 
where Δm is the peak width at 50% of the peak height, as shown in Figure  1.1(b), 
known as the full width at half-maximum (FWHM).  Using the FWHM definition, a 
peak at m/z 400 detected using an instrument with a resolving power of 100,000 
FWHM would have a peak width of m/z 0.004 at 50% peak height.13   
 
 
 
Figure ‎1.1: Diagram illustrating (a) the resolving power defined as the ability to 
distinguish between two peaks at a defined peak height and (b) the resolution 
of an isolated peak.  
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The mass accuracy of an instrument can have a significant effect on the ability to 
interpret the resulting mass spectra.  Instruments with high resolving power, mass 
accuracy and precision can be used to predict or confirm the elemental composition 
of ions from their measured m/z ratios, and could distinguish between ions with the 
same nominal m/z, such as CO2 (m/z 43.98928) and CH3CHO (m/z 44.02567).  The 
accuracy of the proposed molecular formula of an ion is quoted in parts-per-million 
(ppm), and can be determined by calculating the difference between the theoretical 
m/z of the molecular formula and the observed m/z using Equation 1.2 and 
Equation 1.3.14  
  
 Δ m/z = (Observed m/z) – (Theoretical m/z) Equation ‎1.2 
 
 Accuracy (in ppm) = 
zm
zmΔ
lTheoretica
 x 1000000 Equation ‎1.3 
 
Tandem mass spectrometry, often known as MS/MS or MSn, increases the amount 
of elemental and structural information that can be gleaned from a compound of 
interest by isolating specific ions in the mass spectrometer and increasing the 
internal energy of the ion in order to induce bond dissociation.  The resulting product 
ions can provide important information regarding the structure of the precursor ion 
and can be performed on a similar timescale to that of full MS analysis.15  The vast 
amount of structural and elemental information that it can provide has resulted in it 
becoming a well established technique with a wide range of applications in 
industries including pharmaceutical, agricultural, petroleum, plastics, biochemical, 
and many more.  The hyphenation of chromatography, such as Liquid 
Chromatography (LC) or Gas Chromatography (GC), with MS/MS furthers the 
analysis of complex mixtures, including those with components spanning a wide 
dynamic concentration range, by utilising the benefits gained from chromatographic 
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separation of compounds prior to ionisation so as to minimise any interference or 
suppression between compounds.  LC-MS/MS analyses are often carried out by 
alternating MS and MS/MS scans, allowing data to be generated regarding the intact 
sample ions and the product ions so as to maximise the amount of information that 
can be acquired during one experiment, reducing the turn-around time for analyses.  
Typically, the duration of LC peaks is measured over the range of a few seconds, 
thereby requiring MS/MS techniques capable of operating over a millisecond 
range.16-22   
 
1.2. Collision-Induced Dissociation (CID) 
Collision-Induced Dissociation, sometimes referred to as Collision Activated 
Dissociation (CAD), involves the excitation of sample ions through inelastic 
collisions with a neutral gas molecule such as helium or argon.  Each collisions 
causes the transfer of energy from the gas to the ion, increasing the internal energy 
of the ion and creating a vibrationally excited intermediate state.23-24  The vibrational 
energy is rapidly redistributed throughout the ion resulting in bond dissociation via 
the lowest energy pathways, breaking the weakest bonds in the molecule.  The 
centre-of-mass collision energy is the maximum amount of energy that can be 
transferred between the collision gas and the ion, as dictated by the masses and 
velocities of each.  The greater the mass of the collision gas, the greater the amount 
of energy that can be transferred to the ion, and therefore the centre-of-mass 
collision energy is increased.15, 25  Quasi-Equilibrium Theory (QET) explains 
unimolecular bond dissociation in a high vacuum, stating that energy can be 
redistributed throughout all available degrees of freedom, such as rotational, 
electronic, vibrational and translational motion, making each microscopic state for 
the molecular ion equally possible.  Additionally, QET states that the energy barrier 
between the precursor ion and product ions is unidirectional, therefore the bond 
dissociation is irreversible.23, 26  The tendency for CID to follow the lowest energy 
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fragmentation pathways in the molecule often impedes structural characterisation, 
by preferentially cleaving certain weak bonds in the precursor ion and providing 
limited information.27  Altering certain instrumental factors such as the collision gas 
or type of mass analyser can have a significant effect on the resultant product ion 
spectra.  By using argon instead of helium, the size and mass of the neutral gas 
molecule is increased, resulting in greater centre-of-mass collision energy and 
therefore more energy transferred to the precursor ions upon collision, potentially 
increasing the allowed fragmentation pathways by permitting dissociation via higher 
energy routes.15  Collision cells allow ions to travel the length of the cell through the 
collision gas prior to detection, allowing the possibility of multiple collisions, multiple 
bond cleavages and secondary product ion fragmentation (akin to MSn).  
Conversely, ion/neutral collisions in ion traps result in less stable product ions that 
are ejected from the trap, reducing the probability of multiple collisions.28  Although 
not as common, CID can be performed in the FT-ICR cell, a technique known as 
Sustained Off-Resonance Irradiation Collision-Induced Dissociation (SORI-CID), 
which requires the introduction of a collision gas into the FT-ICR cell.  SORI-CID 
involves the excitation of the precursor ion at an RF voltage marginally above or 
below the ion cyclotron frequency.  This off-resonance excitation causes the kinetic 
energy and the radius of ion motion to oscillate, and results in collisions between the 
precursor ion and the collision gas.  The product ions generated by the collisions 
relax towards the centre of the FT-ICR cell until they can be detected.  SORI-CID is 
not commonly used due to the disruption caused to the high vacuum system as the 
collision gas is introduced into the cell, requiring additional time to remove the 
collision gas and re-equilibrate the vacuum prior to ion detection, typically 2 - 3 
seconds, which drastically increases the scan time.25  
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1.3. Infrared Multiphoton Dissociation (IRMPD) 
Infrared Multiphoton Dissociation is a method of photodissociation that uses an 
infrared laser, for the purpose of this project a CO2 laser of wavelength 10.6 µm, to 
increase the internal energy of trapped ions to create a vibrationally excited state 
that releases energy via bond dissociation.  The laser introduces photons that are 
absorbed by the ion(s) of interest, each of which corresponds to 0.117 eV of energy, 
as calculated using Planck’s equation detailed in Equation 1.4; where h represents 
Planck’s constant (4.136 x 10-15 eV s-1)†, c is the speed of light (3 x 10-8 m s-1) and λ 
correspond to the wavelength of the laser (10.6 x 10-6 m).  
 
 E = 
λ
hc
 Equation ‎1.4 
 
Each absorbed photon contributes towards the stepwise activation of the ion 
gradually increasing the vibrational energy of the ion until it reaches its excited state.  
In order for bond dissociation to occur, the rate of energy absorption must be faster 
than the redistribution of energy throughout the ion.  Once the internal energy 
increases beyond the lowest energy bond dissociation threshold, the rapid internal 
vibrational energy redistribution results in the cleavage of the weakest bonds.  
IRMPD does not require the presence of a collision gas in order to induce 
fragmentation, and therefore can be carried out in an FT-ICR cell without the loss of 
resolution caused by introducing a collision gas and disrupting the vacuum in the 
cell.15, 29-31   
 
                                               
†
 Planck’s constant is often expressed as 6.626 x 10
-34
 J s
-1
; 1 J is equal to 6.241 x 10
18
 eV.  
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1.4. Electron Capture Dissociation (ECD) 
Electron Capture Dissociation is a recent development in the field of MS/MS, 
pioneered by Zubarev, et al.,32 that utilises low energy electrons for the 
fragmentation of multiply charged biological molecules such as peptides or proteins. 
It involves the interaction of electrons, 1-5 eV, with the multiply charged cations 
[M+nH]n+, resulting in the capture of an electron and creating an unstable 
hypervalent [M+nH](n-1)+˙ species.  The generation of this electronically excited odd-
electron intermediate differentiates this technique from CID and IRMPD, and alters 
the internal bond energies that affect the subsequent bond dissociation.33-34  Unlike 
CID and IRMPD, ECD product ions are no longer necessarily formed from the 
dissociation of the weakest bonds in the precursor ion, and therefore can provide 
complementary information to CID and IRMPD.  Although the capture of an electron 
is a rapid process, longer irradiation times are required for ECD in order to promote 
the interaction between the narrow electron beam and the ion cloud.15, 34  The poor 
overlap between the electron beam and the ion cloud results in comparatively low 
fragmentation efficiency, however ECD has often been found to generate a higher 
degree of sequence coverage than the vibrational techniques.35  Studies have 
shown that weak or covalently bound modifications, which would typically be lost by 
vibrational excitation techniques, tend to be retained by ECD allowing for their 
identification and location.32, 36-43  ECD is almost exclusively used with FT-ICR 
instruments due to their ability to trap electrons in the cell.44  This combination 
provides the added advantage of allowing product ions to be measured to a high 
degree of accuracy, allowing potential molecular formulae to be generated for the 
observed peaks.  ECD experiments are predominantly used with large 
biomolecules, such as protein and peptides, due to their tendency to form multiply 
charged molecular ions. 
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1.5. Proteins and Peptides Analysis 
In the field of proteomics, MS and MS/MS analysis have become necessary and 
valuable tools for polypeptide sequencing, due to the high sensitivity and speed of 
analysis and the ability to generate a series of product ions following predictable 
fragmentation patterns.  Figure  1.2 details the existing nomenclature for peptide 
backbone cleavages, with N-terminal product ions labelled a, b and c, and C-
terminal containing product ions labelled x, y and z.45-48  
 
bn
yn+1
an
xn+1
cn an+1
zn+1 xn
bn+1
yn
cn+1
zn  
Figure ‎1.2: Common peptide backbone cleavages and their corresponding 
assignments. 
 
 
MS/MS sequencing of peptides and proteins can be carried out by one of two 
approaches; the ‘bottom-up’ method or the ‘top-down’ method.  The bottom-up 
approach involves proteolytic digestion of the protein of interest in order to form 
smaller peptides.  The resultant peptide spectrum is known as a peptide mass-
fingerprint, which can be used to identify or confirm the initial protein by database 
searching or comparison with an in silico digest.  Performing MS/MS on tryptic 
peptides can identify or confirm a high degree of the amino acid sequence and 
pinpoint sequence modifications to the polypeptide.  Bottom-up proteomics reduces 
any solubility issues involved with hydrophobic proteins, as smaller proteolytic 
peptides may be more soluble than the intact protein, and prevents any 
conformational hindrances.49-51  Top-down proteomics involves performing MS/MS 
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on the intact polypeptide, eliminating the need for time-consuming protein 
purification and digestion experiments.  The energy transferred during MS/MS can 
dissipate through more degrees of freedom, reducing the efficiency of fragmentation 
and resulting in poorer sequence coverage.  Fragmentation of the intact protein is 
also affected by the secondary and tertiary protein conformations, the amino acid 
backbone folding and the three-dimensional structure of an intact protein molecule 
respectively, which may prevent bond dissociation in areas of the protein due to 
steric hindrance.42, 51-54  Modifications to the polypeptide sequence, such as 
phosphorylation, may alter the tertiary structure of the ion in the gas phase, 
subsequently affecting intramolecular bonding.  As a result, when conducting top-
down proteomics the product ion spectrum from the modified species may differ to 
the product ions generated from the unmodified polypeptide.39   
 
MS/MS analysis of polypeptides by CID or IRMPD, results in cleavage of the 
weakest bonds in the amino acid sequence, the CO-NH peptide bond, creating a 
series of b and y ions (see Figure  1.2).55  Additionally, CID and IRMPD have the 
tendency to cleave labile covalently-bound modifications on proteins and peptides, 
hindering the identification and location of such modifications.  The predictable 
fragmentation patterns generated by the CID of peptides and proteins allows for the 
identification or confirmation of the polypeptide amino acid sequence.  As the 
molecular weight of the targeted polypeptide increases, the efficiency of CID 
analysis decreases due to the redistribution of energy through more degrees of 
freedom, therefore more energy is required to generate the same degree of 
fragmentation.56  The number of charges on the precursor ion has been shown to 
significantly effect the resulting CID spectrum, with increased energy and greater 
instability associated with higher charge states of the precursor ion resulting in a 
higher degree of fragmentation and sequence coverage.57-58   
 
 21 
Analysis of polypeptides by ECD has been found to generate a high degree of 
amino acid sequence coverage, while also retaining any labile modifications.32  
Using high mass accuracy MS instruments to calculate the empirical formulae of the 
product ions can confirm or suggest chemical formulae and structural assignments 
for each product ion, facilitating the identification of unknown modifications or 
mutations on the polypeptide.  Whereas CID and IRMPD predominantly result in the 
dissociation of the peptide bond to form b/y ions, the major fragmentation pathway 
observed from ECD involves the homolytic cleavage of the N-Cα bond, resulting in 
radical site migration and creating an even-electron c’ ion and an odd-electron z· 
ion.32  Hydrogen migration prior to bond dissociation is a common occurrence in 
ECD, producing odd-electron c˙ ions and even-electron z’ ions.59-60  In addition to 
the backbone cleavages, ECD has been shown to preferentially dissociate 
disulphide bridges within the polypeptide.33, 46, 61  The data generated by ECD has 
been shown to be complementary to data produced by vibrational excitation 
techniques such as CID and IRMPD due to the differences in preferred bond 
cleavages.62-63  The cyclical nature of the proline amino acid inhibits the formation of 
the expected product ion formed via the N-Cα bond cleavage, as shown in Figure 
 1.3, therefore the number of proline components in a polypeptide sequence will limit 
the achievable sequence coverage by ECD.  The effect of proline residues on CID 
and IRMPD spectra is very different from ECD.  Firstly, since CID and IRMPD 
cleave the peptide bonds, sequence coverage is unaffected by the cyclical proline 
residues.  Secondly, the high proton affinity associated with proline promotes 
protonation at these residues and results in increased probability of cleavage at the 
proline N-terminus.36, 46, 64-66  
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Figure ‎1.3: Mechanism of bond cleavage resulting from the ECD of proline. 
 
 
There are two mechanisms which have been postulated to account for ECD bond 
dissociation; The Cornell method, or the ‘Hot Hydrogen’ method, posits that the 
electrons target one of the positively charged sites on the peptide, neutralising the 
charge and creating a hypervalent radical.  This results in the ejection of a mobile 
hydrogen radical which is expected to traverse the peptide backbone and attack an 
oxygen of the peptide bond.  This in turn causes the dissociation of the neighbouring 
N-Cα bond, as shown in Figure  1.4.
36-37  
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Figure ‎1.4: Fragmentation mechanism postulating electron capture at the 
protonated nitrogen atom.36 
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A mechanism for the dissociation of disulphide bonds has also been suggested by 
this method, proposing that the hydrogen radical can also attack the S-S bond and 
resulting in homolytic cleavage to form an S˙ containing product and an SH 
containing fragment, as shown in Figure  1.5.  
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Figure ‎1.5: Proposed mechanism for the dissociation of disulphide bridges via 
the capture of a hydrogen radical.36 
 
 
The Cornell method sufficiently explains the cleavage of the stronger N-Cα bond 
instead of the weaker peptide bond, however more recent experiments have cast 
doubts on the mobile hydrogen mechanism due to the large distances the hydrogen 
atom would be required to travel between protonation sites and the sites of bond 
cleavage.  The second proposed fragmentation mechanism, called the Utah-
Washington method or ‘Superbase’ method, alternatively suggests that the 
hypervalent radical centre induces intramolecular electron transfer to the site of 
bond cleavage or that the electron is captured directly at the cleavage site.  Figure 
1.6 depicts the capture of the electron at the carbonyl group to form a radical anionic 
centre that subsequently reacts to dissociate the neighbouring N-Cα bond and 
neutralise the negative charge via a proximal H+.67-70 
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Figure ‎1.6: Fragmentation mechanism postulating capture of an electron at 
the carbonyl group, leading to dissociation of the N-Cα bond.
67, 71 
 
 
A similar mechanism is postulated for the dissociation of disulphide bridges by ECD, 
whereby the electron is captured by the S-S bond, breaking the bond to form a S˙ 
containing fragment as well as an S- containing fragment that subsequently reacts 
with a proximal H+, as shown in Figure ‎1.7. 
 
S
S
e-
 
Figure ‎1.7: Proposed mechanism for the dissociation of disulphide bridges 
following the Utah-Washington method.67, 71 
 
 
While the c/z product ions are the most commonly observed fragments in ECD 
spectra, they are not the only observed cleavage.  Investigations into the use of 
ECD have noted that cleavage of the peptide bond to form b/y ions or the cleavage 
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of the Cα-CO and CO-NH bonds to form a˙/y ions (involving the neutral loss of CO) 
may also be observed.  The observation of product ions usually generated by 
vibrational excitation techniques would suggest that ECD results in both the 
electronic excitation and vibrational excitation of the precursor ion.36, 38, 46, 72-73   
 
At higher electron energies, beyond 5 eV, the technique becomes known as hot 
ECD (or hECD).  This increase in energy has been found to be sufficient to induce 
secondary fragmentation, creating product ions from amino acid side chain losses in 
addition to the typical a, b, c, y, z, ions.38, 46, 72, 74-76  This secondary fragmentation 
has been shown to provide valuable information regarding the polypeptide 
backbone, including being able to distinguish between the isobaric amino acids, 
leucine and isoleucine.  The mechanisms suggested by Kjeldsen et al. propose the 
formation of w ions from the subsequent side-chain cleavages from z˙ ions with 
terminal leucine or isoleucine residues, as shown in Figure  1.8, and suggest the 
possibility of d ions produced from a˙ ions in a similar manner.34, 72  This theory does 
not take into account the possibility of rearrangement within the intermediate 
fragment ion, initiated from the radical centre and resulting in side-chain 
fragmentation independent of the primary dissociation site.76-78  The increase in 
electron energy has been shown to have an adverse effect on the S/N of the product 
ion spectra, a pattern which is thought to be due to the higher kinetic energies of the 
product ions and the diffusion of the ion cloud from higher energy collisions.72 
 
 26 
 
Figure ‎1.8: Proposed mechanism for the formation of w ions from the 
intermediate z˙ ions of leucine (top) and isoleucine (bottom).  
 
 
As with CID, increasing the molecular weight of the targeted polypeptide has been 
found to decrease the ECD efficiency.  The structural conformation of proteins is 
thought to play a part in the decreased efficiency as intramolecular non-covalent 
bonds are formed to stabilise the secondary and tertiary structure of the protein, 
thus hampering the effect of ECD in the field of top-down proteomics.  To overcome 
these barriers, activated ion ECD (AI ECD) was developed, using CID or IRMPD to 
help break the non-covalent bonds and vibrationally excite the protein before using 
ECD to dissociate the protein backbone.  Results have shown that the combination 
of two MS/MS techniques can generate extensive terminal sequencing without the 
need for proteolytic digestion, however the central portion of the protein remains 
largely intact.46, 52-54, 79-80 
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The charge state of the precursor ion has been found to play an important role in the 
resulting product ion.  Higher charge states are affected by increased coulombic 
repulsion within the molecule making them less stable and therefore fragment more 
readily, however the product ion spectrum generated tends to be more complicated 
due to the multiple charge states that each product ion may form.  In addition, the 
increased number of charges on the molecule reduces the probability of a neutral 
fragment being formed.  Conversely, a lower charge state precursor ion may not 
fragment as effectively as a higher charge state, however the number of charge 
states available to the product ions are reduced and therefore the product ion 
spectrum is simplified.60, 72  
 
Further developments into using electrons to induce bond dissociation resulted in 
the technique Electron Transfer Dissociation (ETD) that, unlike ECD, does not 
require an expensive FT-ICR mass analyser and can be carried out on other, less 
expensive mass analysers, such as quadrupoles or ion traps.  ETD utilises anionic 
molecules with low electron affinities, typically aromatic compounds such as 
fluoranthene or benzoic acid that can form odd-electron species capable of donating 
an electron to the multiply charged precursor ions to form an odd-electron species, 
initiating bond dissociation similar to ECD.81-82  As with ECD, ETD predominantly 
forms c and z ions from the MS/MS of multiply charged polypeptides while retaining 
labile modifications on the protein backbone.83  The energy transfer between the 
ion/ion interactions is lower than the ion/electron energy transfer undergone by 
ECD, due to collisonal cooling or energy redistribution throughout the anionic 
species prior to electron transfer, therefore the resulting fragmentation tends to be 
less efficient.78, 84  Despite the reduced energy transfer, ETD has been shown to 
generate significant amino acid sequence coverage, providing significant 
polypeptide information.85  
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Thus far, electron capture-induced bond dissociation has primarily focused on 
positively charged ions, however Håkansson et al. have been developing ECD for 
the analysis of negatively charged precursor ions, termed negative ion ECD 
(niECD), which has been shown to generate the charge-increased [M-nH](n+1)- 
species from electron capture by the [M-nH]n- precursor.  Electron energies required 
for niECD were found to be slightly higher than ECD, at around 3.5 – 6.5 eV, and 
resulted in backbone cleavages analogous to ECD.86  Increasing the electron 
energy even further, beyond 10 eV, has been found to generate fragmentation via 
the ejection of an electron from the precursor ion, forming the charge-reduced [M-
nH](n-1)- species.  This technique, known as Electron Detachment Dissociation 
(EDD), generates a radical anionic centre that can initiate bond dissociation.  The 
radical ‘hole’ created from electron detachment is proposed to move along the 
polypeptide backbone via neutralisation with an electron.  The electron-hole 
recombination process results in electronic excitation of the precursor ion, which 
induces bond cleavage.  The major product ions observed by EDD occur from the 
homolytic cleavage of the N-Cα bond to create c, z and a˙ ions, the latter formed via 
loss of a neutral CO2 in a method akin to ECD.  Cleavage of the Cα-C bond has also 
been observed, generating the complementary a˙ and x product ion series.  Further 
similarities between EDD and ECD include secondary fragmentation resulting from 
radical-initiated side-chain cleavages.34, 87-89   
 
1.6. Small Molecule Analysis 
The MS and MS/MS analysis of biological molecules is a widely researched field 
that contributes towards a high proportion of published material, however it is not the 
only useful application.  The analysis of small organic molecules is an important 
aspect of drug development in the pharmaceutical industry and has become a key 
area for the use of mass spectrometry.  Mass spectrometry is commonly used to 
provide rapid elemental and structural confirmation, reaction monitoring and 
 29 
identification of unknown compounds.  MS/MS of small organic molecules tends not 
to follow systematic fragmentation patterns or rules due to the lack of a regular or 
predictable chemical structure that governs polypeptides.  Functional groups present 
in the molecule can severely influence dissociation behaviour due to factors such as 
their electron-donating or electron-withdrawing properties, their influence on bond 
lengths and energies, and their ability to stabilise the charge or an unpaired 
electron.90-91  As a result, the MS and MS/MS analysis of small molecules often 
involves unpredictable decomposition reactions, however certain observations and 
proposals have been made regarding commonly detected bond cleavages and 
proposed fragmentation mechanisms.  MS/MS is typically carried out on even-
electron molecular ions, such as [M+H]+ or [M-H]-, formed by electrospray or other 
atmospheric pressure ionisation techniques.  A proposed guideline regarding 
fragmentation patterns of even-electron species, known as the parity rule or the 
even-electron rule, states that it is more favourable for an even-electron precursor 
ion to fragment via the loss of a neutral molecule to form an even-electron product 
ion than it is to lose an odd-electron radical to form an odd-electron product ion.  
This preference is suggested due to the inherent stability of even-electron species 
compared with odd-electron species, and the high energy required to split an 
electron pair.92-93  More recent studies into the MS/MS of small organic molecules 
have suggested that while the formation of even-electron product ions by CID-
MS/MS is extensive, odd-electron species are often observed due to the formation 
of stable radical species or low-energy intermediates.  Aromatic compounds have 
been found to stabilise an unpaired electron, often creating a more stable species 
than the even-electron equivalent, resulting in a higher probability of forming odd-
electron product ions.94-95  Levsen et al. carried out an in-depth study into the 
analyses of protonated and deprotonated aromatic compounds containing functional 
groups such as carboxylic acids, alcohol groups, nitro-containing groups and 
halogens.  CID MS/MS of the range of compounds noted a high probability for the 
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elimination of key functional groups to form stable neutral species; such as CO2, 
NO2, H2O, SO2, HX (X = halide) radical species; such as H
•, CO•, NO•, OH•, NH2
•, X•, 
or charged species; such as SO3
-, PO3
-, H2PO4
-.90-91  Other common cleavages 
include cleavages at carbon-heteroatom bonds, so that the heteroatom can stabilise 
the charge and/or radical.94 
 
Small molecule analysis can also be carried out using Electron Ionisation (EI), an 
ionisation technique typically used on small (< 1 kDa) volatile molecules that 
interacts high energy (70 eV) electrons with the neutral molecules to be analysed.  
The energy of the electrons is much higher than the ionisation potential of the 
molecule being analysed, resulting in the ejection of an electron from the neutral 
species to form an odd-electron radical cation, as shown in Scheme 1.1.  
 
 M +  e-high  →  M
+• +  2e- Scheme 1.1 
 
The high energy transferred from the electrons to the ionised molecules increases 
the internal energy of the subsequent molecular ion, which combined with the 
increased instability of the odd-electron species often results in bond dissociation to 
form more stable fragment ions.  Bond dissociation can occur via two methods; 
Firstly, homolytic cleavage, or radical-site initiated cleavage, which involves the 
migration of unpaired electrons to form an odd-electron radical cation and a neutral 
molecule, as shown in Figure  1.9(a).  The presence of heteroatoms or double 
bonds in the molecular ion promotes the homolytic cleavage, resulting cleavage at 
the α-β bond position.  Secondly, heterolytic cleavage, otherwise known as charge-
site initiation or inductive cleavage, which involves charge migration to form an 
even-electron cation and a neutral radical, as shown in Figure  1.9(b).   
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Figure ‎1.9:‎Examples‎of‎(a)‎homolytic‎α-β‎bond‎cleavages‎and‎(b)‎heterolytic‎
bond cleavages. 
 
 
The charge-site on the molecular ion can have a significant effect on the major 
fragmentation pathways, due to the influence of the charge on the length of 
neighbouring bonds.96  The charge-site can act as an electron-withdrawing group, 
generating a slight negative charge on the neighbouring atoms, which in turn causes 
the α-β bond to lengthen thus making it more susceptible to bond cleavage.  
Conversely, the presence of an electron-donating group would contract the α-β bond 
and therefore alter the preferred bond cleavage.  Other factors proposed to affect 
the fragmentation pathways of small molecules include the size of the molecular ion, 
steric hindrance effecting intramolecular rearrangement, bond angles or the stability 
of the intermediate and/or product ions.97 
 
Similarities have been noted between EI MS and MS/MS, most notably the frequent 
neutral losses of specific functional groups, and the ability for each molecular ion to 
form odd-electron and even-electron fragment ions, therefore it is possible to 
generate the same fragment ion from each technique.  Bond dissociation via 
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rearrangement reactions are common occurrences, both by EI MS and MS/MS, 
proceeding via the formation of more stable intermediates and therefore requiring 
less energy to overcome the transition-state energy barrier between the molecular 
ion and the fragment ion.91  The McLafferty rearrangement, shown in Figure  1.10, is 
a common rearrangement for compounds capable of forming cyclical intermediates, 
resulting in migration of the γ-hydrogen and α-β bond cleavage.98-99 
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Figure ‎1.10: McLafferty rearrangement of a long chain carboxylic acid. 
 
 
The high stability of cyclic structures, in particular aromatic rings, makes cross-ring 
cleavages less likely, although still possible, using CID MS/MS due to the tendency 
for CID to follow the lowest energy fragmentation pathways and therefore breaking 
the weakest bonds in the molecule.  This may result in difficulties determining 
structural differences in analogous molecules, where the major fragmentation 
pathways provide limited information about the minor structural differences, such as 
the location of substituents around a ring.  An in-depth study carried out by Niessen, 
investigated CID MS/MS of a range of protonated drug compounds, noted product 
ions resulting from cleavages across saturated cyclic groups, however no 
fragmentation was observed across aromatic groups.94  Bond cleavages within 
unsaturated cyclical groups are far more likely by EI, due to the stabilisation of the 
unpaired electron by the ring and the high energy imparted on the molecule upon 
ionisation.  The presence of an unpaired electron in an aromatic ring results in the 
disruption of the aromaticity, thereby increasing the probability of radical-site 
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initiated fragmentation within the ring or rearrangement in order to form a more 
stable ion.90, 100   
 
1.7. Electron-Induced Dissociation (EID) 
Electron-Induced Dissociation (EID) is recent development in the field of MS/MS that 
has roots originating in Electron Impact Excitation of Ions from Organics (EIEIO) and 
ECD.  EIEIO was first introduced in the 1970s as an alternative to photodissociation 
spectroscopy (PDS) and CID, utilising the trapping ability of ICR instruments to 
interact compounds with a continuous electron beam.  Neutral molecules were 
ionised by electrons of greater energy than their ionisation potential, essentially 
Electron Ionisation (EI) as shown in Scheme 1.1, to generate a singly charged 
radical cationic species (M+•) before subsequently reducing the energy of the 
electron beam to electronically excite the molecular ion and induce bond 
dissociation, as shown in Scheme 1.2.  Comparisons with CID noted that while 
some product ions were common to both techniques, EIEIO and CID could each 
generate product ions not observed by the other, thought to result from differences 
in energy excitation; whether vibrational, rotational or electronic.101-106   
 
 M+• +  e-low  →  M
+* Scheme 1.2  
 
Subsequent developments in using electrons to induce bond dissociation include the 
increasingly prevalent MS/MS technique ECD, involving the interaction between low 
energy electrons (~5 eV) with multiply protonated species leading to electron 
capture followed by bond dissociation.36, 71  Further progress in this field introduced 
the technique known as Electron Excitation Dissociation (EED), a two-step process 
that combines the experimental concepts from EIEIO and ECD to create an MS/MS 
method capable of fragmenting singly charged even-electron cations, such as 
[M+H]+, generated by atmospheric ionisation techniques.  High energy electrons, 
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between 10 eV and 70 eV, were required to induce secondary ionisation of the 
[M+H]+ precursor by ejecting an electron from the precursor ion to generate the 
[M+H]2+• species, as shown by Scheme 1.3. 
 
 [M+H]+  +  e-high  →  [M+H]
2+•  +  e-low  +  e
-
high   Scheme 1.3 
 
The low energy electrons that were ejected from the precursor ion were then 
reflected back into the FT-ICR cell where they recombined with the doubly charged 
radical cation to generate the singly charged electronically excited [M+H]+* species, 
as shown by Scheme 1.4.   
 
 [M+H]2+•  +  e-low  →  [M+H]
+* Scheme 1.4 
 
EED of singly protonated peptides noted the presence of b, c, y and z ions in the 
resulting MS/MS spectrum, indicating a correlation between EED and ECD.  When 
the reflection of the low energy electrons was removed, only b and y ions were 
evident in the product ion spectrum, thought to result from the vibrational excitation 
of the [M+H]+ species initiated from the high energy electrons.  However, when the 
low energy electrons were recombined with the [M+H]2+• species to create the 
electronically excited state, c and z ions were observed in addition to the b and y 
ions, thus suggesting that the mechanism of fragmentation is dependent on the type 
of excitation occurring and that vibrational excitation and electronic excitation 
fragmentation pathways are both capable from electron irradiation.107-108  Minor 
adaptations to the EED method have resulted in the evolution of EID, a single-step 
technique that uses electrons of approximately 10 – 20 eV in order to directly induce 
fragmentation in singly charged species.109  EID can be performed on an FT-ICR 
instrument using a pre-existing ECD setup, simply increasing the energy applied to 
the electron dispenser cathode beyond what is typical for ECD.  The EID product ion 
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spectra have shown striking similarities to both ECD and EED, such as the 
observation of odd-electron and even-electron species, and the observation of 
product ions resulting from both vibrational excitation and electronic excitation.  
Investigations involving the EID of singly charged peptides noted that the product 
ions generated by EID closely resembled those that would be expected from the 
ECD of the corresponding multiply charged species, namely a, b, y, c, and z ions.110-
113  The similarities between the product ions generated by EID and ECD would 
suggest a similarity in the mechanism of bond dissociation, however the capture of 
an electron by a singly charge species would result in charge neutralisation.  
Following the proposed EED mechanisms, high energy electrons would cause 
secondary ionisation of the precursor; however this alone would not necessarily 
result in bond dissociation without further energy input.  Should the formation of EID 
product ions follow this route, it would imply that further interaction between the 
[M+H]2+• species and the electrons occurs prior to fragmentation.  Ly et al. noted the 
presence of doubly charged product ions from a singly charged precursor, 
suggesting the loss of a neutral moiety from the [M+H]2+• species.111  The 
observation of product ions expected from vibrational excitation techniques suggests 
that either the electrons are able to impart vibrational energy on the trapped ions in 
addition to electronic energy or rapid energy conversion from electronic to 
vibrational occurs within the precursor ion prior to fragmentation.112  The evidence 
thus far indicates that EID of singly charged cations follows competing fragmentation 
pathways, resulting in varied and informative product ion spectra.  A notable feature 
of EID fragmentation is the presence of product ion multiplets; peaks differing by 1 
Da that correspond to species with the same elemental composition save for the 
number of hydrogen atoms.  This mixture of odd-electron and even-electron species 
suggest that rapid migration or rearrangement of hydrogen radicals occurs prior to 
fragmentation.59, 113  
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Recent advances have involved the application of EID to non-peptidic compounds, 
such as cationic clusters,114-115 metal-ligand complexes,116-117 amino acids,113, 118 
metal-bound fatty acids119 and inorganic metallo-porphyrins.120  With the structural 
uniformity present in polypeptides no longer a factor, the method and effectiveness 
of the technique would be expected to change, however several common features 
have become evident.  EID is still shown to generate both odd-electron and even-
electron species upon fragmentation of a singly charged cation, and often results in 
product ion multiplets resulting from H• migration.  Furthermore, doubly charged 
product ions are generated from the EID of the singly charged precursor, further 
indicating that bond dissociation occurs via electron ionisation.  EID product ions 
also observed by CID confirm the competing vibrational and electronic excitation 
pathways; however a variation in product ion abundances between techniques has 
been observed, suggesting that the preferred fragmentation pathways vary for each 
MS/MS technique.  Data gathered from EID has been shown to be complementary 
to CID and IRMPD, with the effectiveness of each technique varying depending on 
the targeted compound its charge state, thereby indicating that employing EID in 
conjunction with other MS/MS techniques would vastly increase the amount of 
structural information available.  
 
Negative ion EID has thus far been carried out on singly deprotonated peptides,121-
122 metabolites123 and carbohydrates124 demonstrating the validity of this technique 
for a wide range of compounds.  As with positive ion analysis, anionic MS/MS has 
noted significant similarities between EID and the multiply charged equivalent EDD.  
The EID of the [M-H]- species of acidic peptides generated a, b, c, x, y and z ions, 
including both odd-electron and even- electron species, while retaining covalently 
bound modifications such as phosphorylation or sulphonation.121  The extensive side 
chain fragmentation also observed parallels the cross-ring fragmentation generated 
from the EID analysis of metabolites and carbohydrates, and increases the amount 
 37 
of structural information available.  Håkansson et al. noted significant variations in 
product ion spectra when the applied electron energy was altered; at lower energies 
the degree of fragmentation declined whereas at higher energies the spectrum 
quality deteriorated as both the precursor ion and product ion intensities dropped.  
An optimal energy range was established between 15 – 20 eV, however for energies 
outside this range the electron irradiation times could be altered to improve the 
resulting product ion spectra.123 
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2. Instrumentation 
 
There is a wide range of mass spectrometers available, each with specific purposes 
and capabilities.  Every MS instrument separates and detects ions according to their 
mass-to-charge ratios (m/z), resulting in a spectrum of m/z against abundance.  
Varying the type of mass analyser, and therefore the detectable mass range, 
resolving power and mass accuracy capabilities, can have a dramatic effect on the 
resulting MS or MS/MS spectra.  
 
There are three stages to mass spectrometric analysis;  
 Ionisation of the sample, converting the neutral sample molecules into 
gaseous ions. 
 Separation of sample ions according to their mass-to-charge ratios. 
 Detection of the ions, creating an electronic signal to generate a spectrum of 
intensity against mass-to-charge.  
 
There are a large number of ionisation techniques and mass analysers that have 
been developed over the years, therefore the instrumentation detailed in this chapter 
has been focussed solely on the four mass spectrometers that have been utilised to 
carry out the work discussed in Chapters 3, 4 and 5;  
 
 Trace GCMS (ThermoFinnigan Corp.), a quadrupole mass analyser fitted 
with an Electron Ionisation (EI) source.  
 LTQ-FT (ThermoFinnigan Corp.), a linear ion trap and an FT-ICR mass 
analyser connected in series, and fitted with an Electrospray (ESI) source. 
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 QToF Premier XE (Waters Ltd.), a quadrupole mass analyser, quadrupole 
collision cell and a Time-of-Flight mass analyser connected in series; fitted 
with an ESI source.  
 Xevo QToF (Waters Ltd.) a quadrupole mass analyser, quadrupole collision 
cell and a Time-of-Flight mass analyser connected in series; fitted with 
interchangeable ESI and Atmospheric pressure Solids Analysis Probe 
(ASAP) sources. 
 
 
2.1. Ion Sources 
The method of ionising samples prior to mass analysis can affect the type and 
stability of the generated molecular ions, which in turn can have a significant affect 
on subsequent MS analysis.  Soft ionisation techniques (such as ESI) have the 
tendency to keep the molecular ion intact, facilitating the confirmation of the 
expected compound(s).  Hard ionisation techniques (such as Electron Ionisation) 
tend to exert more energy on the sample, which often leads to unstable molecular 
ions that dissociate to form more stable product ion species.  ESI, ASAP and EI 
have been discussed further, each of which provides an alternative approach to 
compound characterisation.  
 
2.1.1. Electrospray Ionisation 
ESI is a soft atmospheric pressure ionisation technique that primarily forms intact 
sample molecular ions and can be controlled to minimise in-source dissociation.  
ESI is suitable for continuous sample/solvent introduction, allowing it to be combined 
with Liquid Chromatography (LC), flow injection analysis or direct infusion.  Figure 
 2.1 shows a schematic of a typical ESI source operating in positive ionisation mode.  
The voltage applied to the ESI capillary needle coupled with the nitrogen 
nebulisation gas surrounding the needle creates an aerosol of charged droplets.   
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Figure ‎2.1: Schematic of an ESI source, illustrating positive ionisation mode. 
 
 
Two possible mechanisms for electrospray have been proposed.  The charge-
reduced model postulates that as the solvent evaporates, the charge density of the 
droplets increases until the coulombic repulsion between the ions exceeds the 
surface tension of the solvent droplets (the Rayleigh limit) causing the droplets to 
split into smaller and smaller droplets.  The solvent evaporation process is facilitated 
by a flow of nitrogen desolvation gas, resulting in gaseous analyte ions.  The second 
mechanism, the ion evaporation model, suggests that the coulombic repulsion in a 
small highly charged solvent droplet forces ions to be ejected from the surface of the 
droplet to form the gaseous analyte ions.  A voltage and vacuum gradient between 
the capillary needle and the source cone draws the analyte ions through the source 
cone and into the mass spectrometer. An off-axis ESI probe prevents neutral 
molecules and negatively charged ions‡ from passing through the source cone.  In 
                                               
‡
 In the case of negative ionisation, positive ions would be repelled from the source. 
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positive ionisation mode, the molecular ions are primarily formed through 
ion/molecule interactions, the sample molecules interact with positively charged 
species such as protons (H+), sodium (Na+) or ammonium (NH4
+) from the solute to 
create the positively charged molecular ions such as [M+nH]n+, [M+nNa]n+ or 
[M+nNH4]
n+ .  In negative ionisation mode, the deprotonated molecular ion is 
commonly observed at [M-nH+]n-, although adducts may still be observed such as 
[M+Cl]- or [M+HCOO]-.1-5  High molecular weight compounds such as proteins and 
polymers contain multiple solvation sites, encouraging the formation of multiply 
charged species upon ESI that are observed at lower m/z values, thereby allowing 
mass analysers with a limited mass-range to be used.  This is particularly important 
when using quadrupole or FT-ICR mass spectrometers that operate inefficiently at 
extended m/z ranges.  
 
2.1.2. Atmospheric pressure Solids Analysis Probe  
ASAP ionisation is a recent development in the field of direct analysis, creating a 
versatile ionisation technique used for the rapid analysis of volatile and semi-volatile 
compounds by thermally vaporising samples.  ASAP removes the need for time-
consuming sample preparation and allows the analysis of insoluble compounds by 
directly applying solid or solution phase samples to a disposable glass melting point 
capillary in the ASAP probe.6  Figure  2.2 shows a schematic of an ASAP source, 
illustrating an off-axis sample probe operating in positive ionisation mode.   
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Figure ‎2.2: Schematic of an ASAP source, illustrating positive ionisation 
mode. 
 
 
A stream of heated nitrogen desolvation gas is used to volatilise the sample on the 
glass capillary.  A charged corona discharge needle is then used to ionise the 
gaseous sample molecules, which are then drawn into the mass spectrometer due 
to the potential gradient between the corona needle and the source cone.  Ionisation 
of the sample molecules is proposed to result from charge transfer from the nitrogen 
desolvation gas, as shown in Schemes 2.1 – 2.4.7 
 
 N2  +  e
-  →‎‎N2
+•  +  2e- Scheme 2.1 
 
 N2
+•  +  2N2  →‎‎N4
+•  +  N2 Scheme 2.2 
 
 N4
+•  +  H2O‎‎→‎‎H2O
+•  +  2N2 Scheme 2.3 
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 H2O
+•  +  H2O‎‎→‎‎H3O
+  +  OH• Scheme 2.4 
 
Rearrangement of the proposed reaction schemes can be used to suggest 
mechanisms for the ionisation of sample molecules [M] to form the protonated 
molecular ion, radical cation and hydride abstracted molecular ion respectively, as 
shown in Schemes 2.5 – 2.7. 
 
 H3O
+  +‎‎[M]‎‎→‎‎[M+H]+ +  H2O Scheme 2.5 
 
 N2
+•  +‎‎[M]‎‎→‎‎[M]+• +  N2 Scheme 2.6 
 
 H3O
+  +‎‎[M]‎‎→‎‎[M-H-]+ +  H2O + H2 Scheme 2.7 
 
ASAP is capable of analysing a wide range of compounds, with varying polarities, 
molecular weights and volatilities.6, 8  The temperature of desolvation gas can be 
altered as necessary; higher gas temperatures benefit the analysis of less volatile 
samples but may promote degradation of thermally labile compounds, while lower 
temperatures are more suited for highly volatile samples that may readily dissociate 
at high temperature.  An auxiliary ESI probe is often present to introduce a calibrant 
solution for improved mass accuracy.  
 
The type of molecular ions generated through ASAP ionisation is primarily 
dependent on the sample being analysed, however altering the ASAP source 
conditions can be used to manipulate the molecular ion as required.7  In positive 
ionisation mode the presence of water or other protic solvents, whether from the 
sample preparation or remnants in the source, may promote the generation of the 
[M+H]+ species due to the proton-rich environment as long as the sample has a 
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sufficient proton affinity.  The auxiliary ESI probe can be used as a means of 
introducing the liquids into the source during ASAP analysis.  Conversely, 
introducing a proton-scavenger into the source enclosure or removing any residual 
moisture by using high temperatures and N2 gas would encourage the production of 
the radical cation M+• or the hydride abstracted [M-H-]+ species.6-7 
 
2.1.3. Electron Ionisation 
The technique known as Electron Ionisation, historically referred to as Electron 
Impact, is a well-established ionisation technique that is carried out under vacuum, 
and therefore is commonly combined with Gas Chromatography (GC).  High energy 
electrons are emitted from a heated wire filament and accelerated to 70 eV prior to 
interaction with the gaseous sample molecules.9-10  The interaction between the 
electron and the sample molecule creates a positively charged radical cationic 
species (M+•), as shown in Scheme 2.8.   
 
 M  +  e-  →‎‎M+•  +  2e- Scheme 2.8 
 
The odd-electron molecular ions are typically less stable than the even-electron 
species generated by ESI due to higher internal energy, and therefore often results 
in bond dissociation and/or molecular rearrangement to form more stable products.  
The level of instability is largely dependant on the structure of the analysed 
compounds; however a high degree of in-source fragmentation is a common 
occurrence in EI spectra resulting in a low abundance or even non-existent 
molecular ion.  EI is typically suited for volatile, low molecular weight (< 1 kDa) 
compounds with < 70 eV ionisation potentials.  EI generates highly reproducible MS 
spectra, allowing mass spectral libraries to be created so as to aid sample 
identification by spectral comparison.  EI has been carried out in order to compare 
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the effect of electron/molecule interactions with the proposed electron/ion 
interactions of EID.11 
 
 
2.2. Mass Analysers 
2.2.1. Quadrupole Mass Analyser 
The GC Trace mass spectrometer comprises of an EI ion source connected to a 
single quadrupole mass analyser. Quadrupole mass analysers consist of four 
identical parallel rods arranged, as shown in Figure  2.3, with opposite rods acting 
as a pair.  Each pair has a DC voltage and an RF voltage applied to them.  The RF 
voltages applied to each pair of rods are identical in amplitude but different in 
polarity.  When an ion enters the quadrupole it will be attracted to the rods of 
opposite charge (i.e. a positive ion will be drawn towards the negatively charged 
rods), which if allowed to collide will effectively neutralise the ion.  The RF voltages 
rapidly alternate the polarity of the rods, thereby forcing ions to oscillate along the 
length of the quadrupole.12 
 
 
Figure ‎2.3: Diagram illustrating the motion of ions through a quadrupole. 
 
 
The Mathieu equations shown in Equation 2.1 and Equation 2.2 indicate the 
motion of ions along the quadrupoles.  
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 au = 2
0
2 rmω
zeU8
 Equation ‎2.1 
 
 qu = 2
0
2rmω
zeV4
 Equation ‎2.2 
 
Where au and qu are related to the x- and y-coordinates of an ion travelling through 
the quadrupole, r0 is the radius of the quadrupole, U corresponds to the DC voltage 
applied to the rods, V is the amplitude of the RF voltage, ω is a constant 
corresponding to the angular frequency, m is the mass of the ion, z is the number of 
charges on the ion, e is the charge of an electron.  For each ion, U and V are 
variable, and the ion is stable as long as the values of au and qu remain less than r0. 
Figure  2.4 indicates the stability curves associated with ions travelling through a 
quadrupole, with each curve representing ions of a specific m/z.  The optimum 
variation in U and V occurs when only ions of one m/z are transmitted at any given 
time, as shown in Figure  2.4, allowing ions to be separated according to their m/z 
values.13 
 
 55 
RF (V)
D
C
 (
U
)
Optimum
Poor 
Resolution
No Transmission
Stable
Unstable
D
C
 (
U
)
 
Figure ‎2.4: Stability diagram for ions in a quadrupole mass analyser. 
 
 
Quadrupoles have incredible versatility allowing them to not only separate ions 
according to their m/z, but can be used as a collision cell for performing CID MS/MS 
or function as RF-only ion guides or focussing lenses between components of the 
mass spectrometer.  Quadrupoles can also function as ion trap mass analysers, an 
example of which is incorporated into the LTQ-FT.  
 
2.2.2. FT-ICR Mass Analyser 
Figure  2.5 shows the schematic of an LTQ-FT (ThermoFinnigan) mass 
spectrometer, comprising of an ESI ion source and two mass analysers; a Linear Ion 
Trap (IT or LIT) and an FT-ICR cell connected sequentially.  Quadrupolar ion guides 
are used to transmit ions between the source and the mass analysers.   
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Figure ‎2.5: Schematic of the Thermo LTQ-FT. 
 
 
Linear Ion Trap 
The Linear Ion Trap (a subset of Quadrupole Ion Traps) is made up of four parallel 
hyperbolic rods, each of which is made up of three sections as shown in Figure  2.6.  
During ion accumulation or transmission, the front and back electrodes act as lenses 
allowing the ions to pass through into the centre of the trap or ejecting ions through 
the back lens to clear the trap.  When a Direct Current (DC) voltage is applied to the 
front and back electrodes, they become trapping plates keeping ions confined within 
the central section of the trap.  A helium buffer gas (or damping gas) is contained 
within the ion trap at 10-3 Torr, and is used to collisionally cool ions that enter the 
trap in order to reduce the kinetic energy of the ions and hold ions in the centre of 
the trap.  The rods that make up the main body of the trap are subjected to an 
Alternating Current (AC) voltage, sometimes known as the main RF voltage or the 
storage voltage, with a different polarity applied to each opposing pair, as shown in 
Figure  2.6(a).14 
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Figure ‎2.6: Schematic of (a) the front view of a linear ion trap and (b) the side 
view. 
 
 
The Mathieu equations shown in Equation 2.1 and Equation 2.2 apply to ions in 
the Ion Trap.  The resonance frequency of each ion is dependent on the m/z ratio, 
thereby allowing ions of different m/z to be separated.  Trapped ions oscillate within 
the confines of the trap until the main RF voltage is gradually increased, increasing 
the kinetic energy of ions with the same resonance frequency and resulting in an 
increase in the magnitude of the ion motion.  Figure  2.7 shows the stability curve 
associated with ions in a linear ion trap.  The DC voltage remains constant, 
therefore ions travel along the qu axis as the RF voltage is varied.  As the RF 
voltage is ramped, ions reach their limit of stability and are ejected from the trap in 
order of increasing m/z.  One pair of opposing rods, known as the exit rods, has a 
cut out section through which the ejected ions travel towards a conversion dynode 
detector.   
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Figure ‎2.7: Stability diagram an ion in the linear ion trap. 
 
 
Isolation of an ion of interest is carried out by increasing the DC and RF voltages to 
eject ions from the trap, with the exception of the ion of interest, resulting in an 
isolated precursor ion that can be subjected to MSn experiments.  CID MS/MS is 
performed in the ion trap by applying a resonance excitation RF voltage to the exit 
rods, which increases the kinetic energy of the stored ions and causes multiple 
collisions between the helium buffer gas and the precursor ions.  Figure  2.8 shows 
the stability curve associated with the precursor ion and the placement of the 
product ions along the curve.  Ions with qz values less than 0.908, typically 
corresponding to ions of m/z less than one-third of the precursor ion, are not stable 
enough to remain in the trap and are therefore not observed in the resulting MS/MS 
spectrum.  This rule, known as the one-third cut-off or low-mass cut-off, results in a 
restricted mass range for CID analysis carried out in an ion trap, and reducing the 
amount of structural information that may be gleaned from the resulting MS/MS 
spectrum.15 
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Figure ‎2.8: Diagram of ion ejection in the linear ion trap. 
 
 
Product ions generated by CID in the ion trap can be detected in situ or transmitted 
into the FT-ICR cell to utilise the high resolution and mass accuracy.   
 
Fourier Transform-Ion Cyclotron Resonance 
The Fourier Transform-Ion Cyclotron Resonance (FT-ICR) mass analyser is the 
highest resolution MS instrument available, comparable with the Orbitrap mass 
analyser,16-17 with high sensitivity and mass accuracy capabilities.  In the LTQ-FT, 
the FT-ICR cell, sometimes known as a Penning trap, is cylindrical and situated 
within a static magnetic field inside the bore of a 7 Tesla superconducting magnet.  
FT-ICR mass analysers measure ions according to their frequency of precession, 
rather than measuring ion velocity, and therefore is not affected by the kinetic 
energy distribution among ions of the same m/z.  The FT-ICR cell is held at high 
vacuum so as to prevent collisions between the trapped ions and gas molecules, 
which would affect the ion cyclotron frequencies and the resulting mass accuracy.  
At higher magnetic fields, the ICR frequency increases and the time required 
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decreases, resulting in increased resolving power and accuracy.18-19  Figure  2.9 
shows the schematic of a Penning Trap, with ions entering the trap in the same 
direction as the magnetic field, B, defined as the z-axis.19-25 
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Figure ‎2.9: Schematic of a Penning Trap. 
 
 
As with the ion trap, the Penning Trap includes two trapping electrodes at either end 
of the cell, which confine ions within the cell when an electric potential, known as the 
trapping potential, is applied.  The main body of the Penning Trap consists of four 
electrodes; a pair of excitation electrodes and a pair of detection electrodes.  Ions 
trapped within the FT-ICR cell adopt three types of motion;18 
 
 Cyclotron Motion: High frequency (5 kHz – 5 MHz) ion precessions along the 
x/y plane.  The ion cyclotron frequency is dependant on the m/z of the ion, 
and can therefore be used to determine the m/z of an ion. 
 Trapping Motion: A slight motion along the z-axis between the trapping 
electrodes. 
 Magnetron Motion: Low frequency (1 - 100 Hz) ion precessions along the x/y 
plane, independent of the m/z of the ion, resulting from the effect of the 
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electric and magnetic fields.  Injecting ions into the FT-ICR cell parallel to the 
magnetic field ensures the radius of magnetron motion is minimised, making 
the effect on the resulting mass spectrum negligible.18 
 
When a particular RF voltage is applied to the excitation electrodes, ions with the 
same ion cyclotron frequency experience an increase in the radius of ion cyclotron 
motion, causing the ions to move towards the edge of the cell as shown in Figure 
 2.10.26-28 
 
 
Figure ‎2.10: An RF voltage applied to the excitation electrodes causes the 
radius of the ion cyclotron motion to increase. 
 
 
As the ions travel near the electrodes, as shown in Figure  2.11, the detection 
electrodes record the signal generated by all the ions, by attracting or repelling 
electrons from the detection plate depending on the polarity of the ions and resulting 
in an image current.  The image current of a single ion would be sinusoidal, however 
FT-ICR records the image current of all trapped ions simultaneously by scanning the 
RF frequencies, exciting all the ions and generating a more complex image current 
resulting from a combination of the ion cyclotron frequencies.  A mathematical 
operator known as the Fourier Transform can then be used to extract the individual 
ion cyclotron frequencies.24 
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Figure ‎2.11: Pathway of excited ions in Penning trap exhibiting cyclotron 
motion.  
 
 
The Fourier transformation results in a spectrum of cyclotron frequency against 
signal intensity, which can then be converted into a spectrum of mass-to-charge 
against intensity using Equation 2.3, where B is the applied magnetic field strength, 
νc is the ion cyclotron frequency, m is the mass of the ion and q is the charge on the 
ion.18, 23 
 
 
πm2
qB

c
ν  Equation ‎2.3 
 
Equation 2.3 can be rearranged to show that the mass-to-charge ratio is inversely 
proportional to the cyclotron frequency, as shown in Equation 2.4. 
 
 
cν
1
π2
B
qm   Equation ‎2.4 
 
The ion cyclotron motion can be described in terms of the angular frequency, ωc, 
which is directly related to the ion cyclotron frequency, as shown in Equation 2.5. 
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c
ν
c
π2  Equation 2.5 
 
The voltages applied to the trapping electrodes in order to confine ions within the 
Penning trap create a non-uniform electric field along the FT-ICR cell that causes 
ions to oscillate slightly along the z-axis.  The variation in the electric field has a 
small reductive effect on the forces contributing to the ion cyclotron motion, as 
described in Equation 2.6, where ω is the reduced ion cyclotron frequency and ωz 
is the angular trapping frequency. 
 
 
222
22
zcc   






 Equation 2.6 
 
In order to compensate for the effect of the trapping voltages, frequency-to-mass 
conversion and mass calibration must be carried out using the reduced ion cyclotron 
frequencies so as to achieve high mass accuracy.23, 29  The detection of ions in the 
Penning Trap is non-destructive, allowing ions to be contained and detected for a 
considerable length of time.  A longer image current results in better resolution of 
the resulting MS spectrum, however the duty cycle will also increase.20, 30 
 
The schematic in Figure  2.5 indicates the placement of the indirectly heated 
cathode required for performing ECD MS/MS and the 20 W CO2 laser for performing 
IRMPD MS/MS, both of which are situated behind the FT-ICR cell.   
 
2.2.3. Quadrupole Time-of-Flight Mass Analyser 
The Xevo QTof includes two interchangeable ion sources, an ESI source and ASAP 
source, attached to a quadrupole mass analyser, a T-wave collision cell and a ToF 
mass analyser connected in series, as shown in the schematic in Figure  2.12.   
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Figure ‎2.12: Schematic of the Xevo QToF. 
 
 
The QToF Premier XE mass spectrometer consists of an ESI ion source connected 
to a quadrupole mass analyser, a T-wave collision cell and a Time-of-Flight mass 
analyser connected in series, as shown in the schematic in Figure  2.13.   
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Figure ‎2.13: Schematic of the QToF Premier XE. 
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The quadrupole mass analyser has two purposes; firstly as an ion guide, scanning 
through the RF voltages in order to transmit all sample ions towards the Time-of-
Flight mass analyser for detection.  Secondly, the quadrupole can be used to isolate 
a specific ion, by applying only one RF voltage to eliminate all ions except for the 
precursor ion of interest.  The T-wave collision cell consists of a stack of ring 
electrodes with opposing RF voltages applied to adjacent electrodes.  A DC voltage 
is applied to each electrode in turn, creating a ‘travelling wave’ propelling ions 
towards the exit to the cell.  The collision cell contains an argon buffer gas, held at a 
pressure of 7 psi, which is used for CID MS/MS of the ions travelling through the 
cell.  Increasing the velocity of the ions through the collision cell, by altering the 
speed of the travelling wave and the DC voltage, induces collisions between the 
precursor ions and the argon gas molecules, resulting in product ion formation via 
CID.31 
 
Time-of-Flight (ToF) mass analysers measure the time taken for ions to travel a 
fixed distance in a vacuum, as shown in the schematic in Figure  2.14 and using 
Equation 2.7, where Ek is the kinetic energy of each ion, m is the mass of the ion 
and v is the velocity of the ion.  Following this equation, two ions with the same 
charge but different masses that are given the same kinetic energy will travel at 
different velocities, with the ion of lesser mass travelling faster than the ion with 
greater mass.  Using Equation 2.8, the lower mass (and therefore faster) ions will 
take a shorter time, t, to travel along the fixed distance, d.  Increasing the length of 
the field-free region subsequently increases the time taken for ions to reach the 
detector, but also increases the time difference between the ions, increasing the 
resolving power of the detector.32-33 
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Figure ‎2.14: Schematic of a ToF mass analyser. 
 
 
 
2mv
2
1
kE   Equation ‎2.7 
 
 
t
d
v   Equation ‎2.8 
 
 qVEk   Equation ‎2.9 
 
Equation 2.9 expresses the kinetic energy applied to the ions with respect to the 
charge of an electron, q, and the accelerating voltage, V.  Rearranging Equation 
2.7, Equation 2.8 and Equation 2.9 to express the mass-to-charge ratio, results in 
Equation 2.10, where the mass-to-charge ratio is proportional to t2 when 
2d
V2
 is 
constant.  Following this equation, as the mass-to-charge of a particular ion 
decreases (i.e. the mass decreases or the charge increases), the time taken to 
travel the length of the flight tube decreases.   
 
 
2
2
2 d
Vt2
v
V2
qm   Equation ‎2.10 
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A ToF mass analyser requires a discrete packet of ions in order to distinguish 
between ions of varying mass, therefore in order to combine a ToF analyser with ion 
sources that allow continuous sample introduction (such as ESI), orthogonal 
acceleration is required, whereby the ions enter the analyser perpendicular to the 
flight tube and are ‘kicked’ in a 90° angle by a pulsed voltage to create the required 
packet of ions.34  Figure  2.15 displays a schematic of a ToF mass analyser fitted 
with orthogonal acceleration and an ion reflectron.  A reflectron is a series of 
electrodes of increasing voltage that act as an ion mirror, reflecting the path of the 
ions.  The reflectron effectively increases the length of the flight path for the ions and 
therefore increasing the mass resolution, without increasing the physical length of 
the analyser.  The reflectron also corrects minor variations in the kinetic energy of 
ions with the same m/z, further improving the mass resolution.35-37  In the case of the 
QTof Premier XE, two reflectrons can be employed that lengthen the ion path by 
approximately four times the length of the field-free region. 
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Figure ‎2.15: Schematic of an ToF mass spectrometer fitted with a reflectron 
and orthogonal acceleration. 
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2.2.4. Summary of mass analyser performance 
Performance criteria such as resolving power, mass accuracy, speed, sensitivity and 
mass range should be considered for each mass analyser, prioritising factors 
according to the focus of MS analysis.  Instruments with higher resolving powers are 
essential for the analysis of isobaric compounds or complex mixtures, due to the 
ability to separate ions with a small m/z difference.  Mass accuracy becomes a key 
factor when analysing unknown compounds or when using MS/MS to generate 
structural information.  Speed of analysis is significant when carrying out LCMS and 
LCMS/MS or when rapid sample turnaround is required for high-throughput 
analyses.  Sensitivity of the mass analyser affects the dynamic concentration range 
that can be analysed, with lower sensitivity mass analysers requiring higher sample 
concentrations. Mass range is arguably the least important performance factor due 
to the advent of soft ionisation techniques that allow larger molecules to form 
multiply charged species that appear at in the lower m/z region, however ionisation 
techniques that typically form singly charged ions, such as Matrix-assisted Laser 
Desorption/Ionisation (MALDI) often require mass analysers with a higher mass 
range, such as ToF analysers.  
 
Due to the focus on MS/MS, in particular EID, the work carried out herein has 
predominantly been carried out on an FT-ICR, making use of the high mass 
accuracy and resolving power to characterise MS/MS product ions and identify 
unknown compounds.  Comparisons have been made between data generated on 
an FT-ICR and Linear Ion Trap, Quadrupole and Time-of-Flight mass analysers. 
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3. Electron-Induced Dissociation of Small Singly Charged Molecules. 
 
3.1. Introduction 
EID is a fledgling technique and has thus far been carried out on limited compound 
classes.  In order to further investigate the applications and limitations of EID, the 
work detailed herein has focussed on the use of EID to structurally characterise 
small organic molecules, an area not yet investigated.  An in-depth study has 
concentrated on the factors affecting the degree of fragmentation, such as the 
precursor ion abundances, the charge-carrying species, the electron energy and the 
electron irradiation time.  Comparisons have been carried out between EID and 
more traditional MS and MS/MS techniques such as EI, CID and IRMPD, in order to 
determine whether EID can be viewed as a replacement to the more conventional 
techniques or, as previously suggested, as an additional and beneficial tool to 
increase the available structural information.  A range of small (<1 kDa) organic 
molecules, including pharmaceutical compounds, food dyes and oligosaccharides, 
have been analysed by EID, CID and IRMPD in order to discern any patterns that 
may arise.  All of the molecules analysed contain at least one aromatic ring and one 
heteroatom, as well as a variety of functional groups.  MS/MS analysis was carried 
out on each observed molecular ion, not just the protonated species. 
 
  
3.2. Results and Discussion 
3.2.1. Analysis of haloperidol 
MS/MS analysis was carried out on haloperidol, structure shown in Figure  3.1, an 
antipsychotic drug compound chosen to represent a model pharmaceutical 
compound.  A 5 µg mL-1 solution of haloperidol in methanol was directly infused into 
the FT-ICR mass spectrometer using an electrospray source, preferentially forming 
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the singly protonated molecular ion at m/z 376.1.  The electron energies have been 
calculated according to the voltage offset applied to the cathode, as detailed in 
Chapter 8: Materials and Methods.   
 
O
N Cl
OH
F
 
Figure ‎3.1: Structure of haloperidol with empirical formula C21H23NO2FCl 
 
 
Preliminary MS/MS experiments were carried out by irradiating the [M+H]+ precursor 
with low energy electrons of 3.79 eV at an electron irradiation time of 70 ms, the 
typical parameters used for ECD analysis.  The resulting spectrum, shown in Figure 
 3.2, revealed 4 product ions all of which were lower than 0.2% the relative 
abundance of the precursor ion.  The molecular formulae assignments for each 
observed ion and the calculated relative abundance of each ion, with respect to the 
total ion abundances, have been summarised in Table  3.1.  The Ring-plus-Double-
Bond (RDB) values have been calculated for each assigned molecular formula from 
the number and valences of each element using Equation 3.1, where x is the 
number of elements with valence 4 (such as C, Si), y is the number of elements with 
valence 1 (H, F, Cl, Br, I) and z is the number of elements with valence 3 (N, P). 
 
 RDB = x – ½ y + ½ z + 1 Equation ‎3.1 
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Figure ‎3.2: Spectrum generated from the irradiation of haloperidol [M+H]+ with 3.79 eV electrons. Peaks labelled * or ν denote 
electronic noise and harmonic peaks respectively, and can be disregarded. 
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Observed 
Ion m/z 
Molecular Formula RDB 
ECD 
/ ppm 
Relative 
Intensity 
/ % 
376.14741 C21H24NO2FCl 9.5 0.0 99.752 
374.13176 C21H22NO2FCl 10.5 1.1 0.165 
358.13685 C21H22NOFCl 10.5 1.5 0.042 
165.07102 C10H10OF 5.5 -0.4 0.033 
123.02407 C7H4OF 5.5 -1.3 0.008 
Table ‎3.1: Summary of the ions observed in the low energy EID spectrum of 
the protonated haloperidol shown in Figure ‎3.2.  The spectrum has been 
calibrated using the known precursor ion molecular formula. 
 
 
RDB values ending in ½ are consistent with even-electron product ions, resulting 
from the loss of a neutral fragment(s) from the even-electron precursor ion.  
Conversely product ions assigned integer RDB values are consistent with an odd-
electron product ion corresponding to a radical cation/anion formed from the loss of 
a radical species from the even-electron precursor ion.  The product ions detailed in 
Table  3.1 are all shown to be even-electron species.  The most abundant product 
ion, observed at m/z 374.1, is proposed to result from the neutral loss of H2 from the 
precursor ion.  The product ion at m/z 358.1 is expected to result from the loss of 
H2O from the piperidine ring.  The remaining 2 product ions, at m/z 165.1 and m/z 
123.0 are purported to be formed via the dissociation of bonds on the butanone 
chain, resulting in fragments containing the fluorine-substituted benzene ring.  By 
comparison, CID of haloperidol generated 11 product ions, including 3 of the product 
ions observed by EID at m/z 358.1, m/z 165.1 and m/z 123.0.  EID of haloperidol 
thus far indicates that although it can generate product ions from singly charged 
precursor ions, further development and improvement is required in order to make it 
a suitable and informative method for structural characterisation.  
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Effect of altering electron energy  
In order to determine the optimal energy level for EID analysis, the electron energy 
applied to the haloperidol [M+H]+ precursor was gradually increased from -0.21 eV 
to 23.79 eV (as calculated from the offset applied to the ECD cathode) in stepwise 
increments of 1 eV.  At each energy level the relative abundance of the precursor 
ion and each product ion has been calculated with respect to the total ion 
abundances.  A graph following the effect of increasing the electron energy on the 
total relative intensity of the ions observed in the haloperidol MS/MS spectrum is 
shown in Figure  3.3.  The experiment was repeated twice and the resulting relative 
abundances for each product ion were averaged.  The standard deviation for each 
data point has been calculated from the ion abundances measured from each 
experiment and are displayed as error bars.  A maximum of 49 product ions were 
generated at 23.79 eV.  All product ions that remain below 0.5% of the total ion 
abundance have been removed from the graph for clarity.   
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Figure ‎3.3: The effect of electron energy on the ion abundance of haloperidol 
[M+H]+ precursor and the product ions. 
 
 76 
Below 7.79 eV the effect of altering the electron energy was minimal, with neither 
the precursor ion nor the product ion abundances showing a significant deviation.  
As the electron energy was increased beyond 7.79 eV, the relative abundance of 
the precursor ion follows a steady decline until 19.79 eV, where it appears to 
plateau, indicating that an equilibrium has been reached between ion activation and 
the formation of product ions.  At the highest electron energy, 23.79 eV, the 
precursor ion abundance appears to drop, suggesting that the increase in energy 
overcomes the bond dissociation equilibrium or neutralisation of the precursor ion 
starts to occur.  The graph shown in Figure 3.4 does not include the precursor ion 
curve in order to observe the trends followed by the product ion abundances.  The 
product ions are shown to follow the reciprocal trend to that of the precursor ion, 
following a gradual upwards trajectory with a small plateau or decline after 19.79 eV 
observed for some product ions.  The ion abundances vary according to the each 
product ion, indicating that the effect of the electron energy is different for each 
product ion and is not simply a linear progression.  The formation of product ions is 
observed from an electron energy as low as 3.79 eV, however the key turning point 
appears to occur after 7.79 eV.  This differs from investigations carried out by Lioe 
et al.,1 who investigated the effect of electron energy on tryptophan [M+H]+, noting 
an emergence of EID product ions above 13 eV.   
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Figure ‎3.4: The effect of increasing the electron energy on the relative 
intensity of the haloperidol product ions. 
 
 
The electron energy where product ion abundances reach a maximum appears to 
vary slightly between ions, averaging around 18.79 eV – 20.79 eV.  The magnitude 
of the error bars increases significantly above electron energy 18.79 eV, suggesting 
that the high electron energy affects the reproducibility of the product ion spectra.  
This effect is thought to be a consequence of the higher kinetic energies of the 
product ions and higher energy collisions resulting in ion cloud diffusion.2 
 
As the electron energy was increased, the mass accuracies of the precursor ion and 
the product ions were seen to deteriorate, noting a sharp increase in the mass 
deviation of the precursor ion as the energy is increased beyond 7.79 eV.  This 
pattern is thought to result from the deterioration of the vacuum inside the FT-ICR 
cell as the increasing energy of the electrons heats the inside of the FT-ICR cell.  
The loss in accuracy coincides with a change in vacuum pressure of the FT-ICR 
Penning Gauge, increasing from 1.25 x10-10 Torr during MS analysis to a maximum 
of 1.90 x10-10 Torr at high electron energies, thereby supporting a link between 
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mass accuracy and vacuum.  In order to counter the decline in mass accuracy, post-
acquisition calibration has been carried out using the precursor ion molecular 
formula.  At high electron energies a number of peaks were seen to appear in the 
low m/z region (< m/z 120) that could not be assigned as fragments of the 
haloperidol precursor ion, and were therefore purported to correspond to 
contaminants being emitted from the cathode at high energies.  Validation steps 
have been carried out, detailed in Chapter 9: Appendix A, in order to determine 
which peaks can be assigned as artefacts or chemical noise.  Peaks determined to 
correspond to chemical noise, silicones, plasticisers, or harmonics have been 
disregarded in all further spectra.  Having studied the effect of electron energy on 
the resulting MS/MS spectra, further experiments have been carried out at 18.79 eV 
in order to minimise the detrimental effects of the increased electron energy on 
mass accuracy, peak intensity variation and the increase in artefacts, while 
maintaining a high degree of fragmentation.   
 
EID MS/MS of haloperidol [M+H]+ 
Figure  3.5(a) shows the MS/MS spectrum obtained from the EID of haloperidol with 
an expansion of the lower 2% of the y-axis scale shown in Figure  3.6(a) to highlight 
the low intensity product ions.  A comparison between the EID spectrum of 
haloperidol, carried out at 18.79 eV, and the lower energy EID spectrum, at 3.79 eV, 
shown in Figure  3.2 indicates that the number and intensity of the products ions 
have been greatly improved, with an additional 40 product ions observed by EID 
bringing the total number of product ions to 44.  The major product ion in the lower 
energy EID spectrum corresponding to the loss of H2 at m/z 374.1, has become one 
of the lower intensity product ions at 0.083% relative to the precursor ion in the 
18.79 eV EID spectrum, reduced from 0.165% in the 3.79 eV EID spectrum.  This 
decrease in relative intensity at the higher electron energy implies that either the 
dissociation pathways have changed at increased energy, preferentially forming 
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different product ions, or that the product ion at m/z 374.1 undergoes secondary 
fragmentation to form lower m/z product ions.  Due to the high number of product 
ions formed from the EID of haloperidol, evidence of secondary activation and bond 
dissociation, the relative intensity of one product ion decreasing as another 
increases, is not clear from the graph in Figure  3.4.   
 
CID analysis was also performed on the haloperidol [M+H]+ species, with MS 
detection carried out in both the FT-ICR cell (hereafter labelled CID-FT), see Figure 
 3.5(b) and Figure  3.6(b), and in the ion trap (hereafter labelled CID-IT), see Figure 
 3.5(c) and Figure  3.6(c).  The normalised collision energy employed for CID-FT and 
CID-IT analyses was 25 arbitrary units, as per manufacturer’s software.  CID-IT 
generated 11 product ions, however only 4 were also detected in the FT spectrum, 
indicating that 7 product ions were lost during transmission between mass 
analysers.  The relative intensities of the ions has been shown to vary considerably 
between the CID spectra, most notably the precursor ion that can be seen at < 0.1% 
in the CID-IT spectrum is the second most intense peak in the CID-FT spectrum.  
The shift in relative peak intensities and loss of ions is thought to occur due to 
differences in energy between the precursor ion and product ions, specifically the 
lower product ion internal energies resulting from collisional cooling or the release of 
energy through bond dissociation, reducing the efficiency of axial ejection from the 
ion trap and transmission to the FT-ICR cell.3-4  
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Figure ‎3.5(a) EID (b) CID-FT and (c) CID-IT spectra generated from the MS/MS of the haloperidol [M+H]+. 
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Figure ‎3.6: Expansion of 2% of the y-axis of the (a) EID (b) CID-FT and (c) CID-IT spectra of haloperidol from Figure ‎3.5. 
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Of the 44 product ions observed in the EID spectrum, 8 are also observed in one or 
both of the CID spectra.  Accurate mass measurements from the FT data have 
suggested molecular formulae for each of the observed product ions, of which the 8 
common product ions are shown in Table 3.2 along with proposed structural 
assignments.  The RDB values for the assigned molecular formulae in Table 3.2 
indicate that each common product ion is an even-electron species. 
 
F
O
N
OH
Cl
b d
c e
f
a
H+
 
Product Ion 
m/z 
Chemical 
Formula 
RDB 
Proposed 
Bond 
Cleavage(s) 
358.1 C21H22NOFCl 10.5 f 
206.1 C12H13NCl 6.5 c f 
194.1 C11H13NCl 5.5 e f 
165.1 C10H10OF 5.5 d 
163.1 C10H8OF 6.5 d 
147.1 C10H8F 6.5 a d 
123.0 C7H4OF 5.5 b 
109.0 C7H6F 4.5 a b 
 
Table ‎3.2: Summary of product ions generated by both EID and CID of the 
haloperidol [M+H]+. The proposed bond cleavages do not illustrate hydrogen 
loss/migration. 
 
 
The major product ion in the EID spectrum, seen at m/z 165.1 at a relative ion 
abundance of 23.7%, is also observed in the CID spectrum and is proposed to 
correspond to the cleavage of the C-N bond  (labelled d in Table 3.2) to form a 
fragment containing the fluoro-substituted benzene ring.  Two possible reaction 
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schemes have been postulated in Figure  3.7, both involving bond dissociation 
initiated from the nitrogen lone pair.   
 
(a)
(b)
m/z 165.1
m/z 165.1
 
Figure ‎3.7: Proposed reaction mechanism for bond cleavage d (Table 3.2), 
forming the product ion at m/z 165.1 (a) the linear heterolytic cleavage of the 
N-C bond or (b) the cyclisation of the butanone chain to form a cyclical 
product ion. 
 
 
Figure  3.7(a) shows the fragmentation pathway occurring via the linear heterolytic 
cleavage of the C-N bond, to form the even-electron product ion and a neutral 
species.  An alternative fragmentation pathway has been proposed in Figure  3.7(b), 
involving the rotation of the flexible butanone chain, which gives rise to the 
possibility of forming more stable rearrangements or cyclic product ions resulting in 
stable cyclic intermediates.  Table  3.3 summarises the product ions observed solely 
in the EID product ion spectrum and the corresponding bond cleavages associated 
with each ion.   
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F
O
N
OH
Cl
H+
s
fa
b d
ec
lj
k
i o
p
r
t
g h
q
m
n
 
Product 
Ion 
m/z 
Chemical 
Formula 
RDB 
Proposed 
Bond 
Cleavage(s) 
374.1 C21H22NO2FCl 10.5 loss of H2 
341.2 C21H24NO2F 10 t 
340.2 C21H23NO2F 10.5 t 
284.1 C18H19NOF 9.5 s 
237.1 C13H16NOCl 6 k 
224.1 C12H15NOCl 5.5 c 
221.1 C13H16NCl 6 k f 
220.1 C13H15NCl 6.5 k f 
211.1 C11H14NOCl 5 e 
210.1 C11H13NOCl 5.5 e 
209.1 C11H12NOCl 6 e 
206.1 C12H13NOF 6.5 n 
194.1 C11H13NOF 5.5 m 
192.1 C11H11NCl 6.5 e f 
190.1 C12H16NO 5.5 f h r 
159.1 C11H13N 6 e f t 
146.1 C10H7F 7 a d 
 
Product 
Ion 
m/z 
Chemical 
Formula 
RDB 
Proposed 
Bond 
Cleavage(s) 
139.0 C7H4OCl 5.5 q 
138.0 C8H7OF 5 b 
137.0 C8H6Cl 5.5 f p 
135.1 C9H8F 5.5 a j 
133.0 C9H6F 6.5 a j 
129.1 C10H9 6.5 a d g 
128.1 C10H8 7 a d g 
127.1 C10H7 7.5 a d g 
125.0 C7H6Cl 4.5 f q 
115.1 C9H7 6.5 a g l  
112.1 C6H10NO 2.5 c r 
95.0 C6H4F 4.5 i 
84.1 C5H10N 1.5 e f r 
75.0 C6H3 5.5 g i 
74.0 C6H2 6 g i 
57.1 C3H7N 1 e o 
56.0 C3H6N 1.5 e o 
 
Table ‎3.3: Summary of product ions of haloperidol [M+H]+ unique to EID. 
Proposed bond cleavages do not illustrate hydrogen loss/migration. 
Cleavages labelled in blue are not observed at 3.79 eV.  
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The product ions detailed in Table  3.3 are shown to be a mixture of odd-electron 
and even-electron species, suggesting that EID occurs via multiple fragmentation 
pathways creating product ions formed via heterolytic cleavage, homolytic cleavage 
or intramolecular rearrangements.  The proposed bond cleavages indicate that EID 
has the ability to cleave a greater number of bonds than CID, most importantly 
generating cross-ring fragmentation that was not observed by CID.  Cleavage 
across aromatic rings, labelled h and s in Table 3.3, is proposed to follow electron 
interaction at the aromatic ring, disrupting the π-electron system and initiating bond 
dissociation.5-6  Due to the high mass precision of the FT-ICR MS, the mass 
difference between the peaks can be measured accurately and precisely enough to 
differentiate between the mass of 1H, 1.007825 Da, and the mass difference 
between the 12C and 13C isotopes, 1.003355 Da, as shown in Figure  3.8, lending 
confidence to molecular formulae assignments.  The observation of product ion 
multiplets corresponding to species differing only in the number of hydrogen atoms 
confirms the tendency for EID to allow intramolecular hydrogen migration or 
abstraction, a pattern that is commonly observed by ECD.  The process of electron 
capture and subsequent bond dissociation is rapid, typically in the picosecond time 
scale7, suggesting that hydrogen scrambling occurs prior to electron capture8 or 
after bond dissociation.9  Evidence of hydrogen scrambling by CID is also 
widespread, however due to the slower vibrational energy redistribution, 
intramolecular hydrogen migration is thought to be possible before or after bond 
dissociation.10  EID is proposed to follow any one of several fragmentation 
pathways, including electronic excitation, vibrational excitation or secondary 
ionisation leading to electron capture, therefore the mechanism of hydrogen 
migration is thought to be dependant on the preceding ion activation step. 
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Figure ‎3.8: Peak grouping observed in the haloperidol EID spectrum, where 
the m/z 340.2 and m/z 341.2 peaks differ by an H•, corresponding to the loss of 
HCl and Cl• respectively, and the m/z 342.2 corresponds to the 13C species. 
 
 
Limit of Detection for EID MS/MS 
In order to determine the lower Limit of Detection (LOD) for EID, analysis of 
haloperidol was carried out at a range of concentrations between 50 pg mL-1 and 5 
µg mL-1 via direct infusion and compared with CID-FT and CID-IT on the LTQ-FT.  
The automatic gain control (AGC) adjusts the ion injection time according to the 
number of ions entering the FT cell, so as to avoid space charge effects caused by 
too many ions trapped in the cell.  At low sample concentrations, the injection time 
required to meet the AGC target may be greater than the specified injection time 
limit, thereby trapping and detecting an insufficient number of ions and affecting the 
mass accuracy and signal-to-noise of the resulting spectrum.  As a result, the lower 
LOD may vary according to the preset AGC and injection time limits.  For the 
purpose of these experiments, the maximum injection time and the AGC target 
settings were fixed for all sample concentrations, as detailed in Chapter 8: 
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Materials and Methods.  The product ion spectra were generated by averaging 25 
MS/MS scans for each technique so as to ensure a fair comparison.  The 
experiments were carried out in triplicate and the average numbers of product ions 
generated for each sample have been charted in Figure  3.9.  At a concentration of 1 
ng mL-1 product ions start to appear by EID, gradually increasing in number until 
reaching a maximum at the concentration of 1 μg mL-1.  By comparison, CID-IT 
analysis generated 4 product ions from the 50 pg mL-1 sample, gradually increasing 
until 0.5 µg mL-1 where the number of product ions plateaus.  Due to the loss of low 
energy ions during transmission between the ion trap and the FT, CID-FT generates 
fewer product ions at each concentration, the lower LOD increases to 0.5 ng mL-1 
and the maximum number of product ions is observed at 10 ng mL-1. 
 
 
Figure ‎3.9: Graph indicating the number of product ions generated at each 
sample concentration from the MS/MS of haloperidol. 
 
 
EID has been shown to be less sensitive than CID, requiring higher sample 
concentrations to produce MS/MS data, however EID was found to generate up to 
four times as many product ions for haloperidol, at concentrations higher than 5 ng 
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mL-1, indicating the vast amount of structural information that can be gained by 
using EID.  The detection limits are dependent on a number of instrumental and 
sample factors, including maximum injection time, AGC target, ionisation efficiency 
and MS/MS efficiency, and therefore the lower LOD may vary for different 
compounds and instrumental settings.  Although not universal, the results 
determined for haloperidol provide an insight into the capabilities of EID. 
 
EID MS/MS of haloperidol [M+Na]+ 
Samples ionised by ESI are often observed as adducts corresponding to different 
charge-carrying species, such as [M+Na]+, [M+K]+ or [M+NH4]
+.  In certain cases 
these molecular ions may be preferentially formed over the protonated species, 
therefore it important to understand the effect different charge-carriers may have on 
the MS/MS product ions.  The MS spectrum of haloperidol included the sodium-
adducted species at m/z 398, which was targeted for further MS/MS analysis.  The 
product ion spectrum generated from the EID of the haloperidol [M+Na]+ is shown in 
Figure  3.10(a) and in the expansion of 0 - 2% of the y-axis scale in Figure  3.11(a), 
and has been compared to the EID spectrum generated from the [M+H]+ precursor 
as shown in Figure  3.10(b) and Figure  3.11(b).   
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Figure ‎3.10: EID spectra of haloperidol (a) [M+Na]+ and (b) [M+H]+. 
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Figure ‎3.11: Expansion of the EID spectra of haloperidol (a) [M+Na]+ and (b) [M+H]+ shown in Figure ‎3.10. Product ions common to 
both precursors are highlighted in red. Product ions highlighted in blue represent sodium-adducted species that are observed in 
protonated form in [M+H]+. 
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The EID of the sodium-adducted precursor ion generated 18 product ions, far less 
than the 37 generated by the protonated species, however only 4 of these product 
ions are seen to lose the sodium cation to form product ions common with the 
protonated EID spectrum, as highlighted in Figure  3.11 and graphically represented 
in Figure  3.12.  These common ions are thought to occur via charge transfer from 
the sodium cation, thereby resulting in the loss of a sodium atom and the formation 
of a protonated product ion.  Of the remaining 14 product ions in the [M+Na]+ 
spectrum, only 5 correspond to the sodium-adducted equivalents of product ions 
observed in the protonated spectrum, including the product ion formed by the loss of 
H2 from the precursor ion, and consequently 9 product ions are exclusively formed 
by the [M+Na]+ species.  The product ions observed from the EID of the [M+Na]+ 
species have been detailed in Table 3.4, indicating the proposed bond cleavages.   
 
14 334
[M+Na]+ Product Ions
[M+H]+ Product Ions
9 5
Unique Common Ions
-H / +Na
 
Figure ‎3.12: Venn diagram displaying the comparison between product ions 
generated by the EID of [M+H]+ and [M+Na]+ precursors. 
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Product 
Ion 
m/z 
Chemical 
Formula 
RDB 
Proposed 
Bond 
Cleavage(s) 
Present 
in [M+H]
+
 
EID 
396.1 C21H21NO2FClNa 10.5 loss of H2 - Na / +H 
363.2 C21H23NO2FNa 10 l - Na / +H 
362.2 C21H22NO2FNa 10.5 l - Na / +H 
260.1 C13H16NOClNa 5.5 c - 
237.1 C13H16NOCl 6 c Y 
232.0 C11H12NOClNa 5.5 g - Na / +H 
231.1 C12H15NOFNa 5 i - 
230.1 C12H14NOFNa 5.5 i - 
224.1 C12H15NOCl 5.5 e Y 
216.1 C11H12NOFNa 5.5 h - 
190.0 C9H8OClNa 5 j - 
189.0 C9H7OClNa 5.5 j - 
174.0 C9H8OFNa 5 d - 
173.0 C9H7OFNa 5.5 d - 
165.1 C10H10OF 5.5 f Y 
160.0 C8H6OFNa 5 b - Na / +H 
123.0 C7H4OF 5.5 a Y 
98.1 C6H12N 1.5 e k - 
 
Table ‎3.4: Summary of product ions formed by EID of haloperidol [M+Na]+. 
Proposed bond cleavages do not illustrate hydrogen loss/migration. Bond 
cleavages in blue are not observed in the protonated EID data. Y indicates 
product ions common to [M+H]+ and [M+Na]+. 
 
 
The product ions and bond cleavages proposed in Table 3.4 indicate a significant 
reduction in the number of bonds broken upon EID of the [M+Na]+ species 
compared to the protonated EID data shown in Table 3.2 and Table 3.3.  Cross-ring 
cleavages within the aromatic rings are no longer observed, however a new bond 
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cleavage within the piperidine ring has emerged.  This observation implies that the 
charge-carrying species can not only influence the number of product ions formed, 
but also the resulting fragmentation pathways and therefore analysing multiple 
molecular ions for any given compound can increase the amount of structural 
information that can be produced.  The product ions shown in Table  3.4, in 
particular product ions at m/z 165.1 and m/z 98.1, suggest that the sodium cation 
can reside in at least 2 different positions on the haloperidol molecule, either on the 
piperidine ring or the fluoro-substituted benzaldehyde group whereas by comparison 
the product ions formed from the [M+H]+ precursor suggest protonation could occur 
on the piperidine ring or either of the benzene groups.  Knowledge of cation 
locations could allow for the manipulation of MS/MS product ions in order to focus 
structural information on specific areas of the precursor ion.  Investigations into 
sodium affinities of small molecules and amino acids have determined that the 
interaction between Na+ and aromatic, π-electron systems is particularly stable.11-12  
This suggests that, in the case of haloperidol, the metal cation can reside on the 
piperidine ring or either of the benzene groups, although confirmation of the sodium 
residing on the chloro-subsitituted benzene is not possible from MS/MS data alone.  
 
3.2.2. EID of doubly charged cations 
Multiply charged ions are observed less frequently during ESI MS analysis of small 
organic molecules due to the requirement of more than one charge site in such 
close proximity, however on occasion, when the cation affinity is sufficiently high, 
multiply charged species can be formed.  Haloperidol was not observed as a doubly 
charged ion, therefore further study has been carried out on cediranib, structure 
shown in Figure  3.13, which was observed as a singly and doubly protonated 
molecular ion, at m/z 451.2 and m/z 226.1 respectively, postulated to reside on one 
of the heteroatoms.  
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Figure ‎3.13: Structure of cediranib 
 
 
Cediranib [M+H]+ and [M+2H]2+ were irradiated with 18.79 eV electrons, generating 
product ion spectra for EID and hECD respectively.  A direct comparison between 
the EID of the [M+H]+ precursor, see Figure  3.15(a), and the [M+2H]2+ precursor, 
see Figure  3.15(b), indicated a comparable degree of fragmentation generate by 
each species, with 43 and 40 product ions respectively.  Despite the similarity in the 
number of product ions, each spectrum contains product ions that are unique to their 
respective precursor ion, with only 27 product ions common to both molecular ions.  
A distinct variation in the product ion abundances is also evident between the two 
spectra.  The most abundant product ion in the EID spectrum of the [M+H]+ species 
corresponds to the peak at m/z 112.1, which is proposed to result from the cleavage 
of the C-O bond to generate the propylpyrrolidine fragment.  The propylpyrrolidine 
group is observed as the most abundant ion from CID, indicating that the C-O bond 
is the weakest bond in the molecule.  Conversely, the most abundant product ion 
generated from the [M+2H]2+ precursor is observed at m/z 338.1 corresponds to the 
cleavage of the same C-O bond to form the reciprocal fragment, as shown in Figure 
 3.14.  The change in the major product ion between the [M+H]+ and [M+2H]2+ 
precursor ions suggests that electron capture, and subsequent charge 
neutralisation, occurs at the propylpyrrolidine arm of the doubly charged species, 
thereby creating a neutral propylpyrrolidine fragment and the singly charged indole-
quinazoline. 
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Figure ‎3.14: Major bond cleavage occurring via the MS/MS of cediranib. 
 
 
A significant observation in the EID spectrum of the [M+H]+ species was the 
presence of 2 doubly charged product ions, at m/z 216.1 and m/z 215.6, consistent 
with the loss of F• and HF respectively.  The formation of doubly charged product 
ions from a singly charged precursor is consistent with the proposed theory that 
bond dissociation by EID occurs through electron ionisation, forming the [M+H]2+• 
intermediate that can lose neutral species to form doubly charged product ions, as 
shown in Scheme 3.1 and Scheme 3.2.13-14  
 
[M+H]+  +  e-  →  [M+H]2+•  +  2e- Scheme 3.1 
 
 [M+H]2+•  →   [product ion +H]2+  +  neutral• Scheme 3.2 
 
Singly charged product ions are proposed to form via one of several dissociation 
pathways, detailed in Schemes 3.3 – 3.6; vibrational excitation of the [M+H]+ 
precursor, electronic excitation of the [M+H]+ precursor, electron capture by the 
[M+H]2+• intermediate, or bond dissociation of the [M+H]2+• intermediate to form 2 
singly charged product ions.   
 
[M+H]+  →  [M+H]+* Scheme 3.3 
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[M+H]+  +  e-  →  [M+H]+*  +  e- Scheme 3.4 
 
[M+H]+  +  e-  →  [M+H]2+•  +  2e-  →   [M+H]+* +  e-   Scheme 3.5 
 
[M+H]2+•  →  [product ion]+  +  [product ion]+• Scheme 3.6 
 
No evidence of doubly charged product ions was seen from EID of haloperidol, 
suggesting that the [M+H]2+• intermediate is short-lived, more unstable than the 
cediranib [M+H]2+•, rapidly capturing an electron to form the [M+H]+* excited state ion 
prior to bond dissociation, as shown in Scheme 3.5.13   
 
The EID spectrum of the cediranib [M+2H]2+ contained 7 doubly charged product 
ions, including the 2 generated by the [M+H]+ precursor, which were generated by 
neutral losses from the precursor.  There is no evidence of triply charged species 
formed from the electron ionisation of the doubly charged precursor, suggesting that 
either the [M+2H]3+• species is a short-lived intermediate or that the mechanism of 
fragmentation proceeds via an alternative route, such as electron capture, electronic 
excitation (without secondary ionisation) or vibrational excitation.1, 14  
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Figure ‎3.15: EID of (a) the [M+H]+ precursor and (b) the [M+2H]2+ precursor of cediranib. Inset: Expansion of (b) indicating doubly 
charged product ions formed from neutral losses from the [M+2H]2+ species. 
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3.2.3. EID analysis of anions 
EID analysis has also been carried out on negatively charged precursor ions, to 
determine whether the ionisation polarity has an effect on the ion activation and 
subsequent dissociation.  Among the compounds analysed by negative ion EID was 
the food dye Allura Red, structure shown in Figure  3.16, which contains two SO3Na 
functional groups, both of which have the ability to lose a sodium cation resulting in 
the negatively charged SO3
- group.  As a result, two molecular ions were observed; 
the [M-Na]- and the [M-2Na]2-, which were targeted for MS/MS analysis.   
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Figure ‎3.16: Structure of Allura Red (E129) 
 
 
A direct comparison between EID of the Allura Red [M-Na]- and [M-2Na]2- 
precursors has been shown in Figure  3.17.  Electron irradiation of the doubly 
charged species is expected to result in electron detachment, akin to the EDD of 
multiply charged polypeptides.  The spectrum generated from the singly charged 
precursor resulted in only 1 product ion, at m/z 182.0, corresponding to the 
molecular formula C7H4NO3S and resulting from the cleavage of the N=N bond and 
the loss of the methoxy group from the benzene ring to form the 2-
methylbenzenesulphonate fragment.  The spectrum generated from the doubly 
charged precursor shows a significantly higher degree of fragmentation resulting in 
19 product ions, including 3 doubly charged product ions following neutral losses 
from the precursor ion.  
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Figure ‎3.17: EID spectrum of (a) the [M-Na]- precursor and (b) the [M-2Na]2- precursor of Allura Red. 
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 The peak at m/z 182.0 in the [M-Na]- spectrum is not observed in the [M-2Na]2- 
spectrum, however a peak at m/z 186.0 with the empirical formula C7H8NO3S is 
observed, corresponding to a fragment containing the same portion of the Allura 
Red structure, as indicated in Figure  3.18.    
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Figure ‎3.18: Proposed bond cleavages to form the product ion at m/z 186.0 in 
the [M-2Na]2- spectrum. 
 
 
A peak at m/z 450.0 corresponds to the charge-reduced species [M-2Na]-•, 
suggesting that one possible dissociation mechanism involves electron ejection, 
effectively EDD15, from the doubly charged precursor to create an unstable radical 
anion that results in bond dissociation to form more stable product ions, as shown in 
Scheme 3.7.   
 
[M-2Na]2-  +  e-  →  [M-2Na]-•  +  2e- Scheme 3.7 
 
Bond dissociation via electron detachment may account for the differences in 
product ion spectra between the singly and doubly charge precursor ions.  The 
presence of doubly charged product ions suggests that dissociation of the [M-2Na]2- 
can also proceed via electronic or vibrational excitation of the precursor ion, 
resulting in the loss of neutral fragments, as shown in Scheme 3.8 and Scheme 3.9 
respectively.   
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[M-2Na]2-  +  e-  →  [M-2Na]2-*  +  e- Scheme 3.8 
 
[M-2Na]2-  →  [M-2Na]2-* Scheme 3.9 
 
Doubly charged product ions may also be formed via electron capture by the 
charge-reduced intermediate to form the electronically-excited doubly charged 
species, shown in Scheme 3.10, followed by the loss of neutral fragments. 
 
 [M-2Na]2-  +  e-  →  [M-2Na]-•  +  e-  →  [M-2Na]2-* Scheme 3.10 
 
Product ions resulting from the loss of the N2 group, while retaining both the 
benzene and naphthalene groups, indicates the tendency for structural 
rearrangements before or during bond dissociation.  Product ions resulting from 
structural rearrangements were also noted in the CID and IRMPD spectra 
suggesting that the rearrangements may be due, to some extent, to the vibrational 
excitation of the precursor ion.  Figure  3.19 indicates the bond cleavages occurring 
to form a product ion resulting from structural rearrangement, with the molecular 
formula C16H11O4S, which is observed by EID, CID and IRMPD. 
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Figure ‎3.19: Structural rearrangement of Allura Red, forming the product ion 
C16H11O4S at m/z 299.0. 
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The 5 product ions proposed to result from structural rearrangement to lose the N2 
group all contain the hydroxy-napthalene group and the benzene ring, suggesting 
that a cyclisation reaction occurs between the oxygen and the benzene group, 
releasing the N2 group. 
 
3.2.4. MS/MS analysis of a range of small organic molecules 
A wider range of small organic molecules, between 100 – 1000 Da and observed 
with different charge-carrying species, have been analysed by MS/MS.  The product 
ions generated by CID-FT share a high commonality to the product ions observed 
by CID-IT, and therefore have been excluded from further interpretation unless 
accurate mass measurements are required.  In order to comprehensively compare 
EID with the available MS/MS techniques and overcome the one-third cut-off rule 
governing CID carried out in the ion trap, MS/MS analysis has also been carried out 
using IRMPD performed in the FT-ICR cell, and CID performed on a QToF mass 
analyser.  The resulting product ion data for each compound has been summarised 
in Table 3.5, detailing the number of product ions generated by EID, CID-IT, QToF-
CID and IRMPD, as well as the number of unique product ions observed.   
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Compound 
Precursor 
Ion 
EID CID-IT QToF-CID IRMPD 
Haloperidol 
[M+H]
+
 44 (28) 11 (1) 24 (7) 4 (0) 
[M+Na]
+
 18 (15) 11 (6) 4 (3) 0 (0) 
[M-H]
-
 0 (0) 9 (3) 14 (9) 8 (1) 
Allura Red 
[M-Na]
-
 1 (0) 21 (2) 30 (17) 16 (0) 
[M-2Na]
2-
 19 (3) 22 (3) 31 (12) 39 (8) 
AZ_B1 
[M+H]
+
 70 (30) 31 (6) 44 (2) 30 (1) 
[M+Na]
+
 14 (12) 8 (5) 3 (0) 3 (1) 
[M-H]
-
 0 (0) 21 (8) 4 (1) 1 (0) 
AZ_B2 
[M+H]
+
 39 (26) 16 (4) 12 (2) 10 (0) 
[M+Na]
+
 43 (37) 11 (5) 5 (2) 2 (0) 
[M-H]
-
 7 (4) 12 (0) 5 (0) 47 (33) 
AZ_B3 
[M+H]
+
 7 (1) 18 (1) 21 (4) 18 (2) 
[M+Na]
+
 17 (14) 2 (0) 8 (5) 0 (0) 
AZ_B4 
[M+H]
+
 25 (17) 5 (1) 12 (3) 5 (0) 
[M+Na]
+
 1 (1) 0 (0) 0 (0) 1 (1) 
AZ_C1 
[M+H]
+
 22 (10) 13 (4) 9 (0) 4 (0) 
[M+Na]
+
 3 (2) 10 (7) 10 (6) 3 (1) 
AZ_C2 
[M+Na]
+
 23 (14) 16 (1) 14 (3) 6 (0) 
[M-H]
-
 16 (4) 20 (1) 25 (2) 16 (2) 
AZ_C3 
[M+Na]
+
 7 (1) 8 (1) 9 (3) 5 (0) 
[M-H]
-
 5 (1) 5 (1) 14 (5) 12 (4) 
AZ_C4 
[M+Na]
+
 21 (11) 6 (1) 9 (1) 7 (3) 
[M-H]
-
 0 (0) 7 (0) 10 (2) 15 (6) 
AZ_C5 
[M+Na]
+
 16 (6) 19 (7) 14 (1) 11 (1) 
[M-H]
-
 0 (0) 1 (0) 8 (6) 4 (2) 
Brilliant Blue 
[M-Na]
-
 6 (0) 42 (7) 32 (4) 43 (10) 
[M-2Na]
2-
 21 (4) 30 (7) 27 (9) 6 (0) 
Caffeine [M+H]
+
 10 (0) 9 (1) 10 (2) 1 (0) 
Cediranib 
[M+H]
+
 43 (36) 8 (3) 5 (0) 2 (0) 
[M+Na]
+
 31 (27) 3 (1) 3 (1) 3 (0) 
[M-H]
-
 8 (0) 40 (0) 45 (11) 43 (6) 
Diphenhydramine 
[M+H]
+
 10 (4) 2 (0) 8 (3) 3 (0) 
Fragment 14 (0) 9 (0) 17 (6) 4 (0) 
Gefitinib 
[M+H]
+
 42 (25) 13 (5) 19 (2) 4 (0) 
[M+Na]
+
 6 (3) 7 (2) 3 (0) 1 (0) 
[M-H]
-
 1 (0) 12 (1) 16 (4) 23 (8) 
[M+Cl]
-
 0 (0) 1 (0) 7 (1) 23 (17) 
Omeprazole 
[M+H]
+
 49 (21) 15 (1) 31 (5) 6 (0) 
[M+Na]
+
 27 (14) 13 (0) 11 (2) 5 (1) 
[M+K]
+
 9 (2) 17 (6) 4 (3) 9 (1) 
[M-H]
-
 2 (0) 10 (4) 5 (1) 5 (0) 
Raffinose 
[M+Na]
+
 47 (37) 15 (6) 7 (0) 7 (0) 
[M-H]
-
 2 (0) 13 (0) 24 (0) 35 (15) 
Reserpine 
[M+H]
+
 132 (71) 48 (1) 50 (9) 39 (3) 
[M-H]
-
 1 (0) 18 (3) 14 (4) 29 (15) 
Ritonavir 
[M+H]
+
 16 (6) 20 (3) 22 (1) 10 (0) 
[M+Na]
+
 41 (16) 25 (1) 48 (11) 7 (1) 
Sulfamethazine 
[M+H]
+
 20 (7) 9 (0) 14 (3) 7 (0) 
[M+Na]
+
 6 (3) 3 (1) 4 (2) 2 (0) 
Sunset Yellow 
[M-Na]
-
 5 (0) 27 (0) 45 (26) 27 (4) 
[M-2Na]
2-
 17 (5) 14 (4) 22 (11) 11 (2) 
Terfenadine 
[M+H]
+
 87 (45) 3 (0) 24 (5) 15 (1) 
[M+Na]
+
 13 (12) 4 (2) 3 (2) 0 (0) 
 
Table ‎3.5: Summary of product ions generated from each MS/MS technique for 
each compound and observed molecular ions. Unique product ions have been 
shown in parentheses. 
 104 
The technique(s) generating the greatest number of product ions and/or the highest 
number of unique product ions for each molecular ion have been highlighted in red 
in Table 3.5.  Of the four MS/MS techniques, each is seen to excel for different 
molecular ions, suggesting that no one technique is infallible.  In order to determine 
if any trends are beginning to form, the number of product ions generated by each 
technique and polarity have been summarised in Table 3.6.   
 
  EID CID-IT QToF-CID IRMPD 
Cationic 
Precursors 
Total Product Ions 965 408 481 234 
Average Number of 
Product Ions 
28 12 14 7 
Anionic 
Precursors 
Total Product Ions 112 325 378 403 
Average Number of 
Product Ions 
6 17 20 21 
 
Table ‎3.6: Summary of the total number and the average number of product 
ions generated by each technique for each ion polarity. 
 
 
EID was found to generate an average of 28 product ions for positively charged 
precursors compared to 6 product ions for negatively charged precursors, 
supporting the previous observation that EID favours cationic precursors.  This trend 
is consistent with comparisons between ECD and EDD, where ECD of multiply 
charged cations has been seen to generate a higher degree of fragmentation than 
EDD.16  Discounting the 3 doubly charged anionic precursors, the average number 
of product ions generated by EID of anions reduces by 50%, suggesting that 
electron detachment is the primary dissociation mechanism for negatively charged 
species.   
 
The structures of the analysed compounds, shown in Figure  3.20, Figure  3.21 and 
Figure  3.22, each contained at least one aromatic ring and one heteroatom.  The 
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five most abundant ions in each EID spectrum were studied and the proposed bond 
cleavages have been indicated on each structure.  Two compounds containing an 
N=N bond in the centre of the molecule (Allura Red and Sunset Yellow) generated 
product ions formed via the loss of N2 from the molecular ion.  Similar 
rearrangements were observed for compounds AZ_B2 and AZ_C4, both of which 
contained a CH3SO2 group and noted the loss of SO2 whilst retaining the methyl end 
group, and Sulfamethazine, which lost SO2 from the centre of the molecule.  A high 
proportion of the EID bond cleavages occur on single bonds, such as the C-C alkyl 
bonds, however EID was also seen to generate cross-ring fragmentation and 
product ions formed via multiple bond cleavages, allowing a high degree of 
structural information to be gathered, including information regarding the location of 
ring substituents.  By comparison, CID tends to cleave bonds adjacent to aromatic 
groups, keeping the stable ring systems intact, thereby giving EID the advantage for 
compounds containing aromatic rings.  The ability to cleave multiple bonds is 
important for providing information about the central portion of the molecules and 
not solely the end groups.  Common losses include stable species such as CO, 
CO2, SO2, SO3, HCl, CH3SO2, N2, CH3O, CH3, H2O, t-butyl have been observed, 
supporting previous literature investigations into common fragmentation pathways of 
even-electron molecular ions.5, 17-18  A direct comparison between the product ions 
generated by [M+H]+ and [M+Na]+ precursors showed that, barring three 
compounds, the protonated precursor ions generated more product ions and 
cleaved more bonds than the equivalent sodium-adducted precursor ion, suggesting 
that the sodium cation may restrict electron interaction sites or migration within the 
precursor ion.  This trend is consistent with studies carried out by O’Hair et al.19 into 
EID of tryptophan, which postulated that the presence of a metal cation has a 
significant effect on the product ions formed and severely limits the amounts of 
hydrogen scrambling observed. 
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Figure ‎3.20: Proposed EID bond cleavages generating the most intense product ions for compounds discussed in Table 3.5 (Allura 
Red – AZ_C3). 
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Figure ‎3.21: Proposed EID bond cleavages generating the most intense product ions for compounds discussed in Table 3.5 (AZ_C4 - 
Gefitinib). 
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Figure ‎3.22: Proposed EID bond cleavages generating the most intense product ions for compounds discussed in Table 3.5 
(Omeprazole - Terfenadine). 
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3.2.5. Effect of altering electron irradiation time 
In order to improve the EID spectra generated from negatively charged precursor 
ions, experiments were carried out to observe whether changing the length of 
electron irradiation would have a beneficial effect on the resulting product ion 
spectra.  EID analysis of the haloperidol [M-H]- species at the default electron 
irradiation time of 70 ms failed to generate any product ions.  Further EID analysis 
was carried out at the fixed electron energy of 18.79 eV but altering the electron 
irradiation times between 10 ms to 150 ms, in 10 ms increments, in order to 
determine whether a change in the irradiation time could induce bond dissociation.  
As the irradiation time was increased, the absolute intensity of the precursor ion was 
seen to steadily decrease, however no product ions were observed suggesting that 
the EID of the haloperidol [M-H]- species results in the neutralisation of the precursor 
ion via electron ejection.  The data generated by EID of haloperidol at varying 
electron energies has not been shown.  
 
Further work was carried out on cediranib, which was found to generate 8 product 
ions by EID of the [M-H]- at the default irradiation time of 70 ms.  The relative 
abundances of the observed product ions were calculated at each electron 
irradiation time, ranging from 10 ms to 150 ms.  The experiment was repeated three 
times and the relative ion abundances at each irradiation time were averaged and 
have been graphically represented in Figure  3.23.   
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Figure ‎3.23: The effect of electron irradiation on the relative intensity of the 
observed product ions. 
 
 
As the irradiation time increases, the relative abundances of the product ions were 
seen to increase, indicating that the efficiency of fragmentation varies with the 
electron irradiation time.  The greatest effect of irradiation time is observed between 
10 ms and 50 ms, where the relative ion abundances are seen to gradually 
increase.  Irradiation times longer than 50 ms are shown to have little effect on the 
product ion abundances, displaying a relatively stable signal.  Below 20 ms, the 
three lowest abundant product ions were not observed, suggesting that altering the 
irradiation times can not only affect the peak intensities but also the number of 
product ions.  
 
3.2.6. Comparison between EID and alternative ionisation techniques 
Following on from the observations made from altering the charge carrying species, 
further work has been carried out to determine what effect changing the ionisation 
technique, and thus changing the molecular ion, has on bond dissociation.  The 
compound haloperidol has been analysed using Electron Ionisation (EI) and 
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Atmospheric pressure Solids Analysis Probe (ASAP), previously described in 
Chapter 2, comparing the resulting data with the previously observed spectra from 
EID, CID-FT, CID-IT, QToF-CID and IRMPD. 
 
Electron Ionisation 
Whereas electrospray ionisation readily results in proton transfer from solvent to 
sample generating the even-electron [M+H]+ species at m/z 376.1 and minimal in-
source dissociation, EI generates the unstable odd electron M+• radical cation at m/z 
375.1 that readily dissociates.  One of the proposed fragmentation pathways 
followed by EID occurs via the secondary ionisation of the [M+H]+ precursor to form 
an odd-electron species, and odd-electron product ions are commonly observed, 
therefore a comparison between EI and EID spectra has been carried out in order to 
determine any similarities, as shown in Figure  3.24. 
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Figure ‎3.24: Analysis of haloperidol by (a) EI and (b) EID. Common ions are highlighted in red. 
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The EI spectrum of haloperidol contained 41 ions, compared with 37 generated by 
the EID of the [M+H]+ species, however only 15 ions were common to both 
techniques.  The commonalities between EI and EID suggest that the dissociation of 
the M+• radical cation follows a similar fragmentation pathway to EID of the [M+H]+ 
precursor, further suggesting that EID dissociation can occur via an odd-electron 
species.  The product ions generated by EI MS and the product ions observed by 
the ESI MS/MS analysis of the [M+H]+ species, and have been summarised in Table 
3.7.  IRMPD was the only technique that was not shown to generate any unique 
product ions, whereas each of the other methods generated at least one unique 
product ion.  The low percentages of common product ions (< 41%) between the 
EID product ions and each of the other techniques further supports the 
complementary nature of EID and the benefits of using multiple dissociation 
techniques when attempting to structurally characterise unknown compounds.  
 
 EID CID-IT QToF-CID IRMPD EI 
Total Product 
Ions 
37 11 24 4 41 
Unique Product 
Ions 
14 1 3 0 21 
Product Ions 
Common with 
EID 
N/A 8 15 3 15 
 
Table ‎3.7: Summary of the number of product ions generated by each MS and 
MS/MS technique. 
 
 
Atmospheric pressure Solids Analysis Probe 
ASAP analysis was carried out in an attempt to generate the M+• radical cation 
species, in order to determine whether CID of the odd-electron molecular ion would 
generate different product ion spectra compared with CID of the even-electron 
molecular ion.  The ASAP analysis of a 1 mg mL-1 sample of haloperidol in methanol 
 114 
was found to preferentially generate the [M+H]+ species at m/z 376.1.  By 
comparison, the MS spectrum generated from the solid haloperidol sample under 
dry source conditions produced both the [M-H-]+ and [M+H]+ species, as shown in 
Figure  3.25.  
 
m/z
370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385
%
0
100
Haloperidol_Solid_5 6 (0.205) Cm (4:11) TOF MS  
3.77e6
m/z
370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385
%
0
100
Haloperidol_1 14 (0.478) Cm (9:27) TOF MS  
4.21e7
0
100
R
e
la
ti
v
e
 A
b
u
n
d
a
n
c
e
37 3 3 3 37 3 3 3 386 3 3 2 374 376 3 3 3 384 386
(a) (b)
374.3
376.3
376.3
378.3
0
100
R
e
la
ti
v
e
 A
b
u
n
d
a
n
c
e
m/z m/z
[M+H]+[M-H-]+
[M+H]+
% %
R
e
la
ti
v
e
 A
b
u
n
d
a
n
c
e
R
e
la
ti
v
e
 A
b
u
n
d
a
n
c
e
R
e
la
ti
v
e
 A
b
u
n
d
a
n
c
e
R
e
la
ti
v
e
 A
b
u
n
d
a
n
c
e
 
Figure ‎3.25: ASAP MS of (a) solid-state haloperidol generating a combination 
of the [M+H]+ and [M-H-]+ species and (b) solution-state haloperidol generating 
only the protonated species. 
 
 
The isotopic profile of the solution-state sample displays the typical isotope pattern 
associated with a chlorine-containing compound.  The peak at m/z 376.3 in the 
solid-state sample is expected to correspond to an amalgamation of the [M+H]+ 
species and the 37Cl isotope of the [M-H-]+ species.  The peak at m/z 375.3 in the 
solid-state sample is consistent with 13C isotope of the hydride-abstracted species, 
not the M+• species.  ASAP-CID analysis was performed on both the protonated 
species formed from the solution-state sample and the hydride-abstracted species 
from the solid-state sample.  The M+• radical cation was not observed, therefore 
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comparisons between CID of odd-electron species with EID of even-electron 
species could not be carried out. 
 
A direct comparison between the spectra generated by ASAP-CID of the [M+H]+ and 
the [M-H-]+ precursors noted 3 significant product ions in each spectrum that could 
be used to locate the protonation site or hydride abstraction site.  Each of the 3 
product ions in the [M-H-]+ spectrum are observed at 2 Da less than the product ions 
in the [M+H]+ spectrum, consistent with a difference of H2.  Table 3.8 details the 3 
product ion pairs and their corresponding bond cleavages.  The 3 product ions 
generated from the protonated species are also observed by EID and CID-FT, 
allowing the molecular formulae and structural assignments to be proposed. 
 
H+/-H-F
O
N
OH
Cl
c
ba
 
Product Ion 
m/z Chemical 
Formula 
RDB 
Proposed 
Bond 
Cleavage(s) [M+H]
+
 [M-H
-
]
+
 
358.1 - C21H22NOFCl 10.5 c 
- 356.1 C21H20NOFCl 11.5 c 
206.1 - C12H13NCl 6.5 a c 
- 204.1 C12H11NCl 7.5 a c 
194.1 - C11H13NCl 5.5 b c 
- 192.1 C11H11NCl 6.5 b c 
 
Table ‎3.8: Summary of the 3 product ion pairs generated by ASAP-CID of 
haloperidol.   
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The 3 product ion pairs are all proposed to contain the 4-(4-chlorophenyl)piperidine 
structure of the haloperidol molecule, suggesting that the likely location for hydride 
abstraction is on the piperidine ring, suspected to occur at a carbon atom adjacent 
to the nitrogen atom resulting in a positive charge on the nitrogen.   
 
Further work detailed herein has focused on developing EID as a fast and efficient 
method for LC-MS/MS analysis of pharmaceutical molecules, therefore validation of 
ASAP-MS and the manipulation of source conditions to generate the M+• molecular 
ion has not been carried out.  
 
 
3.3. Conclusions 
Studies thus far have confirmed the suitability for EID analysis of small singly 
charged molecules, producing a high degree of fragmentation and unique structural 
information that other techniques have failed to produce.  Inspection of the resulting 
EID product ion spectra noted the presence of odd-electron and even-electron 
product ions, as well as commonalities between EID and other dissociation 
techniques, which suggests that competing fragmentation mechanisms occur 
following the interaction with electrons.  The mechanistic theory of secondary 
ionisation preceding electron capture or dissociative stabilisation, as shown in 
Schemes 3.1 – 3.2 and Schemes 3.5 – 3.6, is supported by the observation of 
doubly charged product ions resulting from singly charged cationic precursors.8, 13, 20-
21  Electron interaction with doubly charged anionic precursors was shown to 
undergo electron detachment to generate the charge-reduced species, akin to 
secondary ionisation of the singly charged cations.  Electron irradiation of doubly 
charged cationic and anionic precursors resulted in a combination of singly and 
doubly charged product ions, proposed to occur via one of several fragmentation 
mechanisms, including electron capture/detachment, electronic excitation and 
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vibrational excitation.  Similarities between product ions generated by EID and 
vibrational energy MS/MS techniques are thought to result from vibrational excitation 
caused by interactions with high energy electrons or internal energy conversion.21  
The data acquired thus far suggests that EID is more suitable for analysing 
positively charged species over negatively charged precursor ions.  
 
Altering the charge-carrying species for each compound has been shown to have an 
effect on the resulting product ion spectra from each MS/MS technique, resulting in 
an increase in the amount of structural information achievable by considering data 
from molecular ions with different cations.  Results have shown that EID can form 
product ions that retain the charge-carrying species, producing structural information 
regarding the location of the charge(s) on the precursor ion.  The 23 compounds 
that have been analysed thus far do not form a stringent enough series of analogues 
that would allow any underlying trends to be determined, however further study 
would hope to build upon the results detailed herein and highlight any patterns that 
emerge from the manipulation of precursor ion functional groups or charge-carrying 
species.  The vast majority of EID bond cleavages occur in close proximity to a 
heteroatom and/or aromatic ring, a feature commonly observed by EI, however due 
to the high proportion of heteroatoms and cyclical groups in each compound the 
observed trend is inconclusive.  The complementary nature of EID proves that when 
used in conjunction with traditional MS/MS techniques, the amount of structural 
information that can be acquired from each compound can be maximised. 
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4. The Development of Electron-Induced Dissociation combined with 
LC-MS to Analyse Complex Mixtures. 
 
4.1. Introduction 
LC-MS and LC-MS/MS analysis has become an essential tool in the pharmaceutical 
industry for the identification of drug molecules due to the ability to perform rapid 
compound screening and provide in-depth structural characterisation and 
confirmation.  Chromatography allows components from complex mixtures to be 
separated and analysed individually, which is particularly important for the MS 
detection of components with a dynamic range of concentrations.  LC-MS/MS is 
often carried out by CID, however as shown in Chapter 3, this technique has 
limitations that may restrict structural identification and may not be the most suitable 
technique for analysing certain compounds, such as analogous molecules with 
minor structural differences.1  EID has been shown to generate a high degree of 
fragmentation from the MS/MS analysis of small singly charged molecules, 
representative of pharmaceutical molecules, providing complementary data to CID, 
and hence the combination of LC-MS with EID is a natural, but as yet 
unaccomplished, progression.  The direct infusion EID of Haloperidol [M+H]+ 
discussed in Chapter 3 was carried out over 1 minute, generating 23 MS/MS scans 
and resulting in the spectrum shown in Figure  4.1(a), averaging 1 scan every 2.6 s.  
The time taken for each scan includes ion accumulation, isolation of the precursor 
ion, transmission to the FT-ICR cell, electron irradiation of the precursor ion and 
detection of the ions.  Typically, chromatographic peaks elute over few seconds, 
therefore in order to combine EID with LC-MS it is necessary to obtain meaningful 
MS/MS data from over a short time-frame, and therefore from a few MS/MS scans.   
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Figure ‎4.1: EID spectrum of Haloperidol from (a) 23 MS/MS scans and (b) 1 MS/MS scan.  Product ions labelled in bold are not 
observed in the single-scan EID spectrum. 
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The spectrum generated by only 1 EID scan from Haloperidol [M+H]+, shown in 
Figure  4.1(b), shows a decrease in the signal-to-noise (S/N) compared with Figure 
 4.1(a), thereby concealing the low abundance product ions that emerge in the 
spectrum averaged over multiple scans.  Crucially, the single scan EID spectrum still 
contains important product ion data, demonstrating the feasibility of combining EID 
with LC-MS. 
 
The work described herein has focused on the development of LC-EID as a viable 
tool for the structural characterisation of complex mixtures of small molecules.  LC-
EID was primarily developed for the purpose of analysing a pharmaceutical 
development sample of cediranib that contained several low abundance 
compounds.  Preliminary analysis of cediranib by QToF-CID generated limited 
structural information from only 5 product ions, as shown in Figure  4.2, thereby 
prompting further analysis by EID.   
 
 
Figure ‎4.2: QToF-CID spectrum of cediranib [M+H]+. (inset) Expansion of 
higher m/z region to highlight low abundance product ions. 
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Direct infusion EID of cediranib generated 43 product ions, shown in Figure 3.15(a), 
supporting the development of LC-EID as a method to analyse any unknown 
compounds in the sample.  Validation of LC-EID has been carried out using 
Haloperidol as a progression from the direct infusion EID studies carried out in 
Chapter 3.  The steps that contribute towards each FT duty cycle are shown in 
Figure  4.3.  In order to sufficiently minimise the EID duty cycle, parameters such as 
ion injection time and detection time can be reduced, subsequently increasing the 
number of EID scans that can be acquired over a fixed LC peak width.   
 
 
Figure ‎4.3: Diagram detailing the duty cycle for (a) an MS scan and (b) an EID 
MS/MS scan on an FT-ICR mass analyser. 
 
 
4.2. Results and Discussion 
4.2.1. Analysis of cediranib 
The pharmaceutical compound cediranib (trade name Recentin™), 4-[(4-fluoro-2-
methyl-1H-indol-5-yl)oxy]-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline shown 
in Figure  4.4, was developed by AstraZeneca as a potential cancer treatment 
drug.2-4  A process development sample of this compound contained several 
unknown components of low abundance, components that would be significantly 
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reduced during further stages of drug development but that require identification in 
order to determine their activity and any effects they may have if present in the final 
drug.  Direct infusion EID of cediranib, detailed in Chapter 3, generated 43 product 
ions compared with 8 product ions by CID, suggesting that LC-EID would prove to 
be a beneficial tool.  Cediranib and the unknown compounds have been subjected 
to LC-EID and LC-CID-IT analyses with the aim of generating significant structural 
information that could lead towards the identification of each unknown species.  LC-
CID-FT was also carried out, however due to the loss of ions with low internal 
energy during transmission between the ion trap and the FT-ICR cell, the results 
from LC-CID-FT have only been alluded to when accurate mass was required to 
postulate molecular formulae.  
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Figure ‎4.4: Structure of cediranib. 
 
 
LC-MS of cediranib 
A 2 mg mL-1 sample of cediranib was analysed by LC-MS in order to observe and 
identify any compounds present in the sample at concentrations far lower than the 
target molecule.  The resulting Total Ion Chromatogram (TIC) contained 10 
unknown low abundance species in addition to the cediranib molecule that were 
absent in preceding control experiments carried out on a solvent-only sample.  The 
11 compounds have been labelled in the chromatogram in Figure  4.5.  The most 
intense peak 3 is consistent with the protonated cediranib, observed at m/z 451.1, 
with the empirical formula C25H28N4O3F with a mass accuracy of 0.6 ppm.  The 10 
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unknown species observed in the TIC are all less than 10% of the peak intensity of 
the cediranib peak and are assumed to be by-products of synthesis or impurities in 
the reaction mixture.  The apparent low concentrations of these compounds 
demands the hyphenation of chromatography prior to further analysis in order to 
eliminate any detrimental effects caused by the high concentration of the major 
compound, such as ion suppression or incomplete precursor ion isolation due to 
ions close in m/z.   
 
 
Figure ‎4.5(a): Total Ion Chromatogram (TIC) from LC-MS analysis of cediranib 
compared with (b) a blank LC-MS chromatogram.  Peaks labelled 1 - 11 
indicate components proven to be from the cediranib sample. 
 
 
A list of the ten most likely molecular formulae for each unknown compound was 
calculated using the elemental limits C0-50H0-100N0-10O0-10F0-5 and a mass tolerance of 
2 ppm.  The isotopic profile of LC peak 10 suggested the presence of chlorine, 
which was therefore included in the elemental limits.  Criteria such as the nitrogen 
rule, which states that even-electron ions of an even m/z have an odd number of 
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nitrogen atoms and vice versa, the relative intensity of the 13C isotope and the 
feasibility of the suggested molecular formulae were used to reduce the number of 
possible molecular formulae.  The proposed molecular formulae are shown in Table 
4.1. 
 
LC 
Peak 
Observed 
MS peak m/z 
Proposed 
molecular formula 
[M+H]
+
 
Theoretical 
m/z 
RDB 
Accuracy 
/ppm 
1 562.31863 C32H41N5O3F 562.31879 14.5 -0.3 
2 899.40539 C50H53N8O6F2 899.40506 27.5 0.4 
3 451.21371 C25H28N4O3F 451.21400 13.5 -0.6 
4 788.30043 C43H40N7O6F2 788.30026 26.5 0.2 
5 481.18808 C25H26N4O5F 481.18817 14.5 -0.2 
6 340.10901 C18H15N3O3F 340.10920 12.5 -0.5 
7 447.18258 C25H24N4O3F 447.18270 15.5 -0.3 
8 430.15601 C25H21N3O3F 430.15615 16.5 -0.3 
9 339.10133 C18H14N3O3F 339.10137 13 -0.1 
10 921.22676 C48H33N10O5F3Cl 921.22705 35.5 -0.3 
11 691.21147 C37H29N6O6F2 691.21112 25.5 0.5 
 
Table ‎4.1: Summary of the base peaks observed in the MS chromatogram 
corresponding to LC peaks 1 – 11, labelled in Figure ‎4.5. 
 
 
LC-MS/MS analysis of cediranib 
The LC-MS/MS analysis of the protonated cediranib, LC Peak 3 in the TIC (see 
Figure  4.5), was carried out by adapting an existing 20 minute LC method to include 
alternating MS and MS/MS scans throughout the experiment, targeting the cediranib 
[M+H]+ at m/z 451.2 with high energy electrons (~17.5 eV).  The detection time was 
reduced by acquiring data at a resolving power of 50,000 FWHM, instead of 100,000 
FWHM, in order to shorten the time taken for each scan whilst maintaining the high 
resolving power and mass accuracy capabilities of the FT-ICR instrument.  The 
maximum ion injection time was set at 1500 ms in order to allow enough ions to 
accumulate prior to MS/MS dissociation.  Two image currents were averaged for 
each MS/MS scan in order to improve the S/N of the detected ions, hereafter 
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defined as the number of microscans.  The product ion spectrum was produced by 
averaging MS/MS scans across the chromatographic peak.   
 
A comparison between the LC-CID and LC-EID spectra is shown in Figure  4.6 with 
an expansion in Figure  4.7.  Whereas the LC-CID spectrum is limited by the one-
third cut-off that restricts the lower m/z limit in the linear ion trap, the LC-EID 
spectrum shows a wide range of fragmentation providing significant structural 
information.  The major product ion observed in the LC-EID spectrum at m/z 112.1 is 
proposed to correspond to the propylpyrrolidine arm as shown in Figure  4.8(a), 
formed via the heterolytic cleavage of the C-O bond.  Conversely, the major product 
ion in the CID spectrum at m/z 340.2 corresponds to the reciprocal fragment, the 
indole-quinazoline structure of the cediranib molecule, shown in Figure  4.8(b).  The 
product ion corresponding to the propylpyrrolidine arm is not observed in the CID 
spectrum due to the one-third cut-off.  
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Figure ‎4.6: LC-MS/MS of the cediranib [M+H]+ by (a) CID and (b) EID. 
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Figure ‎4.7: Expansion of Figure 4.6 allowing low abundance product ions generated by (a) LC-CID and (b) LC-EID of cediranib to be 
observed. Peaks labelled * denote artefacts or chemical noise peaks. 
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Figure ‎4.8: Formation of (a) the propylpyrroldine group and (b) the indole-
quinazoline group via the cleavage of the C-O bond in cediranib. 
 
 
As mentioned in Chapter 3, low m/z peaks from the cold cathode electron gun are 
evident at higher electron energy levels that may disguise low m/z product ions, 
however in this instance there is a clear separation between the product ion at m/z 
70.06517, corresponding to the pyrrolidine ring of the propylpyrrolidine arm, and a 
chemical noise peak at m/z 70.07774, as shown in Figure  4.9.  The chemical noise 
peak is thought to be a hydrocarbon with molecular formula C5H10, which is emitted 
from the ECD cathode or the FT-ICR cell at high electron energies, as discussed in 
Chapter 3. 
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Figure ‎4.9: High resolution of the FT-ICR allows the distinction between two 
ions with the same nominal mass. 
 
 
A direct comparison between the LC-CID and LC-EID spectra indicates 6 product 
ions that are common to both techniques, at m/z 449.2, m/z 380.1, m/z 366.1, m/z 
340.1 and m/z 324.1.  A peak at m/z 431.2 is unique to CID and corresponds to the 
neutral loss of HF from the cediranib molecular ion.  The formation of this product 
ion is thought to proceed via a cyclisation reaction as shown in Figure  4.10, and is 
supported by the increase in the RDB from 13.5 to 14.5.   
 
 
 132 
N
O
NN
O
O
H
N
N
O
NN
O
O
NH
F
H
-HF
H+ H+
 
Figure ‎4.10: Proposed route of formation for the product ion at m/z 431.2, 
generated from the loss of HF. 
 
 
Overall, LC-EID of cediranib was found to generate 31 product ions compared to 15 
by LC-CID, however the minimal overlap between the product ions indicates that 
both techniques can provide unique information and can complement each other.  
The spectra shown in Figure  4.6 and Figure  4.7 demonstrate the feasibility of using 
LC-EID and the complementary data provided by LC-EID and LC-CID of cediranib, 
initiating the analysis of each unknown low abundance compounds in order to 
generate structural information.  The LC-MS/MS method used to analyse cediranib 
[M+H]+ was altered to target each unknown compound in turn.  Two of the unknown 
species, LC peaks 1 and 6 have been studied in depth and are discussed below.  
Post acquisition calibration was carried out on the resulting LC-MS/MS spectra 
using the precursor ion molecular formulae detailed in Table 4.1 and where 
possible, the product ion corresponding to propylpyrrolidine moiety.  For detailed 
product ion information for cediranib and LC peaks 1 and 6, see Chapter 10: 
Appendix B. 
 
4.2.2. LC-MS/MS analysis of LC peak 1 
The first of the unknown compounds at m/z 562.3, which is seen to elute at 5.69 
minutes (LC peak 1) in Figure  4.5, has been studied in depth by both LC-CID, 
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shown in Figure  4.11(a) (with an expansion in Figure  4.12(a)), and LC-EID, shown 
in Figure  4.11(b) and Figure  4.12(b).  CID generated 14 product ions compared 
with 23 product ions formed by EID.  Significantly, a product ion observed in the LC-
EID spectrum at m/z 451.2 is proposed to have the same empirical formula as the 
protonated cediranib molecule, suggesting that the unknown species is chemically 
related to cediranib.  The relationship between the cediranib and the unknown 
compound can be confirmed by comparing the product ions generated from the 
MS/MS of m/z 562.3 in Figure  4.11 with the spectra in Figure  4.6.  There are 15 
product ions, highlighted in red in Figure  4.12, which are common to both the 
species at m/z 562.3 and cediranib, 12 of which are unique to EID and the 
remaining 3 are unique to CID.  The common ions include the peaks that are 
proposed to correspond to the indole-quinazoline group and the propylpyrrolidine 
arm.  The high number of commonalities between the dissociation of the cediranib 
and that of the unknown species further implies a relationship between the two 
compounds.  The observation of the peaks at m/z 449.2 and m/z 451.2 suggests 
that the unknown compound is equivalent to a cediranib molecule with an unknown 
addition.  Structural assignments have been proposed for the common ions using 
the empirical formulae and the associated RDB values, and have been detailed in 
Table 4.2. 
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Figure ‎4.11: Comparison between (a) LC-CID and (b) LC EID of m/z 562.3, labelled LC peak 1 in Figure ‎4.5. 
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Figure ‎4.12: Expansion of Figure ‎4.11, showing (a) the LC-CID spectrum and (b) the LC-EID spectrum of the unknown species 
observed in LC peak 1 at m/z 562.3.  Peaks labelled in red correspond to product ions also observed by the MS/MS of cediranib. 
Peaks labelled * denote artefacts or chemical noise peaks. 
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Product Ion 
m/z 
Chemical 
Formula 
RDB Proposed Bond Cleavage(s) 
451.2 C25H28N4O3F 13.5 cediranib [M+H]
+
 
449.2 C25H26N4O3F 14.5 loss of H2 from cediranib 
380.1 C21H19N3O3F 13.5 a 
340.1 C18H15N3O3F 12.5 e 
318.1 C18H12N3O3 14.5 e h 
304.1 C18H14N3O2 13.5 f h 
119.1 C8H9N 5 g h 
118.1 C8H8N 5.5 g h 
112.1 C7H14N 1.5 d 
111.1 C7H13N 2 d 
110.1 C7H12N 2.5 d 
96.1 C6H10N 2.5 b 
84.1 C5H10N 1.5 b 
 
Table ‎4.2: Summary of ions common to LC peak 1 and cediranib [M+H]+. The 
proposed bond cleavages do not illustrate hydrogen loss/migration. 
 
 
The neutral loss of 111.1 Da from the precursor ion m/z 562.3 to form the product 
ion at m/z 451.2 is consistent with the loss of a fragment of C7H13N that is thought to 
correspond to a second propylpyrrolidine arm that has attached to the target 
molecule during synthesis.  The site of this addition was investigated by studying the 
product ion spectra from the unknown compound, focussing on the product ions not 
generated by the MS/MS of cediranib.  In particular, there are two product ions that 
have been identified as significant, firstly a peak at m/z 223.2 that is observed by 
EID and CID of m/z 562.3, corresponding to the chemical formula C14H27N2 with an 
error of 0.6 ppm error.  This fragment is consistent with two propylpyrrolidine arms 
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joined together, suggesting that the additional arm has been substituted onto one of 
the seven carbon atoms, labelled C(1) to C(7) in Figure  4.13, or the nitrogen atom 
on the pyrrolidine ring, N(8). 
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Figure ‎4.13: The cediranib molecular structure plus an additional 
propylpyrrolidine moiety (inset) that is expected to combine to form the 
unknown m/z 562.3 compound. 
 
 
The second informative product ion is observed at m/z 360.1 and is only generated 
by EID.  This fragment corresponds to the chemical formula C21H18N3O3, with an 
error of 1.4 ppm, and is due to the neutral loss of one intact propylpyrrolidine arm 
plus the pyrrolidine ring of the second arm and hydrogen fluoride (C7H14N + C4H8N + 
HF).  The loss of HF is proposed to occur via the cyclisation reaction detailed in 
Figure  4.10.  This further indicates that the addition of the second propylpyrrolidine 
arm has taken place on the pyrrolidine ring, C(4) - C(7) or N(8).  Preparative 
separation and NMR analysis conducted at AstraZeneca has confirmed that this 
unknown compound is the result of a second propylpyrrolidine arm substituting onto 
the nitrogen atom of the cediranib pyrrolidine ring, resulting in the structure shown in 
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Figure  4.14(a).  Proposed structures for the two notable product ions at m/z 223.2 
and m/z 360.1 are shown in Figure  4.14(b) and (c).    
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Figure ‎4.14: (a) Confirmed structure of the previously unknown compound at 
m/z 562 that is present at low concentrations in the cediranib sample, and 
proposed structures of product ions at (b) m/z 223 and (c) m/z 360. 
 
 
4.2.3. LC-MS/MS analysis of LC peak 6 
The peak labelled 6 in Figure  4.5 is observed at m/z 340.1 and is consistent with 
the molecular formula of C18H15N3O3F.  This precursor ion has the same empirical 
formula as the product ion observed from the EID and CID of cediranib, which was 
determined to be the indole-quinazoline structure as shown in Figure  4.8.  
Inspection of the LC-EID and LC-CID spectra generated for the m/z 340.1 species 
identifies 17 product ions which are also observed in the product ion spectra from 
the cediranib, highlighted in Figure  4.15, which supports the relationship between 
the two compounds.  The common ions and their proposed structural 
characterisations have been summarised in Table  4.3.   
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Figure ‎4.15: (a) LC-CID and (b) LC-EID spectra for LC peak 6 at m/z 340.1. Product ions also observed from the MS/MS of cediranib 
[M+H]+ have been highlighted in red. Peaks labelled * denote artefacts or chemical noise peaks. 
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Table ‎4.3: Summary of ions observed from the MS/MS of m/z 340.1 and 
cediranib.  
 
 
The bond cleavage labelled g is expected to proceed via the cyclisation reaction 
shown for cediranib in Figure  4.10, resulting in the loss of HF.  The high number 
and nature of the product ions that are common to the cediranib suggests that this 
unknown species is in fact the same species as the product ion at m/z 340.1 seen in 
the MS/MS spectra in Figure  4.6 and corresponds to the spontaneous loss of the 
propylpyrrolidine moiety from the target molecule during synthesis.  This is further 
confirmed by the RDB assignment for the unknown species that is 12.5 and is 
consistent with the indole-quinazoline structure.  The product ion observed at m/z 
Observed Ion 
m/z 
Molecular Formula RDB 
Proposed Bond 
Cleavage(s)  
340.1 C18H15N3O3F 12.5 precursor 
339.1 C18H14N3O3F 13 loss of H from precursor 
338.1 C18H13N3O3F 13.5 loss of H2 from precursor 
325.1 C17H12N3O3F 13 a / i 
324.1 C17H11N3O3F 13.5 a / i 
320.1 C18H14N3O3 13.5 g 
319.1 C18H13N3O3 14 g 
318.1 C18H12N3O3 14.5 g 
305.1 C17H11N3O3 14 a g / g i  
304.1 C17H10N3O3 14.5 a g / g i 
260.1 C16H10N3O 13.5 b g i 
232.1 C15H10N3 12.5 c g e  
175.1 C10H8N2F 7.5 d 
165.1 C9H8NOF 6 h 
164.1 C9H7NOF 6.5 h 
149.1 C9H8NF 6 f 
148.1 C9H7NF 6.5 f 
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232.1, proposed to result from multiple bond cleavages, includes the loss of the 
oxygen connecting the indole and quinazoline rings, bond cleavage e, which is 
thought to be facilitated by the distortion of the molecule upon cyclisation to lose HF. 
 
The spectrum obtained from the LC-EID of this compound showed considerable 
fragmentation, generating 70 products ions compared to 21 and 35 by LC-CID-FT 
and LC-CID-IT respectively.  Of the 70 EID product ions, more than 75% of are 
observed as part of peak groupings corresponding to the same bond cleavage but 
with a varying number of hydrogen atoms, with the remaining 20 of these product 
ions resulting from ‘unique’ bond cleavages.  While the evidence of peak multiplets 
is more prevalent by EID, it is also widely noted in the CID spectrum for this 
compound, suggesting that the aromatic regions of the indole-quinazoline group can 
form highly stable odd-electron species.   
 
4.2.4. LC-MS/MS data for LC peaks 1 - 11 
The information obtained from the LC-MS/MS analysis of the cediranib sample has 
been compiled and detailed in Table 4.4, showing the total number of product ions 
obtained for each eluting compound from each fragmentation technique.  A 
comparison between the CID-FT and EID shows that EID is the superior technique 
for 9 of the 11 compounds, producing a higher degree of fragmentation than CID-
FT.  This is expected to be partly due to the one-third cut-off that governs CID 
carried out in an ion trap, thereby inhibiting the detection of product ions in the low 
m/z regions in which EID was found to generate up to 10 product ions.  The EID and 
CID-FT analysis of LC peak 4, see Figure  4.17, results in both techniques 
generating the same two product ions, suggesting that vibrational excitation 
processes may be governing EID of LC peak 4.  LC peak 11, shown in Figure  4.23, 
generates two more product ions by CID FT than EID, confirming the 
complementary nature of the two techniques and the benefits of using more than 
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one MS/MS technique.  The inclusion of CID-IT data significantly increases the 
number of observed product ions and alters the trend slightly, with 4 compounds 
showing a greater effect from CID-IT than EID, however accurate mass 
measurements and molecular formulae assignments cannot be made from ion trap 
data alone.   
 
LC Peak 
Number 
m/z 
Number of product 
ions observed 
Common 
product ions 
between EID 
and CID-IT 
Number of product 
ions common 
between cediranib 
and unknown EID 
CID 
FT IT 
1 562.3 23 0 14 3 9.7% 15 37.5% 
2 899.4 5 2 8 2 18.2% 6 18.2% 
3 451.2 31 3 15 6 12.2% N/A 
4 788.3 2 2 11 2 20.0% 6 54.5% 
5 481.2 19 4 5 3 14.3% 9 40.9% 
6 340.1 70 21 35 32 41.0% 17* 19.5% 
7 447.2 26 1 3 3 11.5% 11 42.3% 
8 430.2 45 17 29 28 60.8% 9 19.6% 
9 339.1 35 0 26 16 35.6% 12* 26.7% 
10 921.2 6 3 7 5 62.5% 2 25.0% 
11 691.2 1 3 13 1 7.7% 3 23.1% 
 
Table ‎4.4: Summary of all product ions generated by EID and CID for each 
observed compound. Values marked * include the precursor ion. Percentages 
have been calculated from the total number of product ions. 
 
 
The percentage of ions that are common to each technique is seen to vary between 
7% and 63%, demonstrating that both CID and EID have the ability to provide 
unique information and reaffirming their complementary nature.  Each unknown 
compound was found to generate product ions common with cediranib, suggesting a 
connection between the compounds, however the structures proposed for the 
cediranib product ions lend confidence to the assumption that all 10 compounds are 
structurally related to the target molecule.  The indole-quinazoline structure was 
found to be a common feature in all of the 10 unknown compounds, with at least 3 
 143 
compounds, including LC peak 1, proposed to correspond to modified cediranib, due 
to the presence of a product ion consistent with the cediranib molecular formula.  
The similarities between each unknown compound and cediranib strongly suggest 
that each compound is an analogue of the target molecule created unintentionally 
during chemical synthesis or formed from the degradation of cediranib.  EID has 
been shown to generate a wealth of information from singly protonated species that 
has aided in the identification of analogous compounds, and when used in 
conjunction with CID has allowed structural assignments to be made.  
 
The LC-CID and LC-EID spectra for LC peaks 2, 4, 5, 7 – 11 are shown in Figures 
4.16 – 4.23.  Peaks that are also observed in the MS/MS spectra for cediranib 
[M+H]+ have been labelled in red, so as to highlight the common product ions that 
indicate a structural relationship to cediranib.  The number of common peaks in 
each spectrum and the proposed molecular formulae suggest that the unknown 
compounds are all chemically related to cediranib; however the structures remain 
proprietary information of AstraZeneca and cannot be discussed further. 
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Figure ‎4.16: (a) LC-CID and (b) LC-EID spectra for LC peak 2 at m/z 899.4. Product ions also observed from the MS/MS of cediranib 
[M+H]+ have been highlighted in red. Peaks labelled * denote artefacts or chemical noise peaks. 
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Figure ‎4.17: (a) LC-CID and (b) LC-EID spectra for the LC peak 4 at m/z 788.3. Product ions also observed from the MS/MS of cediranib 
[M+H]+ have been highlighted in red. Peaks labelled * denote artefacts or chemical noise peaks. 
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Figure ‎4.18: (a) LC-CID and (b) LC-EID spectra for the LC peak 5 at m/z 481.2. Product ions also observed from the MS/MS of cediranib 
[M+H]+ have been highlighted in red. Peaks labelled * denote artefacts or chemical noise peaks. 
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Figure ‎4.19: (a) LC-CID and (b) LC-EID spectra for LC peak 7 at m/z 447.2. Product ions also observed from the MS/MS of cediranib 
[M+H]+ have been highlighted in red. Peaks labelled * denote artefacts or chemical noise peaks. 
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Figure ‎4.20: (a) LC-CID and (b) LC-EID spectra for LC peak 8 at m/z 430.2. Product ions also observed from the MS/MS of cediranib 
[M+H]+ have been highlighted in red. Peaks labelled * denote artefacts or chemical noise peaks. 
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Figure ‎4.21: (a) LC-CID and (b) LC-EID spectra for LC peak 9 at m/z 339.1. Product ions also observed from the MS/MS of cediranib 
[M+H]+ have been highlighted in red. Peaks labelled * denote artefacts or chemical noise peaks. 
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Figure ‎4.22: (a) LC-CID and (b) LC-EID spectra for LC peak 10 at m/z 921.2. Product ions also observed from the MS/MS of cediranib 
[M+H]+ have been highlighted in red. Peaks labelled * denote artefacts or chemical noise peaks. 
peaks. 
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Figure ‎4.23: (a) LC-CID and (b) LC-EID spectra for LC peak 11 at m/z 691.2. Product ions also observed from the MS/MS of cediranib 
[M+H]+ have been highlighted in red. Peaks labelled * denote artefacts or chemical noise peaks. 
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4.2.5. LC-EID of sodium adducted species  
A recent paper by Mosely et al.5 investigated the use of different charge carrying 
species and the effect altering the charge carrier has on EID analysis.  To further 
this work, the infusion of sodium iodide post-column was carried out in an attempt to 
produce the sodium-adducted species for each of the unknown compounds for EID 
analysis.  The probability of observing sodium-adducted species is dependent on 
the sodium affinity of the species of interest.  Despite using a 1 mg mL-1 solution of 
salt, only two sodium-adducted compounds were observed, the cediranib [M+Na]+ 
species, at m/z 473.2, and the sodium-adducted species of LC peak 5 at m/z 503.2.  
Both sodium-adducted species are observed at much lower ion abundances than 
the [M+H]+ species, indicating that both compounds have a higher proton affinity 
than sodium affinity.   
 
A comparison between the LC-EID of cediranib [M+Na]+ and [M+H]+ is shown in 
Figure  4.24.  There were 17 product ions generated from the EID of cediranib 
[M+Na]+, of which only 4 were seen to lose the sodium cation to form product ions 
that were all observed from the MS/MS of the protonated cediranib.  The four 
common product ions correspond to portions of the propylpyrrolidine arm, at m/z 
112.1, m/z 110.1 and m/z 84.1, and the indole-quinazoline group at m/z 340.1, 
together encompassing the entire cediranib molecule.  The sodium cation was 
retained by 13 of the remaining product ions, all of which contained the indole 
portion of the molecule, suggesting that the sodium cation resides in this area of the 
molecule.  Eight of the sodium-adducted product ions were also observed in their 
protonated form in the MS/MS spectra of the [M+H]+ precursor, while 5 product ions 
are formed by bond cleavages that were unique to the MS/MS of the [M+Na]+ 
precursor, indicating that the amount of structural information generated by EID can 
be maximised by altering the charge-carrying species.  
 153 
 
Figure ‎4.24: LC-EID of cediranib (a) [M+Na]+ and (b) [M+H]+. Product ions highlighted in red are observed in both spectra. Product 
ions highlighted in blue indicate sodium-adducted product ions that are observed in their protonated form from the MS/MS of 
cediranib [M+H]+. Peaks labelled * denote artefacts or chemical noise peaks. 
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A summary of the observations made from the analysis of the cediranib [M+Na]+ and 
the sodium-adducted LC peak 5 is shown in Table  4.5, indicating how many product 
ions are also observed from the MS/MS of the protonated species, either as the 
protonated species or as sodium-adducted equivalents. 
 
Precursor Ion 
EID 
Product 
Ions 
Product Ions 
common to 
[M+H]
+
 
Na
+
 adducts of 
[M+H]
+
 product 
ions 
Unique 
Product 
Ions 
[cediranib + Na]
+
 17 4 8 5 
[LC peak 5 + Na]
+
 7 1 2 4 
 
Table ‎4.5: Summary of the EID product ions generated from the [M+Na]+. 
 
 
EID of the sodium-adducted species generated far fewer product ions than the 
protonated equivalents, with a 45% and 63%  reduction from the cediranib [M+H]+ 
and [LC peak 5 + H]+ respectively, however both sodium-adducted species provided 
unique information.  The LC-EID analysis of the sodium-adducted species in 
addition to the protonated precursor ion demonstrates the benefits of analysing 
multiple charge-carrying species in order to maximise the amount of structural data 
that can be acquired.   
 
4.2.6. Data-dependent LC-EID of cediranib 
The LC-MS/MS experiments thus far have been limited to targeted MS/MS, 
requiring the analysis of each compound to have its own experimental setup.  In the 
case of cediranib, eleven experiments were needed for each MS/MS technique in 
order to fully analyse the sample.  The number of experiments can be reduced by 
using data-dependent LC-MS/MS, selecting the most intense ion in each MS scan 
for subsequent MS/MS analysis and therefore generating MS/MS data for multiple 
species during one experiment.  Preliminary data-dependent experiments have 
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been carried out on cediranib in an attempt to analyse each species observed in the 
sample.  Due to the non-selective nature of the initial data-dependent analyses, only 
7 of the 11 compounds were ever observed as the most intense ion and 
subsequently analysed by EID.  The intentionally high concentration of the target 
molecule, LC Peak 3 in Figure  4.5, overpowered the chromatogram and prevented 
the analysis of neighbouring LC peaks 2 and 4.  While data-dependent LC-MS/MS 
reduces the need for several experiments, the analysis of co-eluting species is 
severely hampered, as evidenced by the MS/MS of species LC peaks 9 and 10 not 
carried out by the data-dependent analysis due to the more abundant co-eluting 
species LC peak 8.  The data-dependent LC-EID analysis of cediranib generated a 
comparable product ion spectrum to the targeted LC-EID analysis (data not shown) 
due to the high abundance of cediranib [M+H]+, however the data-dependent 
analyses of the low abundance compounds suffered slightly due to the non-
selectivity resulting in the loss of some low abundance product ions, as shown in the 
LC-EID of LC peak 6 in Figure  4.25. 
 
Optimisation of the data-dependent MS/MS parameters could significantly improve 
the analysis, such as creating an inclusion or exclusion list to focus the analysis on 
the compounds of interest.  Additionally, limiting the number of MS/MS scans carried 
out for each compound would prevent high abundance ions from suppressing the 
analysis of lower abundance compounds.  Due to the success of targeted LC-EID, 
further study focused on validating the current approach, and therefore the 
development and optimisation of data-dependent LC-EID was not carried out. 
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Figure ‎4.25: (a) Targeted LC-EID compared with (b) data-dependent LC-EID of LC peak 6. Product ions not observed in by data-
dependent analysis have been highlighted in bold in (a). Peaks labelled * denote electronic or chemical noise. 
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4.2.7. Development and validation of LC-EID  
Due to the success of LC-EID for analysing the cediranib sample, studies have been 
carried out to validate the technique using Haloperidol, a pharmaceutical compound 
with no detectable impurities, which was studied in-depth via direct infusion EID in 
Chapter 3.  MS/MS has a longer duty-cycle than MS analysis due to the additional 
steps involved in activating and fragmenting precursor ions.  A delay of 0.03 ms and 
an electron irradiation time of 70 ms contribute towards an increase in scan time 
when performing EID, as shown in Figure  4.26.  For the purpose of these 
experiments, the maximum injection time and the AGC target settings were fixed for 
all sample concentrations, as detailed in Chapter 8: Materials and Methods.   
 
MS Scan
Time
0.03 ms 70 ms
MS/MS Scan
Empty Cell Ions In Delay EID Excite Detect
Empty Cell Ions In Excite Detect
 
Figure ‎4.26: Comparison between MS and EID MS/MS scan times. 
 
 
The number of MS/MS scans achievable is limited to the LC peak width, therefore 
further work has been carried out in order to reduce the time taken for each EID 
scan whilst maintaining a high quality and informative product ion spectrum so as to 
make EID compatible with an LC duty-cycle.  The excitation and detection steps 
make up the majority of scan time, therefore minimising the detection time would 
have a significant effect on the overall scan time.  Acquiring MS/MS data at 
resolving power 50,000 FWHM, instead of 100,000 FWHM, will halve the detection 
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time and significantly reduce the overall scan time whilst preserving sufficiently high 
mass resolution from the FT-ICR.  LC-MS/MS analyses are carried out by 
alternating MS and MS/MS scans, therefore acquiring MS data at 25,000 FWHM 
would subsequently increase the number of MS/MS scans attainable over a fixed LC 
peak width.  Reduction of the maximum ion accumulation time would have little 
effect on the resulting MS/MS scan time, unless sample concentration is reduced 
considerably.  The direct infusion LOD experiments, carried out in Chapter 3, show 
that the maximum ion accumulation time was not required at sample concentrations 
greater than 10 ng mL-1.  In order to demonstrate the effect of altering the resolving 
power, targeted LC-MS/MS analyses were carried out on a sample of Haloperidol.  
The spectrum shown in Figure  4.27(a) was acquired at a resolving power of 
100,000 FWHM for alternating MS and MS/MS scans.  By comparison, Figure 
 4.27(b) was acquired at 25,000 FWHM for MS and MS/MS scans.  The lower 
resolving power has no discernible effect on the number of product ions generated 
by LC-EID, however the signal-to-noise is significantly improved owing to more the 
double the number of MS/MS scans acquired compared to Figure  4.27(a). 
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Figure ‎4.27: LC-EID of Haloperidol carried out at (a) 100,000 FWHM and (b) 25,000 FWHM. Peaks labelled * denote electronic or 
chemical noise. 
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Limit of Detection for LC-EID 
In order for LC-EID to be a practical analytical technique in the pharmaceutical 
industry, it must not only be able to analyse complex mixtures, it must be also able 
to analyse compounds at low concentrations, so as to successfully analyse trace 
level impurities and degradation products.  The work carried out using cediranib has 
confirmed the feasibility of using LC-EID to analyse and identify trace compounds in 
genuine pharmaceutical samples, however the concentrations of the low abundance 
analogues remain unknown.  Typical identification thresholds for impurities in drug 
samples are reported to be < 1% of the target compound, therefore viable analytical 
techniques must be capable of analysing sample concentration over at least one 
order of magnitude.6-7  
 
In order to test the sensitivity of LC-EID, analyses have been carried out to 
determine the lower limit of detection, the LC-MS/MS analysis of Haloperidol was 
carried out over a range of concentrations.  Direct infusion LOD studies carried out  
in Chapter 3, performed on sample concentrations between 50 pg mL-1 and 5 µg 
mL-1.  Whereas sample concentrations remain constant throughout each direct 
infusion experiment, LC peaks create a varied concentration range as the sample 
elutes, therefore it is expected that LC-MS/MS requires higher sample 
concentrations.  The LCMS sensitivity of the LTQ-FT is stated to be in the 
femtomole range which, when injecting a 10 µL injection of Haloperidol, equates to a 
sample concentration of approximately 40 pg mL-1.  As a result, samples were made 
up to concentrations ranging from 10 pg mL-1 to 1 mg mL-1, and analysed in an 
increasing order of concentration by LC-EID, LC-CID-FT and LC-CID-IT.   
 
Experiments were carried out in triplicate and the average numbers of product ions 
for each sample have been charted in Figure  4.28.  LC-CID-IT analysis generated 
product ions from the lowest concentration sample, gradually increasing until 0.5 µg 
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mL-1 where the number of product ions plateaus.  Due to the loss of low energy ions 
during transmission between the ion trap and the FT, fewer product ions are 
observed at each concentration and the lower LOD is increased to 5 ng mL-1, while 
the maximum number of product ions is observed at 1 µg mL-1 for CID-FT.  At a 
concentration of 50 ng mL-1 product ions start to appear by EID, gradually increasing 
in number until 50 µg mL-1, indicating that EID is less sensitive than CID.  
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Figure ‎4.28: Graph indicating the number of product ions generated at each 
sample concentration from the LC-MS/MS of Haloperidol. 
 
 
The data generated by LC-MS/MS follows a similar trend to the results from direct 
infusion, shown in Figure 3.9, with CID-IT proving to be the most sensitive 
technique whereas EID generates the most product ions.  As expected, the 
emergence of product ions from EID and CID-FT occurs at higher sample 
concentrations for LC-MS/MS than direct infusion data, shown in Chapter 3, due to 
the reduced sample volumes and variable precursor ion abundance across the 
chromatographic peak.  LC-EID is less sensitive than LC-CID, however the number 
of LC-EID product ions generated surpasses LC-CID at concentrations higher than 
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0.5 µg mL-1.  EID has been shown to generate extensive structural information, 
complementary to CID, and the development of LC-EID has demonstrated the 
potential for analysing complex mixtures with components over a wide dynamic 
concentration range.  Variation of parameters, such as the LC column dimensions 
and packing, gradient conditions, precursor ion and instrument, would be expected 
to have an effect on the sensitivity of the technique, therefore the detection limits 
detailed above are specific to the LC-MS/MS of Haloperidol using the specified 
instrumental parameters, however they give an understanding of the scope of LC-
EID.   
 
 
4.3. Conclusion 
Direct infusion EID has already shown great promise in the analysis of a wide range 
of compounds, demonstrated in Chapter 3 with the in-depth EID analysis of a range 
of pharmaceutical molecules.  The results discussed herein further confirm the 
suitability of EID for the analysis of small singly charged cations, and prove that EID 
can be effectively coupled to chromatography to provide the same in-depth 
structural information on an LC time-scale to analyse complex mixtures of 
pharmaceutical compounds with varying precursor ion abundances.  Studies carried 
out to determine the sensitivity of LC-EID using Haloperidol indicate a lower limit of 
detection in the region of 50 ng mL-1.  LC-EID has been able to generate vital 
information about the low abundance compounds, which would previously require 
time consuming preparative separation and independent analysis, giving rise to 
proposed structures or structural fragments.  In the case of cediranib, the ten 
unknown compounds that were present in the reaction mixture are believed to be 
structurally analogous to the target compound due to the relatively high percentage 
(≥ 18%) of commonalities between each species and cediranib.  The combination of 
LC-EID and LC-CID data has lead to speculation about the elemental composition of 
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2 low abundance compounds and confirmed structural similarities to cediranib.  LC-
EID has been proven to generate useful structural information for the low 
abundance precursor ions, and is therefore expected to provide fast and efficient 
information during synthesis when sample quantities may be limited, reducing the 
need for time-consuming and expensive large-scale experiments prior to preparative 
chromatography and NMR.  The effect of EID was seen to vary depending on the 
compound, appearing to be more successful for analysing the lower m/z (<m/z 700) 
compounds, whereas the analysis of the 3 compounds greater than m/z 700 
generated fewer than 10 product ions.  Only one protonated compound analysed by 
direct infusion EID in Chapter 3 had a molecular weight greater than m/z 700, 
Ritonavir, which generated 16 product ions by EID, therefore further work is required 
to determine whether the precursor ion molecular weight is a key factor in the 
success of EID MS/MS.  The data generated from LC-EID supports the previously 
discussed dissociation mechanisms, including electronic excitation, vibrational 
excitation and secondary ionisation followed by electron capture and/or bond 
dissociation.  LC-EID of the [M+Na]+ species reaffirmed the results from the previous 
study5 which stated that changing the charge-carrying species has an effect on the 
product ions generated by EID, creating an additional source of information.  
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5. MS and MS/MS Analysis of Proteins Modified by Small Organic 
Molecules 
 
5.1. Introduction 
Proteins have a deep-rooted involvement in key biological processes in living 
organisms, therefore any modifications or mutations of a protein can have a 
dramatic effect on the physical, chemical or biological properties of the protein.  
Such alterations to proteins include biochemical post-translational modifications 
(PTM), such as phosphorylation1 or glycosylation1, and chemical protein 
modifications such as oxidation, carboxylation, small molecule interactions2-3 or the 
interaction with other biological molecules such as lipids.4-6  Protein modifications 
are vitally important in controlling or regulating the function and/or structure of the 
protein, the knowledge of which could further the understanding into the effect of 
diseases on living cells or the effect of seemingly minor mutations on complex multi-
component interactions.7-9 The identification of protein modifications may also shed 
light on biologically active sites and exposed regions of the protein structure, the 
manipulation or mutation of which can have a drastic effect on the ability of the 
protein to function normally.  The interactions between proteins and small 
pharmaceutical molecules can cause inhibition or enhancement of the protein 
function, and is therefore a key area of study in the pharmaceutical industry in 
relation to the treatment of diseases and the effect of drug molecules on naturally 
occurring or disease-affected proteins.  To this end, investigations have been 
carried out on two proteins, the multiple transferrable resistance regulator protein of 
Neisseria gonorrhoeae and the matrix protein of the human respiratory syncytial 
virus.  Both proteins have been analysed by LC-MS as intact proteins and digested 
peptides of the unmodified sample and after modification with small molecules. 
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Intact protein MS, with sufficient resolving power and mass accuracy, can be used 
to detect any changes in protein molecular weight from the unmodified protein to the 
modified protein, providing clues as to the nature of any modifications.  Enzymatic 
digestion of the protein sample, the bottom-up approach, cleaves the protein into 
smaller peptides that can be used to confirm portions of the protein sequence and 
minimises the effect of protein size on the MS analysis, allowing the possibility for in-
depth analysis of proteins of virtually unlimited size.10  LC-MS provides the high 
sensitivity needed for the analysis of complex mixtures at varying concentrations, 
enabling the identification of modified peptides that are often observed at much 
lower concentrations than their corresponding unmodified peptide.  MS/MS analysis 
of the digested peptides can confirm the amino acid composition of the peptides and 
narrow down the location of a suspected PTM.11  
 
5.1.1. The multiple transferrable resistance regulator (MtrR) protein  
The presence of β-lactamase enzymes has been shown to confer antibiotic 
resistance in bacterial and viral infections due to the enzymatic hydrolysis and 
subsequently inactivation of β-lactam antibiotics, such as penicillin or cephalosporin.  
In order to improve the effect of antibiotic treatment, β-lactamase inhibitors have 
been used to irreversibly inhibit the enzymatic activity of the β-lactamases and allow 
the antibiotics to combat the underlying infection.  The β-lactamase inhibitors 
tazobactam and clavulanic acid, Figure  5.1, are frequently used inhibitors for the 
treatment of infections containing β-lactamases in conjunction with β-lactam 
antibiotics.  Investigations into the inhibition of the SHV-1 β-lactamase found in 
Escherichia coli and Klebsiella pneumoniae and the S130G SHV-1 variant have 
yielded significant information regarding the interactions between the proteins and 
inhibitors.  MS analysis of intact and enzymatic digests of the modified proteins, in 
comparison with the unmodified protein, showed a mass increase of less than the 
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molecular weight of the starting inhibitor molecules, suggesting that the inhibitor is 
altered upon reaction with the protein.2-3, 12   
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Figure ‎5.1: Structures of (left) tazobactam, molecular formula C10H12N4O5S and 
(right) clavulanic acid, molecular formula C8H9NO5. 
 
 
The suggested mechanisms for the reaction between the protein residues and 
tazobactam or clavulanic acid have been detailed in Figure 5.2 and Figure 5.3 
respectively.  The interaction between the protein and inhibitor molecules is 
purported to take place at the hydroxyl groups of the serine or threonine residues, 
resulting in the opening of the β-lactam ring of the inhibitor.2-3  The protein-inhibitor 
reaction was found to differ between the SHV-1 and the S130G SHV-1 β-
lactamases.  The SHV-1 enzyme was found to preferentially form the aldehyde 
hydrate modification of C3H4O3, resulting in the mass increase of 88.0 Da, whereas 
the aldehyde moiety of C3H2O2, a modification of 70.0 Da, was determined to be the 
predominant modification for the S130G SHV-1 variant.   
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Figure ‎5.2: Proposed mechanism for the reaction between tazobactam and serine/threonine residues.  Atoms labelled in blue belong 
to the protein.3  
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Figure ‎5.3: Proposed mechanism for the reaction between clavulanic acid and serine/threonine residues.  Atoms labelled in blue 
belong to the protein.2 
 170 
The MtrR protein of Neisseria gonorrhoeae has been shown to have a significant 
effect on antibiotic resistance due to its function in regulating the membrane bound 
MtrCDE efflux pump involved in ejecting antibiotics from infected cells.13  
Investigations using isothermal titration calorimetry have uncovered the β-lactamase 
activity of the MtrR protein, as evidenced by the binding and subsequent hydrolysis 
of β-lactam antibiotics, an additional source of the antibiotic resistance of the virus.  
The inhibition of the β-lactamase function of the MtrR protein via the interaction with 
β-lactamase inhibitors has been studied with the hope of de-activating the 
enzymatic activity and reducing antibiotic resistance.  In the following study, the β-
lactamase inhibitors tazobactam and clavulanic acid were incubated with the MtrR 
protein (carried out by Matthew F. Burton) and acquired for MS and MS/MS 
analysis.14   
 
5.2. Results and Discussion 
5.2.1. MS Analysis of the intact MtrR protein 
The unmodified MtrR protein sequence, shown in Figure  5.4, corresponds to a 
protein with a neutral monoisotopic weight of 25241.8 Da and the most abundant 
isotope at 25256.9 Da.   
 
1 6 11 16 21 26 31 36 41
HHHHH HELMR KTKTE ALKTK EHLML AALET FYRKG IARTS LNEIA
46 51 56 61 66 71 76 81 86
QAAGV TRGAL YWHFK NKEDL FDALF QRICD DIENC IAQDA ADAEG
91 96 101 106 111 116 121 126 131
GSWTV FRHTL LHFFE RLQSN DIHYK FHNIL FLKCE HTEQN AAVIA
136 141 146 151 156 161 166 171 176
IARKH QAIWR EKITA VLTEA VENQD LADDL DKETA VIFIK STLDG
181 186 191 196 201 206 211 216
LIWRW FSSGE SFDLG KTAPR IIGIM MDNLE NHPCL RRK
 
Figure ‎5.4: Amino acid sequence for the histidine-tagged MtrR protein with an 
average molecular weight of 25257.9 Da.  
 171 
The Total Ion Chromatogram (TIC) in Figure  5.5 was generated from the LC-MS 
analysis of the unmodified protein. The major peak maximum, from 17.3 to 20 
minutes, allowed 150 MS scans to be averaged to generate the MS spectrum shown 
in Figure 5.6, which confirms the presence of a high molecular weight species that 
has formed a charge state distribution that can be deconvoluted to determine the 
molecular weight.   
 
 
Figure ‎5.5: Total ion chromatogram generated from the LC-MS analysis of the 
unmodified MtrR protein. 
 
 
The mass resolution is sufficient to resolve the isotopic profile of each charge state, 
as shown in the expansion of the peak at m/z 815.7 in Figure 5.6(inset) that 
corresponds to the [M+31H]31+ charge state.  Deconvolution of the MS spectrum 
was carried out in order to calculate the singly protonated molecular weight for each 
multiply charged species, resulting in the spectrum shown in Figure  5.7.   
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Figure ‎5.6: MS spectrum generated from the unmodified MtrR protein sample with (inset) expansion over the peak at m/z 815.7. 
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Figure ‎5.7: MS spectrum of the unmodified MtrR protein, deconvoluted to the [M+H]+ species from the spectrum in Figure 5.6. The 
species at 25257.9 Da corresponds to the protonated MtrR protein.    
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The most intense deconvoluted peak at 25257.9 Da is consistent with the 
protonated form of the unmodified MtrR protein, accurate to within 2 ppm from the 
most abundant ion of the known amino acid sequence.  The deconvoluted peaks 
observed in the m/z region higher than the unmodified protein at 25273.9 Da, 
25289.9 Da and 25301.9 Da correspond to modified protein species, consistent with 
the single oxidation, double oxidation and carboxylation of the MtrR protein 
respectively.  These modifications are proposed to originate from sample 
preparation.  
 
5.2.2. Incubation of MtrR protein with tazobactam 
The MtrR protein was treated with tazobactam to study the interaction between the 
protein and the inhibitors.  The product was analysed by LC-MS, and the resulting 
MS spectrum was deconvoluted to generate the protonated spectrum shown in 
Figure  5.8.  The most intense deconvoluted peak at 25257.9 Da corresponds to the 
most abundant ion of the protonated MtrR isotopic profile, suggesting that the 
reaction between the inhibitor and protein did not reach completion or that the 
reaction forms an equilibrium between the unmodified and modified protein.  There 
is no evidence of the protein having been modified by an intact tazobactam 
molecule, which would be observed 300.0 Da higher than the unmodified protein at 
25558.0 Da.  The peak at 25328.0 Da, corresponding to a modification of 70.0 Da to 
the protein, is consistent with the aldehyde modification of C3H2O2 shown in Figure 
5.2(a).  The expected peak corresponding to the aldehyde hydrate modification (88 
Da) shown in Figure 5.2(b) is not observed, however the peak at 25342.9 Da is 
consistent with the addition of C3H3NO2 (85 Da) to the MtrR protein.  The peak at 
25356.0 Da, 98 Da higher than the protein, is believed to correspond to the addition 
of C4H4NO2, whereas the peak at 25401.0 Da is thought to correspond to a 
modification of C5H5NO4, resulting in a species 143.0 Da higher than the unmodified 
protein.  The formation of the three modifications at 85 Da, 98 Da and 143 Da higher 
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than the unmodified protein are proposed to follow the reaction mechanisms shown 
in Figure 5.9.  The reaction of the β-lactamase inhibitors with the hydroxyl group is 
purported to occur via nucleophilic attack at the carboxyl group of the β-lactam ring, 
as shown in Figure  5.9, resulting in ring opening and further reaction.  The low 
abundance peaks that were observed in the unmodified protein sample 
corresponding to oxidated and carboxylated protein are also observed in the 
tazobactam treated sample at 25273.9 Da, 25289.9 Da and 25301.9 Da.  
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Figure ‎5.8: MS spectrum, deconvoluted to the [M+H]+ species, of the MtrR protein sample treated with tazobactam. The species at 
25257.9 Da corresponds to the protonated MtrR protein. Additional peaks have been discussed further. 
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Figure ‎5.9: Proposed mechanisms for the formation of the tazobactam modifications observed in Figure 5.8. 
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5.2.3. Incubation of MtrR protein with clavulanic acid 
Figure 5.10 shows the MS spectrum of the MtrR protein treated with clavulanic acid 
and deconvoluted to give the singly protonated ion.  The dominant peak in the 
spectrum corresponds to the unmodified MtrR protein at 25258.0 Da, accurate to 
within 4 ppm.  The low intensity peaks that were observed in the unmodified protein 
sample in Figure  5.7 were also observed in the clavulanic acid sample, at 25274.0 
Da, 25289.0 Da and 25302.0 Da, corresponding to the oxidated and carboxylated 
MtrR protein.  The deconvoluted peaks at 25328.0 Da, 25343.0 Da and 25401.0 Da 
that were present in the tazobactam treated sample in Figure  5.8 are also present in 
the sample incubated with clavulanic acid, and are proposed to correspond to a 
modification of C3H2O2 (70 Da), C3H3NO2 (85 Da) and C5H5NO4 (143 Da) 
respectively, indicating that the clavulanic acid molecule has been altered upon 
interaction with the protein.  The peak at 25455.1 Da is consistent with an addition of 
197.0 Da, which is proposed to result from the loss of H2 following the addition of an 
intact clavulanic acid molecule.  The peaks at 25356.0 Da, 25413.1 Da and 25427.0 
Da are also proposed to correspond to modifications resulting from the reaction with 
the clavulanic acid molecule, consistent with the addition of C4H4NO2 (98 Da), 
C6H6NO4 (155 Da) and C7H7NO4 (169 Da).  The reaction mechanisms shown in 
Figure 5.11 have been suggested to explain the observed modifications in Figure 
 5.10.  Similarly to the reaction between the MtrR protein and tazobactam, the 
reaction with clavulanic acid is purported to occur via nucleophilic attack at the 
carboxyl group of the β-lactam ring, as shown in Figure 5.11.   
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Figure ‎5.10: MS spectrum of clavulanic acid treated sample, deconvoluted to the [M+H]+.  Peaks suspected of corresponding to 
protein adducts have been labelled according to the mass difference from the unmodified protein at 25258.0 Da. 
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Figure ‎5.11: Proposed reaction mechanisms of clavulanic acid to generate the observed adducts shown in Figure 5.10. 
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5.2.4. Tryptic digest of the MtrR protein 
The unmodified MtrR protein and the protein samples treated with the β-lactamase 
inhibitors were digested using trypsin and analysed by LC-MS.  The MS spectra, 
produced by averaging MS scans across each LC chromatogram, were 
deconvoluted to generate singly protonated ions, as shown in Figure 5.12.  The 
enzyme, trypsin, cleaves at the C-terminus of lysine and arginine residues, therefore 
an in silico tryptic digest could be performed on the MtrR amino acid sequence 
shown in Figure  5.4.  The in silico digest provided a list of all possible tryptic 
peptides over an unlimited mass range, allowing for up to 10 missed cleavages.  A 
direct comparison between the tryptic digest of the unmodified MtrR protein and the 
in silico digest identified 19 common peptides, accurate to within 3 ppm, that 
confirmed approximately 70% of the known protein sequence (153 of 218 amino 
acid residues), as shown in Figure 5.13.  The data collected from the MS spectrum 
of the intact unmodified protein sample and the high degree of sequence coverage 
from the tryptic digest supports the identification of the sample as the expected MtrR 
protein.  
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Figure ‎5.12: Deconvoluted MS spectra for tryptic digests of (a) the unmodified MtrR protein, (b) the tazobactam treated sample and (c) 
the clavulanic acid treated sample.
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1 6 11 16 21 26 31 36 41
HHHHH HELMR KTKTE ALKTK EHLML AALET FYRKG IARTS LNEIA
46 51 56 61 66 71 76 81 86
QAAGV TRGAL YWHFK NKEDL FDALF QRICD DIENC IAQDA ADAEG
91 96 101 106 111 116 121 126 131
GSWTV FRHTL LHFFE RLQSN DIHYK FHNIL FLKCE HTEQN AAVIA
136 141 146 151 156 161 166 171 176
IARKH QAIWR EKITA VLTEA VENQD LADDL DKETA VIFIK STLDG
181 186 191 196 201 206 211 216
LIWRW FSSGE SFDLG KTAPR IIGIM MDNLE NHPCL RRK
 
Figure ‎5.13: MtrR protein sequence highlighting (red) amino acid residues that 
have been confirmed from the tryptic digest of the unmodified MtrR protein. 
 
 
The deconvoluted MS spectra generated from the tryptic digests of the modified 
MtrR protein, see Figure  5.12, have been directly compared to the in silico digest of 
the MtrR amino acid sequence.  The tazobactam and clavulanic acid treated 
samples both contained peptides that could be attributed to the MtrR sequence 
including, but not limited to, the peptides observed in the unmodified protein 
samples, thereby allowing the percentage sequence coverage to be increased to 
93% (203 of 218 residues) as shown in Figure  5.14.  The parameters of the in silico 
digest were adjusted to include the modifications previously observed in Figure  5.8 
and Figure 5.10, corresponding to the empirical formulae of the proposed molecular 
modifications C3H2O2 (70 Da), C3H3NO2 (85 Da), C4H4NO2 (98 Da), C5H5NO4 (143 
Da), C6H5NO4 (155 Da), C7H7NO4 (169 Da) and C8H7NO5 (197 Da).   
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Figure ‎5.14: MtrR protein sequence highlighting (red) amino acid residues that 
have been confirmed from the tryptic digest of the unmodified MtrR protein, 
and (green) the additional residues confirmed from the treated MtrR samples. 
 
 
There were 4 peptides observed with the proposed modification of C3H2O2 (70 Da), 
all of which were observed in both treated samples.  All four peptides were identified 
as triply charged species, as shown in Figure  5.15, which deconvoluted to singly 
protonated ions at 1269.6 Da, 1663.8 Da, 1695.8 Da and 1893.0 Da.  Figure  5.16 
highlights the observed peptides that were modified by C3H2O2, with the three 
proposed modification sites labelled in red.  The peak at 1269.6 Da corresponds to 
the amino acid sequence HTLLHFFER with the C3H2O2 modification residing on the 
Thr-99 residue.  The peak at 1695.8 Da corresponds to the peptide 
CEHTEQNAAVIAIAR, residues 124 – 138, with the proposed modification on the Thr-
127 residue.  The peaks at 1663.8 Da and 1893.0 Da are both believed to contain 
amino acid residues 21 – 33, the sequence EHLMLAALETFYR, with the larger 
peptide containing 2 additional amino acid residues on the C-terminus (TK).  There 
are 2 potential modification sites on the peptide at 1893 Da, at Thr-19 and Thr-30, 
however the common residues between the two peptide sequences suggests that 
the modification site is the Thr-30 residue.  This indicates that there are 3 
modification sites contained within the 4 modified peptides, all of which are 
proposed to be threonine residues.  
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Figure ‎5.15: MS spectra of (a) the [M+3H]3+ species of the 4 peptides modified by C3H2O2 and (b) the corresponding protonated 
species generated by deconvolution.
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Figure ‎5.16: Peptides labelled in blue were observed in the modified MtrR 
protein samples with the proposed modification of C3H2O2 (70 Da) on residues 
labelled in red. 
 
 
A quadruply charged peak at m/z 934.0 was only observed in the tazobactam 
treated sample and is consistent with the deconvoluted [M+H]+ species 3732.7 Da.  
This peak is the 32-residue peptide WFSSGESFDLGKTAPRIIGIMMDNLENHPCLR, 
containing 4 potential modification sites, and one proposed modification C4H4NO2 
(98 Da).  Evidence for the modification C5H5NO4 (143 Da) can be seen in both 
treated samples at the deconvoluted peak 1965.9 Da, and in the clavulanic acid 
treated sample only at 4918.6 Da.  The peak at 1965.9 Da corresponds to the 
peptide TKEHLMLAALETFYR, residues 19 – 33 of the MtrR protein sequence with 
two threonine residues as possible modification sites.  The peak at 4918.6 Da is 
consistent with residues 21 – 62, corresponding to the sequence 
EHLMLAALETFYRKGIARTSLNEIAQAAGVTRGALYWHFKNK, a 42-residue peptide 
containing 4 possible modification sites.  Both peptides contain residues 21 – 33, a 
sequence also contained within two of the peptides identified in Figure  5.16 with the 
C3H2O2 (70 Da) modification, suggesting that the modification site of all 4 peptides 
may be the same, however this cannot be confirmed without further analysis of the 
peptides by MS/MS. 
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A summary of all the suspected modified tryptic peptides observed in the protein 
digests of the tazobactam-modified protein and the clavulanic acid-modified protein 
are shown in Table 5.1.  Accurate mass measurements for each peak confirm the 
identity of each peptide to within 4 ppm, all of which were determined to contain only 
one modification.  The C3H2O2 modification is the most abundant modification in the 
LCMS spectra of the intact treated protein samples and the tryptic digests, 
suggesting that it is the most stable protein modification.   
 
Residues 
Theoretical 
Monoisotopic 
[M+H]
+
 Da 
Accuracy 
/ppm 
Modification 
Tazobactam 
Clavulanic 
Acid 
[19 - 33] 1892.95750 0.6 0.6 70 Da 
[19 – 33] 1965.97387 0.6 0.6 143 Da 
[21 - 33] 1663.81485 1.7 3.0 70 Da 
[21 - 62] 4918.55735 - 0.0 143 Da 
[98 - 106] 1269.63748 -0.4 -0.3 70 Da 
[124 - 138] 1695.81189 0.2 0.7 70 Da 
[185 - 216] 3732.78454 3.6 - 98 Da 
 
Table ‎5.1: Summary of the identified peptides from the trypsin digests of the 
unmodified MtrR protein, the tazobactam modified sample and the clavulanic 
acid modified sample. 
 
 
The absence of tryptic peptides containing the modifications C3H3NO2 (85 Da), 
C6H5NO4 (155 Da), C7H7NO4 (169 Da) and C8H7NO5 (197 Da) that were observed in 
the intact protein MS spectrum (see Figure  5.8 and Figure  5.10) is thought to be 
partly due to the significantly higher intensity of the species resulting from the 
modification C3H2O2 (70 Da).  The unobserved modifications may also correspond to 
short-lived intermediates that react further to create a more stable modification 
species, a theory supported by studies carried out by Brown et al. involving the 
incubation of TEM-2 β-lactamase from E. coli with clavulanic acid.15 
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5.2.5. ECD of a proposed modified peptide 
The deconvoluted peak at 1269.6 Da, which was proposed to correspond to the 
amino acid sequence HTLLHFFER, was analysed by LC-MS/MS to confirm the 
peptide sequence and the location of the C3H2O2 modification.  Due to the known 
inhibitor-protein interactions between the serine or threonine residues of the protein 
and the β-lactam ring of the inhibitor molecule, the modification was expected to 
reside on the threonine residue of the targeted peptide.  The lability of the 
modification is unknown, therefore ECD was used to analyse the selected peptide 
due to its ability to preserve chemical modifications while generating a high degree 
of sequence coverage.  The [M+3H]3+ species at m/z 423.8 was targeted with 
electrons of 2.31 eV, resulting in the MS/MS spectrum shown in Figure  5.17.  A total 
of 10 MS/MS scans were generated from the LC-ECD of the m/z 423.8 species, 
which when considering the low abundance of the precursor ion resulted in the low 
signal-to-noise (S/N) of the observed product ions.  The major product ion from the 
ECD of the [M+3H]3+ precursor ion, is the charge reduced species [M+2H]2+ at m/z 
635.3.  As shown in Figure  5.17, LC-ECD generated 88% sequence coverage (7 
out of 8 bonds broken) from a, c, y and z+1 product ions.  The a and c product ions 
observed are consistent with ions including the proposed modification, whereas the 
y and z+1 ions correspond to unmodified residues, thereby narrowing down the 
location of the C3H2O modification to the histidine or threonine residue at the N-
terminus of the peptide.   
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Figure ‎5.17: LC-ECD spectrum generated from the [M+3H]3+ species of the modified peptide HTLLHFFER, narrowing down the 
location of the C3H2O2 modification on the histidine or threonine residues. 
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Table 5.2 summarises the product ion assignments and their corresponding mass 
accuracies, allowing the peptide sequence to be characterised.  All product ions 
have been found to be accurate to within 2 ppm to the expected molecular formula, 
confirming the peptide sequence assignment.  The c2 ion, highlighted in red in Table 
5.2, confirms the location of the modification to the two N-terminal residues, the His-
98 or the Thr-99 residue in the MtrR amino acid sequence shown in Figure  5.4. 
 
Observed 
m/z 
Ion 
Molecular 
Formula 
Accuracy 
/ ppm 
159.10022 z1+1 C6H13N3O2 -0.0 
175.11891 y1 C6H15N4O2 -0.2 
288.14281 z2+1 C11H20N4O5 -0.0 
326.14578 c2 C13H20N5O5 -0.4 
423.88400 [M+3H]
3+
 C60H87N16O15 -0.0 
435.21168 z3+1 C20H29N5O6 1.0 
439.23072 c3 C19H31N6O6 1.7 
552.31442 c4 C25H42N7O7 0.7 
582.28042 z4+1 C29H38N6O7 1.3 
613.32758 a9
2+
 C59H86N16O13 0.2 
635.32251 [M+2H]
2+
 C60H86N16O15 0.2 
689.37171 c5 C31H49N10O8 -1.8 
961.52719 y7 C47H69N12O10 1.8 
1112.55242 c8 C54H74N13O13 0.1 
 
Table ‎5.2: Summary of the product ions generated by LC-ECD of the modified 
peptide shown in Figure ‎5.17. The precursor ion is highlighted in bold. 
 
 
5.2.6. The matrix (M) Protein 
The M protein is a membrane protein from the human respiratory syncytial virus 
(hRSV), a virus that infects the respiratory tract and causes breathing difficulties.  
The analysis of membrane proteins is often hampered by the abundance of 
hydrophobic regions on the protein.  The hydrophobicity of membrane proteins also 
affects their ability to remain soluble under aqueous conditions and promotes protein 
oligomerisation or aggregation, which further impedes analysis.16  The M protein 
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sequence, shown in Figure  5.18, corresponds to a monoisotopic molecular weight 
of 29231.3 Da and the most abundant peak at 29249.3 Da.   
 
1 6 11 16 21 26 31 36 41
HMLEM ETYVN KLHEG STYTA AVQYN VLEKD DDPAS LTIWV PMFQS
46 51 56 61 66 71 76 81 86
SMPAD LLIKE LANVN ILVKQ ISTPK GPSLR VMINS RSAVL AQMPS
91 96 101 106 111 116 121 126 131
KFTIC ANVSL DERSK LAYDV TTPCE IKACS LTCLK SKNML TTVKD
136 141 146 151 156 161 166 171 176
LTMKT LNPTH DIIAL CEFEN IVTSK KVIIP TYLRS ISVRN KDLNT
181 186 191 196 201 206 211 216 221
LENIT TTEFK NAITN AKIIP YSGLL LVITV TDNKG AFKYI KPQSQ
226 231 236 241 246 251 256
FIVDL GAYLE KESIY YVTTN WKHTA TRFAI KPRED
 
Figure ‎5.18: Amino acid sequence of M protein. 
 
 
The LC-MS of the M protein generated a broad peak in the TIC, as shown in Figure 
 5.19.  The MS spectrum averaged from 79 scans under the peak maximum, shown 
in Figure  5.19, revealed at least two overlapping protein charge state envelopes, as 
indicated in Figure  5.20.  The MS spectrum was deconvoluted to the [M+H]+ 
species, resulting in the spectrum shown in Figure  5.21, which indicated some 
discrepancies between the expected most abundant ion calculated from the known 
amino acid sequence, 29250.3 Da, and the experimental average molecular weight.  
The MS spectrum of the M protein observed two protein distributions at 29351.4 Da 
and 29431.4 Da, corresponding to 101.1 Da and 181.1 Da higher than expected.  
The unknown proteins were subjected to further investigation in order to determine 
whether they are consistent with unexpected modifications to the M protein or 
whether they correspond to entirely different proteins. 
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Figure ‎5.19: TIC generated from the LC-MS analysis of the M protein.
 193 
ASP_Mprotein_native #223-257 RT: 6.76-7.28 AV: 35 NL: 8.42E4
T: FTMS + p ESI Full ms [500.00-2000.00]
800 900 1000 1100 1200 1300
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
la
tiv
e 
Ab
un
da
nc
e
m
8 0 9 0 10 0 11 0 12 0 13 0
1013.06
979.39
947.80
890.39
839.59
1049.27
1088.02
1129.95 1175.06
1223.90
1276.99
1338.66
864.29
816.30
794.23
0
10
20
30
40
50
60
70
80
90
1 0
R
e
la
ti
v
e
 A
b
u
n
d
a
n
c
e
[M+33H]33+
R
e
la
ti
v
e
 A
b
u
n
d
a
n
c
e
0
20
40
60
80
100
ASP_Mprotein_native #220-299 RT: 6.70-8.00 AV: 80 NL: 3.90E4
T: FTMS + p ESI Full ms [500.00-2000.00]
890.0 890.5 891.0 891.5 892.0 892.5 893.0 893.5 894.0 894.5
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
10
R
e
la
ti
v
e
 A
b
u
n
d
a
n
c
e
890.0
m/z
891.0 892.0 893.0 894.0
890.38364
892.83750
Re
la
tiv
e 
Ab
un
da
nc
e
Re
la
tiv
e 
Ab
un
da
nc
e
R
e
la
ti
v
e
 A
b
u
n
d
a
n
c
e
R
e
la
ti
v
e
 A
b
u
n
d
a
n
c
e
R
e
la
ti
v
e
 A
b
u
n
d
a
n
c
e
R
e
la
ti
v
e
 A
b
u
n
d
a
n
c
e
R
e
la
ti
v
e
 A
b
u
n
d
a
n
c
e
R
e
la
ti
v
e
 A
b
u
n
d
a
n
c
e
 
Figure ‎5.20: MS spectrum of the M protein indicating the presence of at least two species, and (inset) an expansion of the 33+ charge 
state. 
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Figure ‎5.21: MS spectrum for the M protein, deconvoluted to the [M+H]+ species, indicating protein species at higher m/z than 
expected. 
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5.2.7. Tryptic Digest of M Protein 
In order to investigate the discrepancy in mass, a sample of the unmodified M 
protein was digested using trypsin and analysed by LC-MS.  The resulting MS 
spectrum was deconvoluted to generate the protonated species for each observed 
species, as shown in Figure  5.22.  An in silico tryptic digest of the M protein was 
carried out using the known amino acid sequence, shown in Figure  5.18, calculating 
theoretical tryptic peptides to the [M+H]+ species and allowing for peptides 
containing up to 10 missed cleavages over an unlimited mass range in order to 
ensure a thorough interpretation of the experimental data. A direct comparison 
between the enzymatic digest and the in silico digest identified 28 peptides common 
to both that allowed the confirmation of 222 out of 260 amino acid residues from the 
known sequence, resulting in 85% sequence coverage.  The remaining unidentified 
peaks were studied in order to identify the root of the unknown molecular weight 
discrepancy.  Two deconvoluted peaks were discovered, at 1495.7 Da and 6271.0 
Da, which were found to correspond to 101.0 Da higher than an expected M protein 
tryptic peptide.  The suggested amino acid sequences from the in silico digest for 
both peaks corresponded to portions of the N-terminus of the M protein, as shown in 
Figure  5.22, implying that the unknown modification or mutation had taken place on 
one of residues 1 – 11 of the M protein.  
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Figure ‎5.22(a): Deconvoluted MS spectrum of the trypsin-digested M protein. Two peaks at (b) m/z 1495.7 and (c) m/z 6271.0 are 
proposed to correspond to N-terminal peptides with the unknown addition of 101 Da. 
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LC-CID and LC-ECD analysis were performed on the [M+2H]2+ species at m/z 
748.3, which was thought to correspond to the amino acid sequence HMLEMETYVNK 
plus the unknown modification of 101.1 Da, in order to confirm the nature of the 
modification.  The MS/MS spectra generated by both CID and ECD, shown in 
Figure  5.23, indicated that the increase in molecular weight was not caused by the 
modification of one of the amino acid residues, but instead corresponded to an 
additional amino acid in the peptide, an additional threonine residue located after the 
Glu-4 residue.  The ions observed in the MS/MS spectra have been summarised in 
Table 5.3, confirming the product ion assignments accurate to within 4 ppm.  ECD 
generated 9 backbone cleavages out of 11 (81%) whereas CID was shown to 
cleave all 11 bonds (100%) as shown in Figure  5.23.  The complementary 
information generated by ECD and CID allows confidence in the assignment of the 
extra threonine residue.  The complete sequencing of the peptide allowed the 
confirmation of the N-terminus of the M protein and increased the sequence 
coverage from 85% to 92% (239 out of 261 residues), as indicated in Figure  5.24.  
A comparison between each observed species and its corresponding theoretical 
monoisotopic mass for the [M+H]+ species has confirmed the proposed molecular 
composition of each product ion to within 5 ppm, as shown in Table 5.3. 
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Figure ‎5.23(a): LC-CID and (b) LC-ECD spectra from the [M+2H]2+ m/z 748.3. The addition of 101 Da has been identified as an extra 
threonine residue. Peaks labelled * denote artefact peaks and can be disregarded. 
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Figure ‎5.24: Updated M protein sequence indicating the additional threonine 
residue in blue. 
 
Observed 
m/z 
Ion Molecular Formula 
ECD 
/ ppm 
CID 
/ ppm 
269.10597 b2 C11H17N4O2S  -2.6 
511.23249 b4 C22H35N6O6S  -1.6 
523.28607 y4 C24H39N6O7  -2.7 
608.31548 z5 + 1 C28H44N6O9 -1.6  
612.27962 b5 C26H42N7O8S  -2.2 
624.33306 y5 C28H46N7O9  -3.2 
737.35884 z6 + 1 C64H105N16O21S2 -0.2  
739.34265 b12
2+
 C64H102N16O20S2  -2.2 
743.32032 b6 C31H51N8O9S2  -1.5 
748.34906 [M+2H]
2+
 C64H104N16O21S2 -0.8 - 
868.39925 z7 + 1 C38H60N8O13S -0.3  
872.36181 b7 C36H58N9O12S2  -2.5 
884.41521 y7 C38H62N9O13S  -3.4 
889.39096 c7 C36H61N10O12S2 0.4  
969.44833 z8 + 1 C42H67N9O15S 1.2  
973.40912 b8 C40H65N10O14S2  -2.6 
985.46384 y8 C42H69N10O15S  -1.9 
990.43745 c8 C40H68N11O14S2 -0.9  
1114.50679 y9 C47H76N11O18S  -1.6 
1136.47245 b9 C49H74N11O16S2  -2.0 
1153.50314 c9 C49H77N12O16S2 1.3  
1211.57788 z10 + 1 C53H85N11O19S 3.3  
1227.59091 y10 C53H87N12O19S  -1.5 
1235.54237 b10 C54H83N12O17S2  -0.5 
1252.57280 c10 C54H86N13O17S2 2.2  
1358.63009 y11 C58H96N13O20S  -2.4 
1366.61759 c11 C58H92N15O19S2 3.4  
1479.67909 z12 + 1 C64H101N15O21S2 4.0  
1495.69706 [M+H]
+
 C64H103N16O21S2 3.4  
 
Table ‎5.3: Summary of the product ion assignments for the peaks generated 
by LC-MS/MS in Figure ‎5.23. The precursor ion is highlighted in bold. 
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The assignment of the deconvoluted peak at 29351.4 Da in Figure  5.21 as the 
unmodified M protein allows the other observed protein species to be re-assigned 
accordingly, as shown in Figure  5.25.  The protein at 29431.4 Da corresponds to 
the phosphorylated M protein resulting from the net addition of HPO3 to the protein, 
proposed to originate from the phosphate buffer used for protein storage.  The 
peaks at 29367.4 Da, 29383.4 and 29399.4 Da are thought to correspond to 
oxidated M protein species, resulting from the addition of 1, 2 and 3 oxygen atoms 
respectively, also likely to occur from sample preparation.  The peak at 29463.4 Da 
is thought to correspond to the double oxidation of the phosphorylated species.   
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Figure ‎5.25: Deconvoluted M protein spectrum (from Figure ‎5.21) indicating 
suspected protein modifications. 
 
 
The mass accuracies have been calculated with respect to the theoretical most 
abundant ion for each protein species, all of which have been found to be accurate 
to within 4 ppm.  Tryptic peptides containing modifications consistent with the 
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oxidated or phosphorylated protein species were not observed in the tryptic digest 
spectrum shown in Figure  5.22, preventing the identification of the oxidation or 
phosphorylation sites. 
 
5.2.8. Fluorescent labelling of M Protein 
Fluorescent Resonance Energy Transfer (FRET) microscopy is a frequently used 
technique for studying cell membranes and their interaction with proteins and lipids 
by observing the transfer of fluorescent energy between the donor and acceptor.17  
In order to study the membrane-binding properties of the M protein by FRET, the 
protein must first be reacted with a fluorescent label to produce the fluorescent 
donor.18  The reaction between the M protein and the fluorescent label, 4-chloro-7-
nitrobenzofurazan (NBD-Cl), shown in Figure  5.26, is purported to proceed via the 
reaction between the label and the amine groups of lysine residues or the thiol 
groups of cysteine residues, resulting in the loss of HCl and the production of a 
green fluorescent complex (~ 400-500 nm).19-20  Analysis has been carried out on 
the labelled protein with the intention of confirming the interaction between the label 
and the protein, and determining the number and location of any NBD modifications 
to the protein. 
 
N
O
N
Cl
NO2
 
Figure ‎5.26: Structure of the NBD-Cl fluorescent label that reacts with cysteine 
or lysine residues to give the added molecular formula C6HN3O3. 
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The sample of M protein treated with NBD-Cl was analysed by LCMS and 
deconvoluted to the singly protonated species, see Figure  5.27, which resulted in 3 
major species at 29351.4 Da, 29431.4 Da and 29514.4 Da.  The unmodified protein 
at 29351.4 Da remained the most abundant species, indicating that the reaction was 
not carried to completion or that the reaction forms an equilibrium between the 
modified and unmodified protein.  The loss of HCl upon reaction is confirmed by the 
deconvoluted peak at 29514.4 Da, which was found to correspond to the addition of 
the empirical formula of C6HN3O3 consistent with the addition of one NBD molecule 
to the intact M protein, with a mass accuracy of 0.9 ppm.  The phosphorylated 
protein species at 29431.4 Da does not appear to have a corresponding NBD-
modified species, suggesting that the phosphorylation may inhibit the NBD 
modification. 
 
 
Figure ‎5.27: MS spectrum of the modified M protein sample deconvoluted to 
the [M+H]+ species.  
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5.2.9. Tryptic digest of NBD-modified M Protein 
A sample of the NBD-treated M protein was digested using trypsin and analysed by 
LC-MS.  The spectrum generated from the MS analysis of the digest was 
deconvoluted to generate the [M+H]+ for each species.  The parameters of the in 
silico tryptic digest of the M protein sequences were adjusted to include the optional 
modification of C6HN3O3 (NBD) on all lysine or cysteine residues.  When the 
enzymatic digest of the treated protein was directly compared to the in silico digest, 
29 tryptic peptides were identified, of which 28 were determined to correspond to 
portions of the sequence without the NBD modification, including peptides not 
previously observed in the unmodified protein digests and therefore resulting in 
increased sequence coverage to 96% (250 out of 261 residues confirmed), as 
shown in Figure  5.28.  The deconvoluted peak at 1346.7 Da matches the 
theoretically modified peptide QISTPKGPSLR with the NBD modification proposed to 
reside on the lysine residue, an assignment that has been confirmed with an 
accuracy of 1.4 ppm.  A direct comparison between the tryptic peptides observed in 
the unmodified M protein sample and the NBD-treated sample highlighted peptides 
unique to each sample, which may indicate a change in the secondary and/or 
tertiary structure of the protein as a result of the NBD modification subsequently 
altering which parts of the protein are accessible to the enzyme. 
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Figure ‎5.28: Confirmed sequence coverage of the M protein. The residues 
labelled in green were only observed in the digest of the modified protein 
sample. The proposed modification site, Lys-71, has been labelled in blue. 
 
 
Figure  5.29 shows the crystal structure modelled from the experimental X-ray 
diffraction data of the M protein using the sequence in Figure  5.18 (modelled using 
residues 3 – 259).21  The part of the structure in red corresponds to portions of the 
sequence confirmed by the tryptic digest of the unmodified protein, whereas the 
regions in green correspond to the peptides confirmed from the NBD-protein digest 
only.  The location of the proposed modification site on the Lys-71 residue (named 
as per the amino acid sequence in Figure  5.28) has been shown in blue on the 
crystal structure in Figure  5.29.  The Lys-71 residue is observed on a flexible loop 
portion of the protein structure, free from any noticeable steric hindrance from the 
other residues that may obstruct the site from modification. 
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Figure ‎5.29: Crystal structure§ of the M protein modelled using the amino acid 
sequence in Figure ‎5.18. The proposed modification site has been labelled in 
blue.21  
 
 
The phosphorylated M protein species was not seen to have been labelled upon 
incubation with NBD-Cl, as shown in Figure  5.27, suggesting that the 
phosphorylation inhibits the NBD modification.  Protein phosphorylation is known to 
occur on serine, threonine or tyrosine residues1, and therefore would not be 
expected on the proposed NBD modification site at Lys-71, however the Ser-68 , 
Thr-69 and Ser-74 residues are all in close proximity to the proposed modification 
site and may be involved in phosphorylation.  The tertiary protein structure also 
brings residues Thr-94 and Tyr-109 into close proximity to the Lys-71.  
 
The crystal structure shown in Figure  5.29, modelled using the original M protein 
sequence shown in Figure  5.18, did not identify the presence of the extra amino 
acid at the N-terminus, instead mistaking the threonine residue for the neighbouring 
glutamic acid residue.  The misinterpretation of the X-ray crystal structure of the M 
Protein is due to the flexibility of the protein termini, which resulted in more 
                                               
§
 X-ray diffraction data recorded at a resolution of 1.60 Å. 
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disordered X-ray diffraction data at the termini and prevented the sequence error 
from being discovered.   
 
 
5.3. Conclusion 
5.3.1. MtrR Protein 
The observed interaction of the MtrR protein by tazobactam and clavulanic acid 
supports the proposed β-lactamase function of the protein. The MS analysis of the 
trypsin-digested MtrR protein samples were compared to an in silico digest and 
resulted in a high percentage of the sequence being confirmed.   Full MS analysis of 
the intact modified protein samples has proposed several modifications arising from 
incubation with the β-lactamase inhibitors.  The search for modifications in the 
tryptic digest of the modified samples noted 4 peaks consistent with the modification 
of C3H2O2
 (70 Da), proposed to correspond to three modified amino acid residues, 
Thr-30 and Thr-99 and Thr-127.  Two peptides were observed with the modification 
of C5H5NO4 (143 Da), one that corresponds to the same peptide sequence (residues 
19 – 33) that was determined to contain the modification of C3H2O2 (70 Da) at the 
Thr-30 residue.  The second peptide containing the 143 Da modification 
corresponds to a 42-residue peptide with 4 possible modification sites.  One peptide 
was identified with the proposed modification C4H4NO2 (98 Da) however the peptide 
sequence contains 4 possible modification sites that would require further analysis 
by MS/MS to determine.  The results detailed herein suggest that the modification(s) 
of the MtrR protein occurs at different sites on the protein, indicating a lack of 
specificity between the inhibitor and the protein.   
 
LC-MS/MS analysis of the modified peptide observed at m/z 423.8, deconvoluted to 
m/z 1269.6, has confirmed the peptide sequence and narrowed down the location of 
the suspected modification to the two amino acid residues at the N-terminus of the 
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peptide, supporting the suspected modification site at the Thr-99 residue.  The 
homology model shown in Figure  5.30 has been modelled from the MtrR amino acid 
sequence in Figure  5.4, using a similar protein with a known crystal structure.  The 
portion of the amino acid sequence that was identified from the unmodified MtrR 
protein digest has been coloured red, while the residues observed in the modified 
MtrR digest samples only have been coloured green.  The 3 proposed modification 
sites for the C3H2O2 (70 Da) modification have been highlighted in blue, all of which 
appear to be situated at the outer surface of the protein tertiary structure, free from 
the steric hindrance of other residues in the protein.   
 
 
Figure ‎5.30: Homology model of the MtrR protein.14 The 3 residues proposed 
to contain modifications have been highlighted in blue. 
 
 
The peptides observed with modifications C4H4NO2 (98 Da) and C5H5NO4 (143 Da) 
were found to contain multiple potential modification sites and therefore have not 
been highlighted on the homology model.  Further LC-MS/MS analysis is required to 
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confirm the modified amino acid residues for 3 peptides proposed to contain the 
modifications C4H4NO2 (98 Da) and C5H5NO4 (143 Da).   
 
5.3.2. M Protein 
The intact M protein has shown inconsistencies between the expected molecular 
weight and the measured molecular weight, implying that the amino acid sequence 
had been modified or mutated.  MS and MS/MS analysis has been used to 
successfully identify the major protein species, discovering a discrepancy in the 
molecular weight and successfully identifying the mass discrepancy as an 
unexpected extra threonine residue located near the N-terminus of the protein.  The 
updated protein sequence has subsequently been confirmed with 96% sequence 
coverage from MS analysis of the tryptic digests.  The incubation of the M protein 
with the fluorescent label NBD-Cl was found to result in an M-NBD complex 
containing one NBD molecule.  A study of the trypsin digested sample of the 
modified protein revealed the location of the label to a 10-residue portion of the 
sequence with only one potential modification site.  
 
The use of LC-MS/MS techniques such as CID and ECD has been shown to provide 
vital information regarding peptide sequencing and the identification of protein 
modifications, cementing its importance in biological and chemical analysis. 
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6. Conclusions 
 
Electron Induced Dissociation has been shown to provide complementary data to 
existing MS and MS/MS techniques, generating a high degree of fragmentation from 
a variety of compounds and molecular ions.  The results obtained thus far indicate a 
particular affinity for analysing positively charged precursor ions by EID, while 
altering various instrumental parameters such as electron irradiation time has been 
shown to affect the production and intensity of the product ions formed via negative 
ion EID, indicating a potential for improvement.  The combination of liquid 
chromatography with EID has shown huge promise for analysing complex mixtures 
of small organic molecules, providing a vast amount of structural information from 
previously unknown compounds of varying ion abundances.  The product ion data 
generated by EID of a range of small organic molecules have suggested competing 
fragmentation mechanisms, forming a combination of odd-electron and even-
electron fragments as well as unique bond cleavages and product ions. 
 
The use of Electron Capture Dissociation in the field of proteomics has been known 
to provide valuable data regarding the identification of post-translational 
modifications, and has been used to locate and identify modifications resulting from 
interactions between proteins and small organic molecules.  Using proteolytic 
digestion, LC-MS and LC-MS/MS, investigations into the sequence and small 
molecule modifications of the MtrR protein and the M protein have identified protein 
sequence anomalies and suggested locations and structural characteristics of 
modifications to the protein backbone.  
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7. Future Work 
 
7.1. Electron Induced Dissociation  
EID analysis thus far has been performed predominantly on, but not exclusively 
focussed on protonated, deprotonated and sodium adducted species.  Further study 
into the effect of electron energy on the resulting product ion spectra should 
determine whether the optimal electron energy level for EID MS/MS is affected by 
altering the charge-carrying species or the charge polarity.  The data carried out 
thus far has focussed on compounds containing aromatic rings and heteroatoms.  A 
more expansive range of compounds, involving systematic changes to analogous 
molecules, would hope to determine whether the trends observed are affected by 
the specific functional groups or elemental components of the precursor ion.  Further 
investigations would hope to indicate whether different charge-carrying species 
preferentially reside at different locations, and whether precursor ion fragmentation 
can be manipulated to focus on specific portions of the molecule by altering the 
charge carrier. 
 
Results described herein have shown that EID is better suited for analysing positive 
precursor ions than negative ions, generating limited unique information from the 
anionic compounds analysed thus far.  Preliminary steps to improve the data 
generated by negative ion EID have involved the alteration of the electron irradiation 
time, which has been shown to have a positive effect on ion abundances and 
product ion formation as the duration time is increased.  Further work should involve 
the extension of the current data, increasing the electron irradiation duration to the 
maximum limit of the LTQ-FT, 2000 ms, in order to explore any underlying trends. 
Additionally, experiments should be carried out on molecular ions with different 
 213 
charge-carrying species in order to determine whether the effect of electron 
irradiation time is universal or precursor ion dependant.   
 
MS and MS/MS spectral libraries, such as the National Institute of Standards and 
Technology (NIST) databases, typically include EI and CID spectra that allow users 
to search the databases using observed product ions and their corresponding 
relative intensities.  Work thus far has determined that the product ions generated by 
EID are complementary to EI and CID, with the observed product ion spectra often 
containing ions common to one or both techniques, however the major factor 
preventing the search of current databases using EID product ions is the significant 
variation in product ion relative intensities compared to EI and CID data.  Further 
study into the reproducibility of EID spectra would hope to demonstrate the benefits 
for incorporating EID data into existing spectral libraries to further develop the 
identification of unknown compounds.  
 
The development of LC-EID has primarily focused on targeted LC-MS/MS, 
analysing one compound of interest per experiment.  Preliminary investigations into 
data-dependent analyses, carrying out analysis of multiple compounds during one 
chromatographic experiment, experienced difficulties due to co-eluting ions of 
varying abundances.  Data-dependent EID analyses requires further development to 
become an adaptable analytical technique for analysing complex mixtures.  An 
alternative approach would involve setting up a segmented a LC-MS/MS method, 
targeting specific precursor ions during defined time segments, thereby allowing 
multiple ions to be analysed during one experiment.  This method would ensure that 
only ions of interest are analysed, however co-eluting species would still pose an 
issue.  
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7.2. Protein MS Analysis 
Due to rapid sample depletion of the MtrR protein, a limited number of LC-MS and 
LC-MS/MS experiments have been carried out thus far.  Future work will include the 
repeated incubation of the MtrR protein with the β-lactamase inhibitors in order to 
determine whether the inhibitor-protein reactions are repeatable and to allow LC-
MS/MS analysis to be carried out on the other suspected modified peptides.  
Incubating the MtrR protein and inhibitor for more time may increase the ratio of 
modified protein to unmodified protein, which would also improve the chances of 
observing modified peptides at an intensity suitable for LC-MS/MS and identifying 
other modification sites.  The repetition of the incubation studies will also allow 
reaction monitoring to be carried out for each inhibitor in order to confirm whether 
some of the observed modifications are short-lived intermediates that will disappear 
over time as other species are formed.  The in silico digests have thus far been 
carried out under the assumption that the inhibitor molecules only react with serine 
or threonine residues on the protein.  Allowing for the possibility of modifications on 
other amino acid residues may lead to the identification of other modification sites 
that are not currently expected. 
 
Fluorescence experiments carried out on the intact NBD-modified M protein indicate 
that the label primarily binds to a cysteine residue before transferring to a lysine 
residue upon incubation at 37 °C, as evidenced from a slight shift in the 
fluorescence and UV spectra.**  The fluorescent labelling studies will be repeated in 
order to determine whether the modification site is always found on the Lys-71 
residue, or whether NBD modification can be found a different amino acid, such as a 
cysteine residue.  LC-MS/MS will be performed on the suspected modified peptide 
so as to confirm the location of the modification to within one amino acid residue.   
                                               
**
 Carried out by James A. Freeth 
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The intact M protein has been found to degrade over time into smaller proteins of 
approximately 13-14 kDa in size.  These degradation products appear to correspond 
to C-terminal containing proteins, cleaving along the amino acid chain linking the N-
terminal domain to the C-terminal domain.  Money et al. generated a model of the 
electrostatic surface of the M protein, noting that the C-terminal domain contained a 
large positively charged area that is proposed to interact with the negatively charged 
cell membrane.  The N-terminal domain was found to contain a sizeable negatively 
charged region and is thought to be involved in protein-protein interactions.  The 
absence of the reciprocal N-terminal domain in the MS spectrum is believed to be 
due to the overall negative charge on the domain, therefore further work will include 
analysing the degraded M protein by negative electrospray ionisation to confirm the 
presence of the N-terminal domain and to determine whether this domain is seen to 
oligomerise.   
 
Future work will also include the development of MS procedures for analysing more 
hydrophobic and more difficult membrane proteins. 
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8. Materials and Methods 
 
8.1. Default Instrumental Conditions and Parameters 
8.1.1. LTQ-FT 
An LTQ-FT mass spectrometer (Thermo-Finnigan Corporation, Germany) equipped 
with a 7.0 Tesla superconducting magnet and an ESI source was used for all FT-
ICR-MS and FT-ICR-MS/MS analyses.  Direct infusion analysis was administered 
via a syringe pump at a flow rate of 5 µL min-1.  Ion source conditions such as N2 
sheath gas flow, auxiliary gas flow, sweep gas flow, capillary voltage and tube lens 
were optimised to achieve the most stable and optimal signal for the ion of interest.  
The capillary needle was heated to 250 °C.  The source cone voltage was held 
between 4 – 4.5 kV in positive ionisation mode and at -3.5 kV in negative ionisation 
mode.  The LTQ linear ion trap contains a helium damping gas at a pressure of 10-3 
Torr, used for collisional cooling of trapped ions as well as CID experiments.  
Isolation of the precursor ion for MS/MS analysis takes place in the ion trap using an 
isolation window of m/z 4 (unless otherwise stated) in order to encompass the entire 
isotopic profile of the ion of interest while eliminating any other ions.  AGC for the ion 
trap was set at 3x104 ions for MS scans and 1x104 ions for MS/MS scans.  FT 
experiments were carried out using a default maximum injection time of 1 s for MS 
analyses and 1.5 s for MS/MS analyses.  Two microscans were recorded and 
averaged for each MS/MS scan in order to improve the sensitivity of the data 
produced.  LC-MS/MS analyses were carried out by targeting a specific ion of 
interest and alternating MS and MS/MS scans throughout the experiment.  A 
resolving power of 50,000 FWHM was used for LC-MS/MS analyses in the FT-ICR 
cell in order to minimise scan time while maintaining good mass resolution.  All other 
experiments were carried out at 100,000 FWHM.  AGC for the FT-ICR was set at 
5x105 ions for MS scans and 2x105 ions for MS/MS scans.  Spectra were analysed 
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using XCalibur QualBrowser version 2.0.7 (Thermo Fisher Scientific Inc.).  When 
required, post-acquisition calibration was carried out using the embedded program 
Recalibrate Offline (Thermo Fisher Scientific Inc.) and performed using the empirical 
formulae of the precursor ion and, where possible, a known product ion.   
 
Detection of CID product ions was carried out in either the LTQ ion trap (CID IT) or 
the FT-ICR cell (CID), and has been stated where appropriate.  The normalised 
collision energies applied for CID analysis on the LTQ-FT have been stated in 
arbitrary units, as per manufacturer’s software.  ECD and EID analyses were carried 
out using low energy electrons generated by an indirectly heated dispenser cathode 
situated behind the FT-ICR cell.  The calibration of the cathode was carried out 
using Substance P (purchased from Sigma-Aldrich, Dorset, UK), adjusting the 
voltage offset applied to the cathode so that the most efficient energy level for ECD 
analysis was 5 (arbitrary units).  The corresponding electron energy has been 
calculated using Equation 8.1. 
 
 Electron Energy = Energy Level – Voltage Offset.   Equation 8.1 
 
The electron energies quotes have been adjusted according to the voltage offset 
applied to the cathode at the time of analysis.  A default electron irradiation time of 
70 ms and a delay of 0.03 ms were maintained, unless otherwise stated.  IRMPD 
analyses were carried out on a similarly equipped LTQ-FT mass spectrometer, 
courtesy of AstraZeneca (Alderley Edge, UK), fitted with a 20 W CO2 IR laser 
situated behind the FT-ICR cell and entering the cell through a ZnSe coated lens.  
The power and duration of the laser pulse was varied according to the resulting 
product ion spectra, between 10 – 100% and 50 – 300 ms respectively. 
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8.1.2. Xevo QToF / QToF Premier XE 
QToF-MS and QToF-MS/MS analyses were carried out on one of two instruments; a 
Xevo QToF (Waters Ltd, UK) or a QToF Premier XE (Waters Ltd, UK) both 
equipped with an ESI source.  The Xevo QToF included an interchangeable ASAP 
source with an auxiliary ESI probe incorporated into the ASAP source housing for 
simultaneous calibrant infusion during analysis.  Spectra were analysed using 
MassLynx version 4.1 (Waters Ltd, UK).  Accurate mass measurements were 
carried out using the embedded program Elemental Composition version 4.0. 
 
ESI analysis was carried out via direct infusion using an in-built infusion system at a 
flow rate of up to 15 µL min-1.  The source temperature was set between 120 °C – 
150 °C and the voltage applied to the capillary needle was ±3 kV depending on the 
polarity of ionisation.  The nitrogen desolvation gas was heated to a temperature of 
450 °C and infused at a flow rate of 600 L hr-1.  ASAP analysis was carried out on 
both solid and solution state samples, as stated where appropriate, by applying the 
sample to the exterior of a sealed glass melting point tube. The N2 desolvation gas, 
used to volatilise the sample, was infused at a flow rate of 600 L hr-1 and the 
temperature in the range 100 °C – 600 °C according to the sample being analysed 
and the resulting MS spectrum.  A current of 2.5 µA was applied to the corona 
needle.  The auxiliary ESI probe was used, where stated, to infuse a 50:50 (v/v) 
mixture of methanol and water in order to create a proton-rich environment within 
the source enclosure.  
 
The voltage offset applied to the MS source cone was 25 V.  The argon buffer gas in 
the collision cell was maintained at a pressure of 7 psi with a gas flow rate of 0.3 mL 
min-1 and applied a voltage of 4 V (MS analyses only). The length of time taken per 
scan was 1 s. The detected mass range was varied according to the ion(s) of 
interest.  Spectra were recorded in centroid mode.  QToF-CID analyses were carried 
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out by increasing the collision energy applied to the ions in order to promote 
collisions with the argon buffer gas.  The collision energy was varied according to 
the sample being analysed and the subsequent MS/MS spectrum, usually between 
20 V – 40 V, and has been stated where necessary. 
 
8.1.3. GC Trace 
All GC-MS analyses were carried out on a GC Trace (Thermo-Finnigan Corporation, 
Germany) fitted with an EI source. 1 µL aliquots of each sample were injected 
through a GC inlet heated to 220 °C to evaporate the solvent and subsequently 
infused into a helium carrier gas flow of 25 mL min-1 prior to a 20:1 split.  The 
resulting gas flow of approximately 1 mL min-1 was directed onto a 30 m VF—5MS 
GC column with a 0.25 mm inner diameter and a 0.25 µm film thickness.  A 26 
minute temperature gradient was used, ramping from an initial temperature of 40 °C 
to a maximum at 300 °C at a rate of 10 °C min-1.  The emission current applied to 
the heated wire filament (electron source) was 150 µA, the electron energy was 
70eV, and the MS source temperature was set at 200 °C.  Ions were detected over 
the mass range m/z 20 - m/z 680 using a single quadrupole mass spectrometer.  
Spectra were analysed using XCalibur QualBrowser version 2.0.7 (Thermo Fisher 
Scientific Inc.). 
 
 
8.2. Instrumental Parameters for Chapter 3 
8.2.1. Sample Preparation  
All solvents were HPLC grade, purchased from Sigma-Aldrich, Dorset, UK.  
Cediranib, Ritonavir, Gefitinib, Omeprazole and samples labelled with the prefix AZ- 
were supplied by AstraZeneca, Avlon, UK.  All other samples were purchased from 
Sigma-Aldrich, Dorset, UK.  The haloperidol dilution series was carried out using 
samples of haloperidol made up in methanol to a range of concentrations; from 10 
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pg mL-1 and 50 pg mL-1 increasing ten-fold until 0.5 mg mL-1 and 1 mg mL-1.  All 
other samples analysed by direct infusion were made up to 5 µg mL-1 and 10 µg mL-
1 in methanol and selected according to the intensity of the ion(s) of interest.  
 
8.2.2. Mass Spectrometry 
The offset applied to the cold cathode electron gun was set to 1.21 V, resulting in 
approximate electron energies of 18.79 eV for EID and hECD experiments and 3.79 
eV for low energy EID and ECD experiments.  Electron energy studies involved 
increasing the energy level stepwise from 0 to 25 arbitrary units which corresponds 
to approximately -0.21 eV to 23.79 eV (in increments of 1 eV), allowing 90 seconds 
acquisition time per energy level.  An electron irradiation time of 70 ms, a delay of 
0.03 ms and a maximum injection time of 1.5 s were maintained.  One microscan 
per MS/MS scan was recorded for the haloperidol dilution series.  The laser power 
for IRMPD analysis was optimised for each compound to produce the greatest 
degree of fragmentation. The IRMPD pulse duration was varied according to the 
resultant spectra. 
 
 
8.3. Instrumental Parameters for Chapter 4 
8.3.1. Sample Preparation  
A sample of cediranib was obtained courtesy of AstraZeneca, Avlon, UK. All 
solvents were HPLC grade, purchased from Sigma-Aldrich, Dorset, UK.  Cediranib 
was made up to three different concentrations in methanol depending on the method 
of analysis; 2 mg mL-1 sample for LC-MS and LC-MS/MS, 5 µg mL-1 sample for 
direct infusion MS and MS/MS and a 1 mg mL-1 sample for GC-MS. 
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8.3.2. Chromatography 
For the purposes of chromatography, 10 µL aliquots of the cediranib sample were 
injected onto a Luna C18 (2) 3 µm, 100 Å, 2x150 mm column (Phenomenex) which 
required a 200 µL min-1 mobile phase flow rate.  Gradient conditions started at 95% 
(H2O + 0.1% formic acid) / 5% (CH3CN + 0.1% formic acid) and finished at 5% (H2O 
+ 0.1% formic acid) / 95% (CH3CN + 0.1% formic acid.  A 12 minute gradient was 
used, resulting in an overall analysis time of 20 minutes to include a wash step at 
100% acetonitrile and equilibration of starting solvent conditions.  In order to induce 
sodium-adducted species, a 1 mg mL-1 solution of sodium iodide solution was 
infused post-column using a T-piece, via syringe pump at a flow-rate of 2 µL min-1.  
 
8.3.3. Mass Spectrometry 
Direct infusion QTof-CID was performed at a normalised collision energy of 25 V.  
For the LC-MS/MS analysis of the compound observed at m/z 921 (LC peak 10) the 
isolation width was increased to m/z 8 in order to incorporate the chlorine isotope.  
The normalised collision energy for LC-CID detected in the LTQ ion trap was 
generated at CID energy 18 (as per manufacturer’s software) and LC-CID data 
detected in the FT were produced at CID energy 30.  The voltage offset applied to 
the cathode was 2.5 V for LC-EID experiments resulting in the approximate electron 
energy of 17.5 eV for EID analysis.  The offset during direct infusion EID analysis 
and ECD analysis was 2.1 V resulting in the corresponding electron energy of 17.9 
eV and 2.9 eV respectively.   
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8.4. Instrumental Parameters for Chapter 5 
8.4.1. Sample Preparation  
All solvents and reagents were purchased from Sigma-Aldrich, Dorset, UK.  HPLC 
grade solvents were used.  Samples of recombinant MtrR protein were obtained 
from Matthew F. Burton (Durham University).  Samples of recombinant M protein 
were obtained from James A. Freeth (Durham University). 
 
8.4.2. Chromatography 
Two columns were used for liquid chromatography depending on the nature of the 
compounds being analysed.  Protein LC-MS was carried out on a X-Bridge BEH300 
C4 3.5 µm, 2.1x150 mm column (Waters, Ltd.) capable of a solvent flow rate of 200 
µL min-1.  Peptide LC-MS analysis was carried out on an Atlantis dC18  5 µm, 1.0 x 
50 mm column (Waters, Ltd) with a maximum solvent flow rate of 100 µL min-1.  
Samples were injected onto the relevant column with an injection volume of between 
1 – 10 µL, depending on the sample concentration.  Gradient conditions started at 
95% (H2O + 0.1% formic acid) / 5% (CH3CN + 0.1% formic acid) and finished at 5% 
(H2O + 0.1% formic acid) / 95% (CH3CN + 0.1% formic acid).  The length of the LC 
gradient was optimised to 12 minutes, allowing for an overall experiment time of 20 
minutes to incorporate a wash step at 100% acetonitrile and equilibration of starting 
solvent conditions.  LC-MS and LC-MS/MS of the tryptic digests were performed 
using the peptide column, using a 13 minute LC gradient, but at a reduced flow rate 
of 100 µL min-1 resulting in a total analysis time of 20 minutes.    
 
8.4.3. MtrR Protein 
Modification of the protein was carried out by incubating equal parts of MtrR protein 
(39 µM) with tazobactam or clavulanic acid (8 mg mL-1) at 37 °C for up to 4 hours.  
The protein was precipitated using an excess of ice cold acetone and the mixture 
was stored at -20 °C for 1 hour.  The trypsin digest was performed using a starting 
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solution containing 0.2 mg mL-1 trypsin in hydrochloric acid (1 mM), of which 1 µL 
was added to 20 µL of ammonium hydrogen carbonate buffer (25 mM).  The protein-
trypsin mixture was incubated at 37 °C overnight, before freeze-drying to remove the 
solvent.  The resulting peptide mixture was re-dissolved in 50:50 water:acetonitrile 
(v/v) for MS analysis.   
 
LC-MS/MS Analysis of Tryptic Peptide of MtrR Protein 
LC-MS/MS of one MtrR tryptic peptide was carried out by targeting the [M+3H]3+ ion 
at m/z 423.8 for analysis.  A total of 10 MS/MS scans were found to contain useable 
data to produce the MS/MS spectrum shown in Figure 5.17.  The offset applied to 
the cathode was 3.69 V, resulting in an electron energy of 2.31 eV being applied to 
the precursor ion.  A maximum injection time of 1000 ms was used in order to 
reduce the length of time taken for each scan.  
 
8.4.4. M Protein 
Samples of M protein were obtained in phosphate buffered saline containing 137 
mM sodium chloride (NaCl), 2.7 mM potassium chloride (KCl), 8 mM disodium 
hydrogen phosphate (Na2HPO4) and 1.46 mM potassium dihydrogen phosphate 
(KH2PO4).  The protein concentration varied according to the results from protein 
expression.  Modification of M protein, performed by J. A. Freeth, was achieved by 
mixing M protein (~ 20 µM) and 4-chloro-7-nitrobenzofurazan (1 mM in DMSO) in a 
1:1 molar ratio.  The resultant mixture was incubated at room temperature for 1 hour 
at pH 7.4.  The protein sample was dialysed into water in order to remove salts and 
buffers from the sample.  
 
Tryptic Digests 
In order to perform the tryptic digest of the M protein, a buffer solution of 
Tris(hydroxymethyl)aminomethane (50 mM) and calcium chloride (10 mM), pH 7.6 
 224 
(hereafter referred to as Tris buffer), which was used as a key component in the 
solutions involved in digestion.  Protein samples were made up to an approximate 
concentration of 0.5 mg mL-1 in Tris buffer.  Trypsin was dissolved in 1% acetic acid 
to a concentration of 10 µg µL-1, of which 2 µL was added to 80 µL of Tris buffer to a 
final concentration of 0.25 mg mL-1 trypsin.  Dithiothreitol (DTT) was dissolved in Tris 
buffer to a final concentration of 100 mg mL-1.  A 1 µL aliquot of the trypsin solution 
and 3 µL of DTT solution were added to each 100 µL volume of protein.  The 
resultant mixture was shaken at 37 °C for 1-2 hours prior to MS analysis.  
 
LC-MS/MS Analysis of Tryptic Peptide of M Protein 
LC-MS/MS was carried out on one M protein tryptic peptide, proposed to correspond 
to an N-terminal peptide, by targeting the [M+2H]2+ ion at m/z 748.3 for analysis.  A 
total of 7 CID MS/MS scans and 6 ECD MS/MS scans were found to contain 
useable data to produce the MS/MS spectra shown in Figure 5.23.  The ECD offset 
applied to the cathode was 2.11 V, resulting in an electron energy of 4.89 eV being 
applied to the precursor ion.  CID analysis was carried out at a normalised collision 
energy of 20.  A maximum injection time of 1000 ms was used for both LC-MS/MS 
analyses in order to reduce the length of time taken for each scan.
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9. Appendix A: Supplementary Information for Chapter 3 – Electron 
Induced Dissociation of Small Singly Charged Molecules. 
 
9.1. Effect of electron energy on mass accuracy 
As the electron energy was increased, the mass accuracy of the precursor ion was 
seen to deteriorate, as illustrated in Figure  9.1, noting a sharp increase in the mass 
deviation of the precursor ion as the energy is increased beyond 7.79 eV.  A similar 
decline in the mass accuracy of the product ions is also observed as the electron 
energy increases.   
 
 
 
Figure ‎9.1: The effect of increasing the electron energy on the mass accuracy 
of the Haloperidol [M+H]+ precursor. 
 
 
9.2. Validation of artefact peaks 
As the electron energy was increased, a number of peaks are seen to appear in the 
low m/z region (< m/z 120) that could not be assigned as fragments of the precursor 
ion, and were therefore purported to correspond to contaminants being emitted from 
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the cathode or the FT-ICR cell at high electron energies.  The accurate mass 
measurements suggest that these peaks correspond to hydrocarbons emanating 
from the ECD cathode or the inner surface of the FT-ICR cell under the high energy 
conditions.   
 
In order to establish which peaks could be removed from further consideration, two 
control spectra were recorded during an infusion of methanol with the ESI spray 
voltage turned off in order to disable electrospray ionisation.  The distribution of 
peaks observed in Figure  9.2(a) is considered to be electronic or chemical noise 
originating from the FT-ICR cell.  When the ECD cathode was turned on and 
emitting high energy electrons (~ 28 eV), peaks in the low m/z region emerge, as 
shown in Figure  9.2(b) and expanded in Figure  9.3.   
 
The peaks observed in the control spectra have been disregarded in all MS and 
MS/MS spectra.   
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Figure ‎9.2: MS control spectra indicating artefact peaks (a) with the ECD cathode switched off (b) with the ECD cathode on. 
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Figure ‎9.3:Expansion of Figure ‎9.2(b) showing the low m/z peaks that emerge at high electron energies. 
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10. Appendix B: Supplementary Information for Chapter 4 – The 
Development of Electron Induced Dissociation for use in conjunction 
with LC-MS to analyse complex mixtures. 
 
The following tables detail the product ions generated for cediranib and the two 
unknown compounds that have been examined in Chapter 4, including the assigned 
molecular formulae, the corresponding RDB values and the mass deviation between 
the measured m/z and the theoretical m/z for the proposed formulae for each 
observed ion.  The precursor ion for each experiment has been highlighted in bold.  
Spectra have been calibrated post-acquisition using the theoretical m/z values of the 
precursor ion and in some cases a known product ions, marked * in the tables;  Ions 
observed in the ion trap have been quoted to the nearest integer unless there is 
corresponding FT data to accurately assign molecular formulae and accurate mass 
measurements.  Ions labelled ‘Y’ indicate the presence of an ion at the specified 
m/z.  
 
10.1. LC-MS/MS of cediranib 
Table  10.1 details the product ions generated from MS/MS analysis of the 
protonated cediranib species observed at m/z 451.2.  The resulting FT data was 
calibrated using the theoretical m/z of the precursor ion with the molecular formula 
C25H28N4O3F and, for EID only, the propylpyrrolidine group with the proposed 
molecular formula C7H14N.  
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Theoretical 
m/z 
Molecular 
Formula 
RDB 
EID  
/ ppm 
CID FT / 
ppm 
CID IT 
451.21400 C25H28N4O3F 13.5 *0.0 *0.0 Y 
450.20617 C25H27N4O3F 14 2.6 - - 
449.19835 C25H26N4O3F 14.5 -0.2 - Y 
431.20777 C25H27N4O3 14.5 - 0.3 Y 
421.3 unknown - - - Y 
405.1 unknown - - - Y 
392.3 unknown - - - Y 
380.14050 C21H19N3O3F 13.5 0.3 - Y 
366.12485 C20H17N3O3F 13.5 1.6 - Y 
354.12485 C19H17N3O3F 12.5 - -0.5 Y 
340.10920 C18H15N3O3F 12.5 2.1 -0.6 Y 
339.10137 C18H14N3O3F 13 1.6 - - 
338.09355 C18H13N3O3F 13.5 0.9 - - 
326.09355 C17H13N3O3F 12.5 1.0 - - 
325.08572 C17H12N3O3F 13 1.5 - - 
324.11428 C18H15N3O2F 12.5 1.2 - Y 
320.10297 C18H14N3O3 13.5 1.3 - - 
319.09514 C18H13N3O3 14 1.4 - - 
318.08732 C18H12N3O3 14.5 1.5 - - 
306.08732 C17H12N3O3 13.5 1.3 - - 
305.07949 C17H11N3O3 14 1.4 - - 
304.10805 C18H14N3O2 13.5 1.3 - - 
287.16283 C16H21N3O2 8 0.9 - - 
280.7 unknown - - - Y 
260.15193 C15H20N2O2 7 1.0 - - 
232.2 unknown - - - Y 
175.06660 C10H8N2F 7.5 0.4 - - 
165.05844 C9H8NOF 6 0.2 - - 
164.05062 C9H7NOF 6.5 0.4 - - 
149.06353 C9H8NF 6 0.1 - - 
148.05570 C9H7NF 6.5 0.2 - - 
143.8 unknown - - - Y 
128.10699 C7H14NO 1.5 0.2 - Y 
118.06513 C8H8N 5.5 0.4 - - 
112.11208 C7H14N 1.5 *0.0 - - 
111.10425 C7H13N 2 0.1 - - 
110.09643 C7H12N 2.5 0.1 - - 
96.08078 C6H10N 2.5 0.1 - - 
84.08078 C5H10N 1.5 0.3 - - 
83.07295 C5H9N 2 0.4 - - 
82.06516 C5H8N 2.5 0.4 - - 
70.06517 C4H8N 1.5 0.6 - - 
Table ‎10.1: Summary of product ions observed from the MS/MS of cediranib 
[M+H]+. 
 
 
10.2. LC-MS/MS of unknown species in cediranib sample 
Table  10.2 details the product ions generated from MS/MS analysis of the species 
detected in LC peak 1, observed at m/z 562.3.  The resulting FT data was calibrated 
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using the theoretical m/z of the precursor ion with the proposed molecular formula 
C32H41N5O3F, determined from the previously run MS spectrum.  
 
Theoretical 
m/z 
Molecular 
Formula 
RDB 
EID  
/ ppm 
CID FT / 
ppm 
CID 
IT  
Present in 
cediranib 
562.31879 C32H41N5O3F 14.5 *-0.0 - Y - 
560.30314 C32H39N5O3F 15.5 0.7 - Y - 
542.31257 C32H40N5O3 15.5 3.4 - Y - 
532.3 unknown - - - Y - 
503.3 unknown - - - Y - 
491.3 unknown - - - Y - 
465.3 unknown - - - Y - 
451.21400 C25H28N4O3F 13.5 2.3 - - Y 
449.19835 C25H26N4O3F 14.5  - Y Y 
436.19052 C24H25N4O3F 14 2.3 - - - 
433.3 unknown - - - Y - 
380.14050 C21H19N3O3F 13.5 - - Y Y 
360.13427 C21H18N3O3 14.5 1.4 - - - 
340.10920 C18H15N3O3F 12.5 2.3 - - Y 
336.2 unknown - - - Y - 
326.09355 C17H13N3O3F 12.5 1.0 - - Y 
319.09514 C18H13N3O3 14 -0.2 - - Y 
318.08732 C18H12N3O3 14.5 1.5 - - Y 
308.08298 C17H11N3O2F 13.5 4.4 - - - 
304.10805 C18H14N3O2 13.5 - - Y Y 
290.09240 C17H12N3O2 13.5 2.4 - - - 
259.3 unknown - - - Y - 
223.21688 C14H27N2 2.5 0.6 - Y - 
183.3 unknown - - - Y - 
146.06004 C9H8NO 6.5 0.2 - - - 
140.14338 C9H18N 1.5 0.0 - - - 
126.12773 C8H16N 1.5 0.3 - - - 
118.06513 C8H8N 5.5 0.4 - - Y 
112.11208 C7H14N 1.5 *0.0 - - Y 
111.10425 C7H13N 2 0.1 - - Y 
110.09643 C7H12N 2.5 0.1 - - Y 
96.08078 C6H10N 2.5 0.3 - - Y 
84.08078 C5H10N 1.5 0.4 - - Y 
70.06513 C4H8N 1.5 0.8 - - Y 
Table ‎10.2: Summary of product ions generated from the MS/MS of LC Peak 1, 
observed at m/z 562.2. 
 
 
 
Table  10.3 details the product ions generated from MS/MS analysis of the species 
detected in LC peak 6, observed at m/z 340.1.  The resulting FT data was calibrated 
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using the theoretical m/z of the precursor ion with the proposed molecular formula 
C18H15N3O3F, determined from the previously run MS spectrum. 
 
Theoretical 
m/z 
Molecular 
Formula 
RDB 
EID 
/ ppm 
CID FT / 
ppm 
CID IT 
Present in 
cediranib 
340.10920 C18H15N3O3F 12.5 *0.0 *0.0 Y Y 
339.10137 C18H14N3O3F 13 1.4 -0.3 - Y 
338.09355 C18H13N3O3F 13.5 0.6 0.3 Y Y 
336.07790 C18H11N3O3F 14.5 -0.8 0.9 - - 
325.08572 C17H12N3O3F 13 1.1 0.6 Y Y 
324.07790 C17H11N3O3F 13.5 0.5 1.7 Y Y 
320.10297 C18H14N3O3 13.5 0.4 1.2 Y Y 
319.09514 C18H13N3O3 14 0.2 0.5 Y Y 
318.08732 C18H12N3O3 14.5 1.4 1.1 Y Y 
312.11428 C17H15N3O2F 11.5 0.3 1.2 Y - 
310.09863 C17H13N3O2F 12.5 0.5 1.3 Y - 
308.08298 C17H11N3O2F 13.5 0.1 1.2 Y - 
305.07949 C17H11N3O3 14 0.5 1.0 Y Y 
304.07167 C17H10N3O3 14.5 0.5 - Y Y 
300.07675 C18H10N3O2 15.5 - 1.1 Y - 
297.09081 C16H12N3O2F 12 -0.0 1.1 Y - 
296.08298 C16H11N3O2F 12.5 -0.4 - - - 
292.10805 C17H14N3O2 12.5 -0.1 0.8 Y - 
290.09240 C17H12N3O2 13.5 0.2 1.3 Y - 
288.07675 C17H10N3O2 14.5 -0.5 - - - 
282.2 unknown - - - Y - 
277.08458 C16H11N3O2 13 -0.5 1.0 Y - 
276.07675 C16H10N3O2 13.5 -0.5 - - - 
275.06893 C16H9N3O2 14 -0.3 - - - 
269.07208 C15H10N2O2F 11.5 -0.3 - Y - 
268.08807 C15H11N3OF 11.5 -0.5 - - - 
267.08024 C15H10N3OF 12 - - Y - 
265.07717 C16H10N2OF 12.5 - - Y - 
262.09749 C16H12N3O 12.5 -0.7 - Y - 
260.08184 C16H10N3O 13.5 -0.6 - - Y 
254.08499 C15H11N2OF 11 -0.6 - - - 
253.07717 C15H10N2OF 11.5 -0.5 - - - 
252.09315 C15H11N3F 11.5 -1.0 1.0 Y - 
249.08966 C15H11N3O 12 -0.9 0.9 Y - 
248.08184 C15H10N3O 12.5 -0.9 - - - 
240.09315 C14H11N3F 10.5 -1.3 - - - 
237.2 unknown - - - Y - 
232.08692 C15H10N3 12.5 -0.9 - - Y 
225.08225 C14H10N2F 10.5 -1.6 - - - 
222.07876 C14H10N2O 11 -1.2 - - - 
221.07094 C14H9N2O 11.5 -1.4 - - - 
210.05878 C13H7N2F 11 -1.5 - - - 
207.2 unknown - - - Y - 
203.06037 C14H7N2 12.5 -2.2 - - - 
193.06077 C9H9N2O3 6.5 -2.1 - - - 
191.04512 C9H7N2O3 7.5 -2.1 - Y - 
189.02947 C9H5N2O3 8.5 -2.1 - Y - 
178.03729 C8H6N2O3 7 -3.0 - - - 
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177.06585 C9H9N2O2 6.5 -2.6 - - - 
176.05803 C9H8N2O2 7 -2.4 - - - 
175.06660 C10H8N2F 7.5 -2.5 - Y Y 
173.05095 C10H6N2F 8.5 -2.6 - - - 
170.05602 C6H8N3O3 4.5 - -2.5 - - 
165.05844 C9H8NOF 6 -2.7 - - Y 
164.05062 C9H7NOF 6.5 -2.8 - - Y 
164.03422 C8H6NO3 6.5 -2.6 0.9 Y - 
155.06037 C10H7N2 8.5 -2.9 - - - 
152.03422 C7H6NO3 5.5 -3.0 - - - 
151.02639 C7H5NO3 6 -3.0 - - - 
149.06353 C9H8NF 6 -3.1 - Y Y 
148.05570 C9H7NF 6.5 -3.1 - Y Y 
147.04788 C9H6NF 7 -3.0 - Y - 
146.06004 C9H8NO 6.5 -3.0 - - - 
144.04439 C9H6NO 7.5 -3.0 - - - 
138.05496 C7H8NO2 4.5 -3.2 - Y - 
136.05570 C8H7NF 5.5 -3.2    
136.03930 C7H6NO2 5.5 -3.3 - Y - 
135.04788 C8H6NF 6 -3.3 - - - 
134.02365 C7H4NO2 6.5 -3.2 - - - 
128.04948 C9H6N 7.5 -3.3 - - - 
123.03148 C6H5NO2 5 -3.6 - - - 
121.04480 C8H6F 5.5 -3.5 - - - 
120.03698 C8H5F 6 -3.6 - - - 
116.04948 C8H6N 6.5 -3.6 - - - 
108.04439 C6H6NO 4.5 -3.7 - Y - 
101.03858 C8H5 6.5 -3.7 - - - 
95.03657 C5H5NO 4 -3.8 - - - 
80.04948 C5H6N 3.5 -3.8 - - - 
Table ‎10.3: Summary of product ions generated from the MS/MS of LC Peak 6, 
observed at m/z 340.1. 
 
 
10.3. LC-EID of cediranib [M+Na]+ 
Table  10.4 details the product ions generated from MS/MS analysis of the sodium-
adducted cediranib species observed at m/z 473.2.  The resulting FT data was 
calibrated using the theoretical m/z of the precursor ion with the molecular formula 
C25H27N4O3FNa and the propylpyrrolidine group with the proposed molecular 
formula C7H14N.  Peaks labelled (-Na/+H) indicate product ions that are present as a 
sodium-adducted species in the EID spectrum of the [M+Na]+, and as a protonated 
species in the EID of the [M+H]+. 
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Theoretical 
m/z 
Molecular 
Formula 
RDB 
EID  
/ ppm 
Present in [M+H]
+
 
473.19594 C25H27N4O3FNa 13.5 *0.0 N/A 
472.18812 C25H26N4O3FNa 14 2.4 Y (-Na/+H) 
453.18971 C25H26N4O3Na 14.5 2.0 Y (-Na/+H)  
452.18189 C25H25N4O3Na 15 2.7 - 
438.16624 C24H23N4O3Na 15 0.5 - 
421.16350 C24H22N4O2Na 15.5 2.3 - 
373.11970 C20H17N3O2FNa 13 2.1 - 
362.09114 C18H14N3O3FNa 12.5 1.6 Y (-Na/+H)  
361.08332 C18H13N3O3FNa 13 1.1 Y (-Na/+H)  
360.07549 C18H12N3O3FNa 13.5 1.7 Y (-Na/+H)  
342.08491 C18H13N3O3Na 13.5 1.7 Y (-Na/+H)  
341.07709 C18H12N3O3Na 14 1.6 Y (-Na/+H)  
340.10920 C18H15N3O3F 12.5 1.7 Y 
327.06144 C17H10N3O3Na 14 1.5 Y (-Na/+H)  
187.04039 C9H7ONFNa 6 0.8 - 
112.11208 C7H14N 1.5 *0.0 Y 
110.09643 C7H12N 2.5 -0.1 Y 
84.08078 C5H10N 1.5 -0.3 Y 
Table ‎10.4: Summary of product ions generated from the MS/MS of sodium-
adducted cediranib, observed at m/z 473.2. 
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11. Appendix C: Supplementary Information for Chapter 5 – MS and 
MS/MS Analysis of Proteins Modified by Small Organic Molecules. 
 
The following tables detail the MS analysis of the tryptic digests of the protein 
samples that have been discussed in Chapter 5, including sequence information, 
molecular formulae, theoretical m/z values and the corresponding mass deviation 
associated with the experimentally obtained data.  
 
Table  11.1 details the tryptic peptides generated by enzymatic digestion of the 
native MtrR protein, the tazobactam treated protein and the clavulanic acid treated 
protein.  The peptides highlighted in red are proposed to contain modifications to the 
native amino acid sequence. 
 
Table  11.2 details the tryptic peptides generated by enzymatic digestion of the 
native M protein and the NBD-labelled M protein.  The peptide highlighted in red is 
proposed to contain the NBD modification.  
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Residues 
Theoretical 
Monoisotopic 
[M+H]
+
 m/z 
Native 
MtrR 
/ppm 
Tazobactam 
/ppm 
Clavulanic 
Acid 
/ppm 
Sequence 
Protonated Molecular 
Formula 
[12- 18] 
[14- 20] 
790.46689 0.310 -0.651 -0.664 
TKTEALK 
TEALKTK 
C34H63N9O12 
[14- 18] 561.32425 0.422 -0.825 -0.772 TEALK C24H44N6O9 
[19- 33] 1822.95202 0.929 0.260 0.403 TKEHLMLAALETFYR C83H132N21O23S 
[19- 33] 1892.95750 - 0.573 0.621 TKEHLMLAALETFYR + C3H2O2 C86H134N21O25S 
[19- 33] 1965.97387 - 0.616 0.634 TKEHLMLAALETFYR + C5H5NO4 C88H137N22O27S 
[21- 33] 1593.80937 1.34 0.273 0.405 EHLMLAALETFYR C73H113N18O20S 
[21- 34] 1721.90434 - - 0.042 EHLMLAALETFYRK C79H125N20O21S 
[21- 33] 1663.81485 - 1.723 2.973 EHLMLAALETFYR + C3H2O2 C76H115N18O22S 
[21- 62] 4918.55735 - - 0.024 
EHLMLAALETFYRKGIARTSLNEIAQAAGVTRGALYWH
FKNK + C5H5NO4 
C222H346N63O62S 
[34- 38] 544.3565 - -0.967 -1.004 KGIAR C23H45N9O6 
[35- 38] 416.26159 - -0.994 -0.946 GIAR C17H33N7O5 
[39- 52] 1430.75978 1.767 0.788 0.795 TSLNEIAQAAGVTR C59H104N19O22 
[39- 72] 3910.00348 - - 1.215 TSLNEIAQAAGVTRGALYWHFKNKEDLFDALFQR C178H270N49O51 
[53- 60] 1021.52541 0.066 -0.502 -0.492 GALYWHFK C52H69N12O10 
[53- 72] 2498.26154 - - 0.733 GALYWHFKNKEDLFDALFQR C119H169N30O30 
[61- 72] 1495.75397 1.037 0.128 0.329 NKEDLFDALFQR C67H103N18O21 
[63- 72] 1253.61608 1.374 0.400 0.608 EDLFDALFQR C57H85N14O18 
[73-138] 7597.70557 - - 1.485 
ICDDIENCIAQDAADAEGGSWTVFRHTLLHFFERLQSN
DIHYKFHNILFLKCEHTEQNAAVIAIAR 
C338H511N95O100S3 
[ 98-106] 1199.63200 0.014 -0.653 -0.636 HTLLHFFER C57H83N16O13 
[ 98-106] 1269.63748 - -0.411 -0.293 HTLLHFFER + C3H2O2 C60H85N16O15 
[107-115] 1117.56365 -0.052 -0.715 -0.706 LQSNDIHYK C49H76N14O16 
[107-138] 3736.93804 1.476 0.141 0.133 LQSNDIHYKFHNILFLKCEHTEQNAAVIAIAR C168H263N48O47S 
[116-123] 1031.60366 0.210 -0.177 -0.090 FHNILFLK C52H79N12O10 
[116-138] 2638.39224 1.385 0.142 0.199 FHNILFLKCEHTEQNAAVIAIAR C119H189N34O32S 
[124-138] 1625.80641 - -0.513 -0.261 CEHTEQNAAVIAIAR C67H113N22O23S 
[124-138] 1695.81189 - 0.169 0.652 CEHTEQNAAVIAIAR + C3H2O2 C70H115N22O25S 
[139-145] 938.53190 -0.517 -1.018 -0.964 KHQAIWR C43H67N15O9 
[140-145] 810.43693 -0.151 -0.681 -1.076 HQAIWR C37H55N13O8 
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[146-175] 3331.75191 3.26 1.948 2.153 EKITAVLTEAVENQDLADDLDKETAVIFIK C147H244N35O52 
[148-167] 2173.08705 - 2.025 2.145 ITAVLTEAVENQDLADDLDK C92H154N23O37 
[148-175] 3074.61435 3.788 - 2.224 ITAVLTEAVENQDLADDLDKETAVIFIK C136H225N32O48 
[176-184] 1060.57857 0.980 0.358 0.509 STLDGLIWR C48H77N13O14 
[185-196] 1359.62156 1.730 0.995 1.083 WFSSGESFDLGK C63H87N14O20 
[185-200] 1784.86022 - - 0.401 WFSSGESFDLGKTAPR C81H118N21O25 
[185-216] 3732.78454 - 3.608 - 
WFSSGESFDLGKTAPRIIGIMMDNLENHPCLR + 
C4H4NO2 
C164H253N45O49S3 
[197-200] 444.25651 - -0.941 -0.946 TAPR C18H33N7O6 
[201-216] 1868.91796 - - -1.721 IIGIMMDNLENHPCLR C79H134N23O23S3 
Table ‎11.1: Summary of all observed peptides from the native and modified MtrR protein digests. Peptides confirmed to have 
modifications have been highlighted in red. 
 
 
Residues 
Theoretical 
Monoisotopic 
[M+H]
+
 m/z 
Native M 
/ppm 
M-NBD 
/ppm 
Sequence 
Protonated 
Molecular 
Formula 
[1- 12] 1495.69196 0.554 -0.322 HMLETMETYVNK C64H102N16O21S2 
[1- 55] 6271.04224 -0.006 - HMLETMETYVNKLHEGSTYTAAVQYNVLEKDDDPASLTIWVPMFQSSMPADLLIK C280H433N67O88S4 
[13- 30] 2023.01310 0.987 2.691 LHEGSTYTAAVQYNVLEK C90H139N23O30 
[13- 55] 4794.36812 1.045 2.322 LHEGSTYTAAVQYNVLEKDDDPASLTIWVPMFQSSMPADLLIK C216H333N51O68S2 
[13- 65] 5888.01766 1.064 - LHEGSTYTAAVQYNVLEKDDDPASLTIWVPMFQSSMPADLLIKELANVNILVK C266H420N64O82S2 
[31- 55] 2790.37287 1.704 3.431 DDDPASLTIWVPMFQSSMPADLLIK C126H196N28O39S2 
[56- 65] 1112.66739 -0.095 0.822 ELANVNILVK C50H89N13O15 
[66- 76] 1346.68114 - 1.420 QISTPKGPSLR + NBD C57H91N19O19 
[83- 92] 1031.55539 0.143 0.890 SAVLAQMPSK C44H78N12O14S 
[83-104] 2380.19993 -2.998 -2.175 SAVLAQMPSKFTICANVSLDER C102H170N28O33S2 
[93-104] 1367.66238 0.624 1.597 FTICANVSLDER C58H94N16O20S 
[105-118] 1567.80362 3.642 4.433 SKLAYDVTTPCEIK C69H114N16O23S 
[107-118] 1352.67663 -0.192 0.688 LAYDVTTPCEIK C60H97N13O20S 
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[119-126] 838.41612 0.308 1.274 ACSLTCLK C34H63N9O11S2 
[119-128] 1053.54311 - -3.050 ACSLTCLKSK C43H80N12O14S2 
[129-135] 806.44405 0.470 2.355 NMLTTVK C34H63N9O11S 
[141-161] 2358.20097 0.508 1.614 TLNPTHDIIALCEFENIVTSK C104H168N26O34S 
[141-162] 2486.29594 0.561 1.631 TLNPTHDIIALCEFENIVTSKK C110H180N28O35S 
[141-175] 3984.19907 1.203 2.161 TLNPTHDIIALCEFENIVTSKKVIIPTYLRSISVR C180H299N47O52S 
[162-170] 1102.69829 0.443 1.069 KVIIPTYLR C53H91N13O12 
[163-170] 974.60333 0.884 1.910 VIIPTYLR C47H79N11O11 
[176-191] 1880.96000 - 2.590 NKDLNTLENITTTEFK C81H133N21O30 
[178-191] 1638.82211 0.179 1.307 DLNTLENITTTEFK C71H115N17O27 
[178-198] 2351.20889 0.347 1.589 DLNTLENITTTEFKNAITNAK C101H167N27O37 
[178-215] 4191.27988 -0.136 - DLNTLENITTTEFKNAITNAKIIPYSGLLLVITVTDNK C188H312N46O61 
[178-219] 4594.50183 1.916 2.942 DLNTLENITTTEFKNAITNAKIIPYSGLLLVITVTDNKGAFK C208H341N51O65 
[199-215] 1859.08883 1.013 1.723 IIPYSGLLLVITVTDNK C87H147N19O25 
[199-219] 2262.31078 1.489 2.431 IIPYSGLLLVITVTDNKGAFK C107H176N24O29 
[220-237] 2112.13757 0.479 1.507 YIKPQSQFIVDLGAYLEK C100H154N22O28 
[220-248] 3496.80388 1.163 2.207 YIKPQSQFIVDLGAYLEKESIYYVTTNWK C166H246N36O47 
[220-261] 5019.60434 1.677 - YIKPQSQFIVDLGAYLEKESIYYVTTNWKHTATRFAIKPRED C233H352N58O66 
[238-248] 1403.68416 0.315 1.170 ESIYYVTTNWK C66H94N14O20 
Table ‎11.2: Summary of all observed tryptic peptides in the native and modified M protein samples. The NBD-modified peptide has 
been highlighted in red. 
Published: April 07, 2011
r 2011 American Chemical Society 4068 dx.doi.org/10.1021/ac200045n |Anal. Chem. 2011, 83, 4068–4075
ARTICLE
pubs.acs.org/ac
Electron-Induced Dissociation of Singly Charged Organic Cations
as a Tool for Structural Characterization of Pharmaceutical Type
Molecules
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Mass spectrometry is one of the most valuable analyticaltechniques employed by the pharmaceutical industry in the
quest of compound characterization, to the extent that virtually
every analytical or synthetic laboratory has access to this kind
of technology. This is due, in part, to online compatibility with
separation techniques such as gas or liquid chromatography,
which allows even highly complex mixtures to be simpliﬁed
ahead of the mass spectrometer. Sheer sensitivity toward com-
pounds in very low abundance, particularly in the presence of
more concentrated samples, as is typical of impurities arising
from synthesis, makes up-front separation a necessity in many
cases. Tandem mass spectrometry, the ability to further isolate
desired precursor ions in the gas phase and subject them to
conditions that induce fragmentation, undoubtedly adds that
extra dimension of molecular information. For the pharmaceu-
tical industry, the resulting fragmentation patterns from the
tandem mass spectrometry of small organic molecules can
provide a means to structural characterization, identiﬁcation of
impurities or degradation products and metabolites. Historically,
characteristic fragmentation patterns from electron impact (EI)
ionization have been established to the point that spectral
libraries from EI ionized chemicals are routinely used to identify
compounds “on-the-ﬂy”.1 True tandem MS can be achieved in
numerous ways including collision-induced dissociation
(CID)2,3 and surface-induced dissociation (SID),4 infrared mul-
tiphoton dissociation (IRMPD),5,6 electron capture dissociation
(ECD)7 and electron transfer dissociation (ETD).8 Most com-
mon by far is CID, and recent studies into the reproducibility of
CID product ion spectra have demonstrated that CIDMS data is
suﬃciently reproducible across a range of diﬀerent instrument
types to allow instrument-independent CID libraries to be
considered a viable approach to structural identiﬁcation.9 ECD,
a relatively new technique, has found its niche in the proteomics
arena and routinely provides data, complementary to CID data,
for the tandem MS studies of peptides10 and intact proteins.11
Whereas CID induces bond cleavage via the lowest energy
pathways,12 crucially ECD has been shown to fragment some
bonds leaving labile functional groups attached, thus able to
locate and identify such modiﬁcations as phosphorylation,13
glycosylation,14 acetylation15 or sulphation.16 Subsequently, a
great deal of research has been carried out into the fragmentation
mechanisms occurring during ECD.7,17 The concept of ECD has
beenmainly considered for multiply charged species, whether for
multiply protonated species18 or species containing a metal atom
with a valence of n (where n > 1).1922 These studies have led to
the proposal of two diﬀerent mechanisms. The ﬁrst mechanism,
the hot hydrogen atom mechanism, was described by Zubarev
and co-workers and suggests an incoming electron neutralizing
Received: January 7, 2011
Accepted: April 7, 2011
ABSTRACT: Collision-induced dissociation (CID) and elec-
tron-induced dissociation (EID) have been investigated for a
selection of small, singly charged organic molecules of pharma-
ceutical interest. Comparison of these techniques has shown
that EID carried out on an FTICRMS and CID performed on a
linear ion trap MS produce complementary data. In a study of
33 molecule-cations, EID generated over 300 product ions
compared to 190 product ions by CID with an average of only
3 product ions per precursor ion common to both tandem MS
techniques. Even multiple stages of CID failed to generate many of the product ions observed following EID. The charge carrying
species is also shown to have a very signiﬁcant eﬀect on the degree of fragmentation and types of product ion resulting from EID.
Protonated species behave much like the ammonium adduct with suggestion of a hydrogen atom from the charge carrying species
strongly aﬀecting the fragmentation mechanism. Sodium and potassium are retained by nearly every product ion formed from
[M þ Na]þ or [M þ K]þ and provide information to complement the EID of [M þ H]þ or [M þ NH4]þ. In summary, EID is
proven to be a ﬁtting partner to CID in the structural elucidation of small singly charged ions and by studying EID of a molecule-ion
holding diﬀerent charge carrying species, an even greater depth of detail can be obtained for functional groups commonly used in
synthetic chemistry.
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the positive charge on a solvated carbonyl group of a peptide and
inducing hydrogen atom transfer which results in cleavage of the
NCR bond.23,24 More recently, the second mechanism, pro-
posed by Turecek et al., describes electron capture that does not
result in a mobile hydrogen atom.2527 Here, electron attach-
ment to a peptide amide π* orbital, which is viable as such
orbitals can be stabilized by Coulomb interaction with a positive
charge, results in a strong base that undergoes proton transfer
leading to bond cleavage within the amide (NCR). Both of
these mechanisms only concern initial electron capture and
primary fragmentation. Secondary fragmentation has been re-
ported whereby nonergodic electron capture generates a radical
species that, following radical migration, can lead to multiple
radical rearrangements resulting in numerous cleavage sites.2830
It is, however, important to note that most mechanistic studies
have involved peptides.
Investigation into the electron interactions with single posi-
tively charged molecules in an FTICR MS has not been
thoroughly examined as it has been assumed that charge neu-
tralization will occur when a single positively charged ion
captures an electron, resulting in a neutral species,31 although
studies as long ago as 1979 clearly show this not to be the case if
electron energy is suﬃciently high.32 In this research, and
subsequent studies, Cody and Freiser showed that interaction
between radical cations and electrons can be used to pro-
vide valuable structural information.32,33 Budnik and Zubarev
later showed that a singly protonated peptide could be further
ionized by “fast” electrons and that subsequent capture of “slow”
Table 1. Number of Product Ions Observed Following CID in the LTQ and EID in the LTQFT and a Comparison of Product Ions
Common to Both Techniques
number of product ions observed > m/z 80
compound name EID CID (MS2)
product ions common to EID and CID
(number common product ions; m/z of the common product ions)
[haloperidol þ H]þ 5 4 3; (m/z 123, 165, 194)
[sulfamethazine þ H]þ 9 8 6; (m/z 92, 108, 124, 156, 186, 213)
[diphenhydramine þ H]þ 6 2 2; (m/z 88, 167)
[diphenhydramine fragment]þ >7 1 1; (m/z 152)
[caﬀeine þ H]þ 7 4 2; (m/z 110, 138)
[reserpine þ H]þ 13 15 6; (m/z 195, 236, 365, 397, 436, 448)
[raﬃnose þ Na]þ >21 5 4; (m/z 203, 275, 305, 365)
[terfenadine þ H]þ 10 2 2; (m/z 436, 454)
[tazobactam þ H]þ 13 6 3; (m/z 168, 257, 283)
[AZ_A þ H]þ >14 14 1; (m/z 340)
[AZ_A þ 2H]2þ 15 15 5; (m/z 216, 310, 325, 338, 366)
[AZ_B(i) þ H]þ 4 4 1; (m/z 399)
[AZ_B(ii) þ H]þ 2 2 2; (m/z 325, 280)
[AZ_B(ii) þ Na]þ 7 11 4; (m/z 331, 400, 464, 515)
[AZ_B(iii) þ H]þ 18 12 7; (m/z 165, 179, 224, 238, 272, 316, 167*)
[AZ_B(iii) þ Na]þ 7 5 2; (m/z 125, 163)
[AZ_B(iv) þ H]þ 6 5 0
[AZ_C(i) þ H]þ >16 2 1; (m/z 471)
[AZ_C(i) þ NH4]þ >18 3 2; (m/z 471, 516)
[AZ_C(i) þ Na]þ >19 12 6; (m/z 250, 263*, 278, 295, 357, 460)
[AZ_C(ii) þ H]þ 12 4 2; (m/z 91, 93, 103, 120)
[AZ_C(iii) þ H]þ 0 3
[AZ_C(iii) þ NH4]þ >9 4 4; (m/z 211, 354*, 381, 398)
[AZ_C(iii) þ Na]þ 17 8 6; (m/z 234, 262, 278, 306, 342, 384*)
[AZ_C(iii) þ K]þ 10 7 3; (m/z 147, 154*, 358)
[AZ_C(iv) þ H]þ 10 10 2; (m/z 120, 164)
[AZ_C(iv) þ NH4]þ 12 2 2; (m/z 408, 352)
[AZ_C(iv) þ Na]þ 15 4 2; (m/z 330,374)
[AZ_C(iv) þ K]þ 6 3 1; (m/z 390)
[AZ_C(v) þ H]þ 3 >7 3; (m/z 146, 164, 336)
[AZ_C(v) þ NH4]þ 6 4 3; (m/z 164, 336, 392)
[AZ_C(v) þ Na]þ 13 1 3; (m/z 120, 164, 358)
[AZ_C(v) þ K]þ 6 5 2; (m/z 164, 374)
Total Number of precursor ions studied
33 > 330 > 190 Average 3 peaks in common
* suspected corresponding EID fragment 1 m/z higher than CID
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electrons could result in fragmentation.34 Yet, only a few studies
have been done since to investigate the interaction between
electrons and ions (protonated or deprotonated) holding a single
charge and the fragmentation that results from this electron-
induced dissociative (EID) technique. Lioe and O’Hair reported
EID fragmentation eﬃciency of singly protonated aromatic
Figure 1. MS2 spectra for protonated diphenhydramine. (a) LTQCID spectrum obtained with normalized collision energy of 20 and (b) LTQFT EID
spectrum obtained with electron energy set to 20%. Collision energy and electron energy values were set as per manufacturers’ software.
Scheme 1. Dissociation of Diphenhydraminea
a (i) Product ions common to CID and EID of 256 m/z. (ii) Additional fragments produced from EID of 256 m/z. (iii) CID of 167 m/z. (iv) EID of
167 m/z. All EID mass measurements were performed in the FTICR MS and are accurate to <1 ppm. The CID experiments resulting in 123 m/z and
152 m/z were performed in the LTQ ion trap and were measured to nominal mass.
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amino acids at high electron energies.35 The experiment, akin in
approach to hot ECD (hECD) for multiply charged molecules,
demonstrated that electron energies of approximately 1525 eV
induced fragmentation that resulted in diﬀerent product ions toCID.
Figure 2. MS2 spectra for the precursor ion 167.1 m/z, formed from in-source dissociation of protonated diphenhydramine. (a) LTQ CID spectrum
obtained with normalized collision energy of 25 and (b) LTQFT EID spectrum obtained with electron energy set to 20%. Collision energy and electron
energy values were set as per manufacturers’ software.
Figure 3. Comparison of CID and EID for compound AZ_C(i). (a) LTQ MS2 spectrum for the protonated precursor ion at 517.1 m/z leading to
(b) MS3 of 471.1 m/z. These CID spectra were obtained with normalized collision energy of 20. (c) LTQFT EID spectrum for the precursor ion
517.1 m/z obtained with electron energy set to 20%. Collision energy and electron energy values were set as per manufacturers’ software. Peak
assignments are given in Table 2.
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Sargaeva et al. used electron energies of this order to show that
EID, as well as ECD, could be used to diﬀerentiate between
aspartic and isoaspartic acid residues in a peptide.36 Wolﬀ et al.
have investigated EID for singly deprotonated glycosaminogly-
cans and show EID produces far greater fragmentation for these
molecules than IRMPD.37 By comparison, Hakansson et al.’s
study of singly deprotonated phosphate-containing metabolites
concluded with EID providing complementary data to IRMPD
and CID, yet EID was not as eﬃcient as the other techniques.38
This study has not only successfully dissociated small positive
singly charged ions through collisions with electrons but shown
that high quality data that is produced is shown to be comple-
mentary to both CID and EI.
’EXPERIMENTAL SECTION
Sample Preparation. A wide variety of small organic mol-
ecules of varying chemical structures were dissolved to produce a
concentration of 1 μgmL1 in methanol or acetonitrile depend-
ing on solubility. Named compounds were commercially avail-
able and were purchased from Sigma-Aldrich, Dorset, U.K. All
solvents and reagents were also purchased from Sigma-Aldrich,
Dorset, U.K. Compounds identified with the prefix AZ were
supplied courtesy of AstraZeneca, Avlon, U.K.
Mass Spectrometry.Mass spectrometry measurements were
made using a ThermoFinnigan LTQFT mass spectrometer
equipped with a 7.0 T magnet (Bremen, Germany). Samples
were introduced into an electrospray ion source using a syringe
pump delivering a flow at 5 μLmin1. The nitrogen sheath gas
was set to 3 arbitrary units on the manufacturers’ software; the
auxiliary gas and the sweep gas were negligible, thus providing a
stable signal. The heated capillary was set to 250 C. The
electrospray ion source was operated with a spray voltage of
4.0 kV, and the tube lens was optimized to deliver the maximum
intensity for the desired positive ion. For all MS/MS experi-
ments, the isolation window was set to comfortably encompass
the full isotopic envelope. CID experiments were carried out in
the LTQ using helium as the collision gas. The collision energy
was optimized between settings of 15 and 25 for the normalized
collision energy as per the manufacturers’ software, to produce
the desired degree of fragmentation. Product ions weremeasured
by the LTQ-MS and the FTICR MS. EID was performed by an
indirectly heated dispenser cathode within the FTICR MS.
Cathode offset was 2.9 V and the energy, as set in the software,
was between 15 and 25%, thus giving an electron energy of
between 12.1 and 22.1 eV. Operating at these elevated electron
energies is often termed hot ECD. The electron irradiation
duration was 70 ms. Data was recorded and processed using
Xcalibur software (version 2.0) (ThermoFinnigan, San Jose,
CA).
’RESULTS AND DISCUSSION
EID and CID results were compared for a selection of small
molecules. Table 1 lists the compounds investigated and sum-
marizes the tandem mass spectrometry results. Diphenhydra-
mine provides a good example of a particular problem that can
arise from a limitation of CID. The CID spectrum of protonated
diphenhydramine (Figure 1a) shows only two peaks, one corre-
sponding to a highly abundant product ion at 167.1m/z and one
relatively low abundant product ion at 88.1 m/z. Scheme 1(i)
demonstrates the fragmentation pathway, that is, cleavage at a
single location, the middle of the molecule-ion, resulting in two
possible charged fragments that reveal limited structural infor-
mation. In comparison, EID, which also results in the same two
product ions as CID, generates additional product ions as shown
in Figure 1b, providing information regarding the structure of the
aromatic portion of diphenhydramine. These extra fragments are
detailed in Scheme 1(ii). In fact, by increasing the tube lens
voltage to optimize the intensity of the in-source dissociation
product 167.1 m/z, this even electron fragment of diphenhydra-
mine could be selected as the precursor ion for further tandem
mass spectrometric studies. EID of 167.1 m/z produced four
times the number of product ions when compared to CID
(Table 1 and Figure 2). Some of the EID product ions were
observed previously from the fragmentation of 256.2 m/z;
however, four new peaks arose from the fragmentation of
167.1 m/z (Scheme 1(iv)), and when all EID product ions are
considered together, the overall information attained matches
that from traditional EI data.39,40
As with diphenhydramine, CID in the ion trap was only able to
provide limited structural information regarding the compound
AZ_C(i) ([M þ H]þ = 517 m/z). Here, the two product ions
corresponding to the loss of water and formic acid from proto-
nated AZ_C(i) give no insight as to molecular structure. These
results are shown in Figure 3a. An additional stage of CID,MS3 of
517.1 m/z and 471.1 m/z, led to a further eight product ions as
given in Figure 3b. In comparison, a single EID spectrum of the
protonated precursor 517.1 m/z resulted in an identical set of
Table 2. Summary of EID Product Ions for the Compound
AZ_C(i)
EID product
ion (m/z)
proposed
formula
mass deviation from
theoretical m/z
value/ppm
structure of product
ions unique to EID
165.0367 C9H9OS 1.04
175.0752 C11H11O2 0.95 yv
179.0523 C10H11OS 0.96
189.0731 C12H13S 0.83
209.0629 C11H13O2S 0.66 mn
223.1116 C16H15O 0.64 zx
249.1273 C18H17O 0.49
283.1151 C18H19OS 0.15
318.0921 C17H18O4S 0.09 x
345.0792 C18H17O5S 0.32 w
363.0898 C18H19O4S2 0.40
377.0878 C19H21O4S2 0.49
396.0698 C18H20O6S2 0.65 u
437.1421 C25H25O5S 0.87
471.1299 C25H27O5S2 1.06
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product ions as the combined eﬀort of MS2 and MS3 by CID,
plus several additional peaks unique to EID (Figure 3c). This
complementary information now allows empirical formulas to
be proposed for six extra fragments, highlighted in Table 2. These
fragments encompass the majority of the structure of the mole-
cule including a peak at 396 m/z which represents cleavage
at u, the thioether, resulting in the loss of ethyl phenol. Cleavage
at or close to the thioether is common to the six unique EID
fragments. The peaks at 345m/z and 318m/z (cleavage atw and
x respectively) both retain the mesylate end group whereas
223 m/z, 209 m/z and 175 m/z all result from multiple bond
cleavages releasing the central part of the molecule. These
internal fragments are given in Table 2 as zx, mn and yv
respectively. In the case of mn, two bonds have been suggested
for each ofm and n as cleavage at either location would result in
product ions of the same empirical formula. Although in this case
the full molecule can also be pieced together fromMS3 CID data,
the complementary fragments observed by EID demonstrate the
full extent of information that can be attained from a single EID
MS/MS experiment using an instrument with very high resolving
power and precise accurate mass measurement.
Numerous molecule-ions carrying only a single positive
charge have been studied, and for the 33 species listed in Table 1,
EID generated over 330 product ions, 1.5 times more than
generated by CID, indicating that for many compounds EID can
provide a greater depth of information. Perhaps the most
interesting fact, however, is the small overlap in the data obtained
by the two techniques. On average, there were only three product
ions common to both EID and CID, highlighting the comple-
mentary nature of these experimental approaches.
Effect of the Charge Carrying Species on EID.Many of the
compounds used in this investigation were observed as proton,
sodium, ammonium, and potassium adducts. The nature of the
charge-carrying species can be seen to affect the product ions
generated. EID spectra for compound AZ_C(iv) are given in
Figure 4, and interestingly, but perhaps not surprisingly, the vast
majority of the positively charged fragments retain the nitrogen
atom. The protonated molecule (Figure 4a) fragments heavily
within the BOC-aniline portion of the molecule. Loss of H•, O•,
and H2O are not structurally helpful; however, there are three
fragments corresponding to the break up of t-butyl. Loss of C4H8,
C4H8O, and C5H8O2 clearly characterize this portion of the
molecule with the ninth t-butyl hydrogen relocated to the amine
for stabilization resulting in NH3
þ as the terminal group of this
fragment ion. Fragmentation is depicted in Table 3 where
the bonds labeled h, g and f are cleaved respectively. Information
regarding the aniline BOC can still be obtained from the
ammonium adduct via cleavage at h and f as shown in
Figure 4b; however, these neutral losses of C4H8 and C5H8O2
from the ammonium adduct are both accompanied by neutral
losses of NH3 and [NH3þH•]41 and are visually recognizable as
pairs of peaks separated by 1 m/z. Exact mass measurement
with the FTICR confirms assignment. The pairing of peaks
separated by 1m/z associated with all t-butyl fragments from the
Figure 4. Comparison of the LTQFT EID data for the compound AZ_C(iv) with diﬀerent charge carrying species. (a) [MþH]þ, (b) [MþNH4]þ,
(c) [MþNa]þ, and (d) [Mþ K]þ. LTQFT EID spectrum obtained with electron energy set to 20%. Collision energy and electron energy values were
set as per manufacturers’ software. Note, * indicate the presence of silicones. Peak assignments are given in Table 3.
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ammonium adduct suggests that two processes may be occurring
during EID: electron interaction causing charge transfer from
NH4
þ to the compound and proton transfer to the compound,
each resulting in fragmentation. Bond cleavage at h and f,
involving relocation of the ninth t-butyl hydrogen, was also
observed when the charge carrying species was an alkali metal
cation. Overall, the protonated molecule-ion provides more
significant information regarding the aniline BOC end of the
molecule.
Similarity between the dissociation of the ammonium adduct
and the alkali metal cation adducts can been seen at the mesylate
end of the molecule. For the ammonium adduct, in contrast to
the t-butyl fragmentation peak pairing, a single peak was ob-
served corresponding to cleavage at position a, resulting in the
simultaneous neutral loss of CH3SO2
• and NH3, suggesting
proton transfer may have occurred. Evidence for small neutral
losses from the mesylate end of the molecule becomes far more
prevalent when themolecule carries an alkali metal cation such as
Naþ or Kþ. In fact, the most intense peaks from [MþNa]þ and
[M þ K]þ relate to cleavage at bonds labeled a (neutral loss
of CH3SO2
•) and b (neutral loss of methane sulfonic acid,
CH3SO3H) in Table 3. It is theorized that the larger cationic
species reside on or in close proximity to the aromatic ring42
adjacent to the mesylate, thus directing interaction with an
electron to this locale, resulting in preferential bond cleavage in
this area and may explain the ability of a hydrogen to relocate to
during bond cleavage at b to result in the neutral loss of
CH3SO3H. The protonated species now stands alone as there
is a complete absence of any cleavage at a and b, but instead a
unique cleavage at c on the central side of the aromatic ring.
As observed for the EID of compound AZ_C(i), multiple
bonds were also broken for AZ_C(iv). Small neutral loses from
both ends of the molecule leave the central portion of the
molecule carrying the charge. This evidence is given by the
three product ions at the lower m/z region of the spectrum for
[M þ H]þ (Figure 4a) corresponding to [C8H10N]þ (df),
[C9H8NO]
þ (dg) and [C9H10NO2]
þ (dh). In comparison,
fragmenting the ammonium adduct led to the same three
product ions at the low m/z range as shown in Figure 4b. There
is only very weak evidence for the three product ions
[C8H10N]
þ, [C9H8NO]
þ and [C9H10NO2]
þ resulting from
the EID of [M þ Na]þ (Figure 4c) and a complete absence of
these peaks from the EID of [Mþ K]þ (Figure 4d). This would
suggest a hydrogen atom from the original charge carrying
species is heavily involved in the formation of these product
ions that correspond to the central portion of themolecule.Weak
evidence for [C8H10N]
þ (df) from [MþNa]þ does suggest the
possibility that, in the absence of any protons on the charge
carrying species, a hydrogen can be abstracted from another part
of the molecule, but that this is not as favorable as retaining the
original charge carrying atom as shown by the relative intensity of
the product ion [C8H9Na]
þ. There is further evidence for
multiple bond cleavage for [M þ NH4]þ, [M þ Na]þ, and
[MþK]þ. Thebeginnings of a trend canbe seenwith [MþNH4]þ
and [M þ Na]þ both fragmenting at ag/bh and ah. In addition,
[M þ Na]þ also fragments at af, this being the only fragmenta-
tion site for [M þ K]þ.
Overall, a degree of similarity can be seen between the EID of
the proton adduct and ammonium adduct and then between the
ammonium adduct and the alkali metal cation adducts. Ammo-
nium was not retained in its entirety by any of the product ions
but was seen to donate either the charge or a proton to product
ions. This is in contrast to the alkali metal adducted species
where the sodium is retained by all but two product ions from
[MþNa]þ and potassium is retained by every product ion from
[M þ K]þ as shown in Table 3. Irrespective of dissociation
mechanisms involved, changing the charge carrying species can
be used to extract increasing amounts of molecular information,
with ammonium and sodium providing the optimum for this
particular molecule.
’CONCLUSION
For the molecules employed in this study, EID was shown to
provide a much greater depth of information. In many cases, EID
resulted in a much greater number of product ions than CID,
with very little overlap between the two techniques. The
complementary nature of these techniques can be signiﬁcantly
enhanced by changing the charge-carrying species. This can be
explained by diﬀerent charge-carrying species residing at diﬀer-
ent locations of these small molecules and as such heavily
inﬂuence the product ions generated. In practice, EID appears
Table 3. Summary of EID Product Ions for the Compound
AZ_C(iv)
terminal product ions internal product ions
precursor ion
empirical
formula
bond
cleavage
site
empirical
formula
bond
cleavage
site
[M þ H]þ C13H19NO3 c C8H10N df
C16H18NO6S h C9H8NO dg
C16H18NO5S g C9H10NO2 dh
C15H18NO4S f
[M þ NH4]þ C16H17NO6S h C8H10N df
C16H18NO6S h C9H8NO dg
C15H17NO4S f C9H10NO2 dh
C15H18NO4S f C15H14NO3 ag/bh
C19H23NO4 a C15H15NO4 ah
[M þ Na]þ C16H17NO6SNa h C7H7NNa ef
C15H17NO4SNa f C8H9NNa df
C15H16NO4SNa f C6H5O2Na ad
C19H22NO4Na a C7H6O2Na ae
C19H21NO3Na b C15H15NO4Na ah
C15H13NO3Na ag/bh
C14H14NO2Na af
C8H10N df
C9H10NO2 dh
[M þ K]þ C16H17NO6SK h C14H14NO2K af
C15H17NO4SK f
C19H22NO4K a
C19H21NO3K b
C13H18NO2K d
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to allow very speciﬁc parts of a molecule to be probed. For
example, the t-butyl functional group of the molecule studied can
be easily classiﬁed from the ammonium adduct as pairs of peaks
corresponding to small neutral losses from this functional group
allow this portion of the molecule to be assigned at a glance.
Conversely, location of a sodium or potassium cation at an
aromatic portion of the molecule closest to the mesylate group
would go some way to explaining why themesylate portion of the
molecule is better characterized from these adducts. Overall, EID
results from proton and ammonium adducts were reasonably
comparable, with ammonium providing a slight advantage. The
presence of a sodium cation gave similar but slight improvement
over potassium. What is clear is the involvement of more than
one dissociation mechanism coming into play, particularly
evident from the ammonium adduct where proton transfer and
charge transfer can both be observed.
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Abstract
LC ESI FTICR MS of a sample of cediranib identified this pharmaceutical target molecule plus
an additional 10 compounds of interest, all of which were less than 10% total ion current (TIC)
peak intensity relative to cediranib. LC FTICR tandem mass spectrometry using electron
induced dissociation (EID) has been achieved and has proven to be the best way to generate
useful product ion information for all of these singly protonated molecules. Cediranib [M+H]+
fragmented by EID to give 29 product ions whereas QTOF-CID generated only one very intense
product ion, and linear ion trap-CID, which generated 10 product ions, but all with poor S/N.
Twenty-six of the EID product ions were unique to this fragmentation technique alone. By
considering the complementary LC-EID and LC-CID data together, all 10 unknown compounds
were structurally characterized and proven to be analogous to cediranib. Of particular
importance, EID produced unique product ion information for one of the low level cediranib
analogues that enabled full characterization of the molecule such that the presence of an extra
propylpyrrolidine group was discovered and proven to be located on the pyrrolidine ring of
cediranib, solving an analytical problem that could not be solved by collision induced
dissociation (CID). Thus, it has been demonstrated that EID is in harmony with the
chromatography duty-cycle and the dynamic concentration range of synthetic compounds
containing trace impurities, providing crucial analytical information that cannot be obtained by
more traditional methodologies.
Key words: Tandemmass spectrometry by electron induced dissociation, Structural characterization
of pharmaceuticals, LC MS/MS for low abundant compounds
Introduction
Liquid chromatography-mass spectrometry (LC-MS) isan integral part of drug discovery and development in
the pharmaceutical industry, routinely used to reveal and
characterize trace-level impurities, by-products, and degra-
dation products, which are common occurrences in synthetic
chemistry reactions [1]. The need to identify all components
present alongside a synthetically produced target compound
is often hampered by the fact that these undesirable
molecules can be structurally similar to the target compound,
yet present at much lower concentrations. LC ESI MS/MS
has the sensitivity with which to detect molecules at low
concentrations and the experimental flexibility to extract
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information that can lead to proposed empirical formulae
and molecular structure [2–6]. There are many MS/MS
techniques available, the most common one used in the
pharmaceutical industry being collision induced dissociation
(CID). CID involves collisions between precursor ions and
neutral gaseous atoms or molecules, which results in the
conversion of a precursor ion’s kinetic energy into internal
energy. This increase in internal energy causes bond
dissociation within the precursor ion, typically favoring the
lowest energy fragmentation pathways [7–9]. Problems often
arise upon the CID analyses of analogous compounds as
product ions observed from the cleavage of the weakest
bonds may not allude to the location of, or nature of, such
small structural molecular changes, demanding that other
analytical approaches be explored. A more recent addition to
the tandem MS toolbox is electron capture dissociation
(ECD), an electron-based fragmentation technique primarily
used to fragment and characterize multiply charged peptide
and protein cations [10–12]. It involves the interaction of
low energy electrons (1–5 eV) with multiply protonated
species, resulting in charge reduction and bond cleavage [13,
14]. ECD of peptides/proteins has been shown to produce a
simple but regular distribution of product ions that comple-
ment the CID distribution, but the ability of ECD to preserve
labile covalently bound modifications gives this technique a
distinct advantage over CID [15–18]. In an attempt to gain
yet further information regarding peptide structure, Zubarev
et al. increased the ECD electron energy beyond what is
common for multiply charged peptides (910 eV), generating
hotter electrons [13, 19]. Applying these higher energy
electrons to multiply charged peptides is known as hot
electron capture dissociation (hECD) and has been shown to
produce a significant increase in side chain fragmentation
producing an even greater depth of information [20, 21].
More recently, the interaction between hotter electrons and
singly charged cations has been shown to induce fragmen-
tation and is referred to as electron induced dissociation
(EID) [19, 22–29]. In a very recent study with pharmaceu-
tical type molecules, EID produced extensive product ion
data that largely complemented CID, was comparable to
electron ionization (EI), and was more tolerant to a wider
range of charge carrying species than CID [29].
ECD is somewhat notorious for its lack of efficiency
compared with other techniques such as CID [10, 15].
Historically, in order to achieve usable spectra, samples of
high concentration were preferred and S/N allowed to build-
up by accumulating many spectra. Significant inroads have
been made in optimizing methodologies to facilitate ECD of
peptides on the LC time-scale [3, 4, 30]. For EID to be
widely pertinent to real-world applications, it too must be
coupled to chromatographic techniques, producing spectra
of sufficient quality that information can be gained for
compounds of a wide dynamic concentration range from the
limited number of spectra achievable across a chromato-
graphic peak. This development will show that LC-EID is
achievable, plus it provides unique information not afforded
by LC-CID. The power to generate multiple datasets of
complementary information on one instrument in the very
short LC time-scale facilitates greater in-depth analysis of
complex mixtures of small molecules, which are typical of
the pharmaceutical industry.
Experimental
Sample Preparation and Sample Introduction
The sample of cediranib was supplied by AstraZeneca,
Macclesfield, UK. All solvents were purchased from Sigma-
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Figure 1. Total Ion Chromatogram (TIC) from LC FTICR MS analysis of cediranib. Peaks labeled 1 to 11 indicate the presence
of components proven to be from the cediranib sample. A comparison of sample and control is given in supplementary
information Figure S1
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Aldrich, Dorset, UK. For the chromatography, a solution of
cediranib was made to 2 mg mL–1 in methanol; 10 μL
aliquots were injected on to either a Luna 3 μm C18 (2),
100 Å, 150×2 mm column (Phenomenex) with a mobile
phase flow rate of 200 μL min–1 for a 12 min separation or a
4.5 min separation using a Zorbax SB-C18 1.8 μm 4.6×
50 mm column (Agilent Technologies) with a mobile phase
flow rate of 1 mL min–1 and a 1:4 split prior to the mass
spectrometer. Gradient conditions started at 95% (H2O+
0.1% formic acid)/5% (CH3CN+0.1 % formic acid) and
finished at 5 % (H2O+0.1% formic acid)/95% (CH3CN+0.1
% formic acid). A 5 μg mL–1 solution of cediranib in
methanol was used for occasional experiments requiring
direct infusion. In such instances a syringe pump delivered
the sample solution at a flow rate of 5 μL min–1.
Mass Spectrometry
Unless stated otherwise, measurements were made using a
ThermoFinnigan LTQFT mass spectrometer fitted with a 7
Tesla magnet and equipped with an electrospray ion source
(Bremen, Germany). The following ion source parameters
were optimized for the most stable ion signal: the nitrogen
sheath gas was kept between 8 and 10 arbitrary units, the
auxiliary gas and sweep gas were set between 2 and 4
arbitrary units, as per the manufacturer’s software, the
capillary was heated to 250 °C, and the spray voltage was
held at 4–4.5 kV. The tube lens voltage was varied to deliver
the optimal ion intensity.
Isolation of the precursor ions was carried out in the LTQ
ion trap with a fixed isolation window of 4m/z in order to
include the full isotopic profile of the compound of interest.
All LC-MS/MS experiments were performed by alternating
MS and MS/MS scans throughout the chromatographic run.
CID experiments were performed entirely within the LTQ
ion trap using helium as a collision gas and optimized at a
normalised collision energy level of 25 as per the manu-
facturer’s software, unless otherwise stated. EID was
performed entirely within the FTICR cell using an indirectly
heated dispenser cathode. To generate ‘hot’ electrons
required for EID and hECD, the electron energy was set at
20 arbitrary units, as per the manufacturer’s software. The
cathode offset was 2.5 V for LC-MS/MS experiments and
2.1 V for the direct infusion experiments, resulting in
approximate electron energies of 17.5 and 17.9 eV, respec-
tively. For ECD, the electron energy was set at 5 arbitrary
units, as per the manufacturer’s software, and the cathode
offset was 2.1 V resulting in an approximate electron energy
of 2.9 eV. The electron irradiation time was fixed at 70 ms.
Data was recorded using the acquisition software Xcalibur
ver. 2.0.7 (Thermo Fisher Scientific Inc.) and processed
using the embedded program Qual Browser. Comparative
direct infusion ESI QTOF MS measurements were made on
a Waters QTOF Premier (Manchester, UK). QTOF-CID
experiments were performed using ion source parameters
that optimized the precursor ion peak intensity, argon as a
collision gas and a collision energy of 25 eV.
Results ad Discussion
LC-MS/MS of Cediranib
The process for manufacturing cediranib, as with all
pharmaceuticals, is rigorously developed and controlled to
ensure that any impurities present are well below interna-
tionally recognized safety limits. The inherent sensitivity of
mass spectrometric methods allows detection of trace level
impurities that are below these permitted safe levels. A
process development sample of cediranib containing higher
Table 1. Summary of product ions following LC-CID and LC-EID of cediranib labeled LC peak number 3 and analogues labeled LC peak number 1, 2, and
4–11
LC peak
number
Observed MS
peak m/z
Proposed molecular
formula for [M+H]+
Number of product ions observed Number of product
ions common between
EID and CID
Number of product ions
common between Cediranib
(peak 3) and an analogueEID CID
1 562 C32H41O3N5F 17 15 2 11
2 899 C50H53O6N8F2 5 7 2 5
3 451 C25H28O3N4F 29 10 3 N/A
4 788 C43H40O6N7F2 2 11 1 4
5 481 C25H26O5N4F 12 5 4 4
6 340 C18H15O3N3F 21 15 5 9
7 447 C25H24O3N4F 19 3 3 6
8 430 C25H21O3N3F 17 21 9 8
9 339 C18H14O3N3F 17 9 9 6
10 921 Unknown 4 8 3 2
11 691 C37H29O6N6F2 2 16 1 4
N
O
O
N
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O NH
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Figure 2. Structure of cediranib with the propylpyrrolidine
subunit atoms labeled C(1) to C(7) and N(8)
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levels of impurities than the marketed compound was
analyzed by LC FTICR MS, which separated and detected
eleven different compounds of varying ion abundance.
Those compounds are labeled 1 to 11 on the total ion
chromatogram shown in Figure 1. The most intense peak,
3, relates to a precursor ion at 451.21370m/z, which
corresponds to the empirical formula C25H28N4O3F with
an accuracy of 0.7 ppm and is taken to be protonated
cediranib, as expected. Accurate mass measurements for 1,
2, and 4 to 11 suggested molecular formulae in each case,
as given in Table 1, however molecular structures
remained unknown.
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Initial CID experiments to probe the structure of cediranib
(Figure 2) were carried out by direct infusion of sample into a
QTOF MS. The protonated cediranib molecule fragmented to
give only one product ion peak at 112m/z (S/N930,000/1, data
not shown), corresponding to the cleavage of the C(1)–O bond
of the propylpyrrolidine arm. This provides very little useful
information about the molecular structure, highlighting the
need for additional analytical techniques. Identification of the
unknown species by tandem mass spectrometry was hampered
by their low ion abundances, particularly in the presence of
such a hugely abundant target compound. Coupling MS with
chromatographyminimized in-source ion suppression, improv-
ing precursor ion S/N in preparation for MS/MS. In this
instance, both CID and EID have been employed to target and
identify the unknown species present in the cediranib sample.
Figure 3a shows the spectrum obtained from the LC-CID of
cediranib performed and detected in the LTQ of the LTQFT.
The single product ion at 112m/z that was observed from the
QTOF CID is not observed due to the one-third cut-off, which
affects MS/MS carried out in quadrupole ion traps [31]. This
results in the majority of CID product ions being present in the
higher m/z region, including 340m/z, which corresponds to the
neutral loss of the propylpyrrolidine moiety. By comparison,
the results from LC-EID shown in Figure 3b display the
opposite trend for product ion distribution, providing unique
information at the lower m/z range. The peak at 112.11208m/z
corresponds to the empirical formula C7H14N with an accuracy
of 0.04 ppm, confirming the identity of the propylpyrrolidine
arm of the molecule. Comparison of LC-CID and LC-EID
product ion spectra really highlights the complementary nature
of these two techniques, supporting previous studies [29], but
also demonstrates that both are achievable in the LC timescale.
LC-MS/MS of Unknown Species
The first of the unknown species to be studied was the first
to elute from the column, peak 1 with a retention time of
5.69 min (see Figure 1). This relates to a mass peak
562.31897m/z, which corresponds to the empirical formula
C32H41N5O3F with an accuracy of 0.3 ppm. The LC FTICR
MS/MS of this precursor ion is given in Figure 4 for (a) LC-
CID and (b) LC-EID. Comparison shows the LC-EID data to
be the most immediately useful data, despite being a
summation of 13 times less spectra than for LC-CID.
Accurate mass measurement on the product ion at 451m/z
proposed a molecular formula C25H28N4O3F with an
accuracy of 0.1 ppm. This is the same empirical formula as
protonated cediranib, so at a glance the likely relationship
between these two molecules is established. The neutral loss
from 562 to 451m/z during EID is consistent with a
fragment having the empirical formula C7H13N and is
considered to be most likely due to the addition of a second
propylpyrrolidine arm onto the parent molecule during
synthesis. Further indication into the structural similarities
can be gained by comparing the LC-EID for cediranib
shown in Figure 3b directly with the LC-EID of 562m/z in
Figure 4b. LC-EID of cediranib and the unknown species at
562m/z resulted in the product ions 70, 84, and 112m/z and
accurate mass measurements allowed the empirical formulae
C4H8N, C5H10N and C7H14N to be assigned, respectively.
These three fragments are all from the propylpyrrolidine
arm, a conclusion supported by visually comparing
Figure 4b against EI mass spectral library records for a
number of molecules with alkylpyrrolidine functional
groups. Also in common is a product ion at 340m/z,
confirmed by accurate mass measurement despite lower S/
N in Figure 4b, which corresponds to the protonated
indolphenol structure given in Figure 5a and represents
cediranib minus the propylpyrrolidine arm that is such an
intense product ion in itself. In total, nine product ions
observed in the LC-EID of the unknown compound at 562
m/z can be explained by comparison with the LC-EID of
protonated cediranib, lending credence to the proposal that
both molecules are closely structurally related. Now that the
unknown molecule with [M+H]+=562m/z is considered to
be related to cediranib, the difference being an additional
propylpyrrolidine moiety, the question remains as to the
location of the second propylpyrrolidine. There are eight
H+(a)
NN
O
O
N +
O
N
F
N
(b)
NN
O
HO
O
N
F
N
N
Figure 5. Structures of (a) indolphenol and (b) quaternary
ion
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peaks observed in Figure 4b for the LC-EID spectrum of
562m/z, which are not observed from the LC-EID of
protonated cediranib, two of which provide insight to the
location of the extra functional group. First, the peak at 223
m/z has been determined to have a molecular formula of
C14H27N2 (0.7 ppm error), consistent with two propylpyrro-
lidine arms. As the C(1)–O is the main cleavage site within
this molecule, this suggests that the addition of the second
propylpyrrolidine is situated on one of seven carbon atoms
labeled C(1) to C(7) or the nitrogen atom N(8) as described
in Figure 2. In fact, evidence for this at very low abundance
is also present in the LC-CID spectrum in Figure 4a. Second,
the peak at 360m/z has been identified as a fragment with
the molecular formula C21H18N3O3 (1.4 ppm error), which
is proposed to correspond to the loss of one intact
propylpyrrolidine moiety plus the pyrrolidine ring of the
second arm and hydrogen fluoride (C7H14N1+C4H8N1+
HF). This further implies that the addition is located on the
pyrrolidine ring C(4)–C(7) or N(8). NMR analysis of the
extracted impurity corroborates the MS findings and further
identifies the location of the second propylpyrrolidine as the
N(8) atom, giving a quaternary ion as shown in Figure 5b.
The remaining unknown compounds labeled 2, 4–11 in
Figure 1 have been investigated using the same LC-CID and
LC-EID methodology and results are summarized in Table 1.
Here, the total number of product ions has been counted for
each technique (LC-CID and LC-EID). It can clearly be seen
that EID provides a usable number of product ions for all the
precursor ions studied, and that the number of EID product
ions is comparable or often greater than to CID. The most
interesting fact here, though, comes from comparing the
observed product ion m/z values for each technique. There is
very little overlap between the observed product ions,
highlighting the complementary nature of these two techni-
ques. Delving further shows that when this complementary
data is considered as a whole, the number of peaks that each
unknown compound has in common with cediranib is
sufficiently high to suggest a strong likelihood that each
unknown species is chemically related to the cediranib. As
with the compound at LC peak 1 (Figure 1), further
analytical techniques may be ultimately required to confirm
the full molecular structure, however in this case the
unknown species labeled 2, 4–11 remain proprietary
information of the pharmaceutical company and cannot be
discussed further.
Tandem MS of [M+2H]2+ for Cediranib
Cediranib was observed in two charge states: singly and
doubly protonated. Doubly charged ions were not observed
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Figure 6. Tandem mass spectrometry of doubly protonated cediranib by direct infusion. Comparison of (a) CID (normalized
collision energy of 18) with (b) ECD (electron energy=2.9 eV) and (c) hECD (electron energy=17.9 eV)
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for any of the weakly abundant, co-sprayed cediranib
analogues. The doubly protonated adduct of cediranib,
despite being considerably less abundant, would tend to be
the precursor ion of choice as multiply charged species are
generally accepted to provide the superior product ion
spectrum [32, 33]. Figure 6a shows CID for 226m/z, [M+
2H]2+ for cediranib performed with a normalized collision
energy of 18. As could be expected, this spectrum represents
a huge improvement over the CID of the singly protonated
precursor (Figure 3a) in terms of number of product ions
observed and provides comparable data to EID of the singly
protonated species (Figure 3b).
As mentioned previously, the interaction between low
energy electrons and multiply charged cations is considered
to result in the capture of an electron and subsequent bond
dissociation, a technique known as electron capture
dissociation (ECD). When the ECD approach was
employed to study the [M+2H]2+ for cediranib
(Figure 6b), irradiation with low energy electrons (electron
energy=2.9 eV) gave very limited information. There is
weak evidence of deprotonation from [M+2H]2+ to give
[M+H]+ but the main dissociation point is cleavage of the
C(1)–O bond (Figure 2) to create product ions
corresponding to protonated indolphenol and the propyl-
pyrrolidine arm. In an experiment akin to hECD, using
identical instrumental conditions to the EID experiments,
the impact of hotter electrons (electron energy=17.9 eV)
was able to induce a much greater degree of dissociation as
shown in Figure 6c. This spectrum closely resembles EID
of [M+H]+ (Figure 3b) and CID of [M+2H]2+ (Figure 6a)
in terms of relating product ions to structure. Overall, ECD
was of no benefit when characterising this small molecule
but hECD of the doubly charged species and EID of the
singly charged species are both informative suggesting that
the charge state of the precursor ion is not as crucial for
the electron based fragmentation techniques.
Conclusion
The electron energy required to generate the optimum mass
spectrum in terms of number of product ions and the S/N
ratio of the peaks is of the order of 18 eV, regardless of
whether the molecule is singly or doubly protonated,
although if this choice is presented, the doubly protonated
precursor ion would be more desirable. Using this value for
electron energy, rapid EID has been achieved on the LC
timescale and for compounds of a wide dynamic abundance.
Perhaps most importantly, LC-EID has proven to be a very
powerful tool in that it provided crucial information about
the identity and location of a molecular modification to an
impurity that would otherwise require preparative isolation
and NMR, a time-consuming and expensive alternative. This
solution facilitates identification and characterization at a
much earlier stage of drug development where sample may
be limited.
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